syndrome	score	normalized_score
DRAVET SYNDROME	2.6691683399999997	100.0
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	2.1832764639999995	81.79613219899048
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.14628166	80.41012729830297
HEMOGLOBIN--BETA LOCUS	2.136743	80.0527628017647
MYASTHENIA GRAVIS	2.078186619	77.85895658420705
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	2.0	74.92970638187624
AUTOIMMUNE HEPATITIS	1.9346259199999998	72.48047607218359
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	1.7851737999999997	66.88127433730912
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	1.672395449	62.65604997397804
OROTIC ACIDURIA	1.643402554	61.56983541922275
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	1.6331731	61.18659042688931
CHILDHOOD ABSENCE EPILEPSY	1.52074085	56.97433268671245
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	1.500545554	56.21771888692491
TETRAGAMETIC CHIMERISM	1.333333	49.953125099633105
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	1.327643269	49.73996016302217
LYSINURIC PROTEIN INTOLERANCE	1.3073542299999998	48.979834295501945
IGG4-RELATED RETROPERITONEAL FIBROSIS	1.2902239	48.338048996939634
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	1.2435070999999998	46.5878109433892
MYOCLONIC-ASTASTIC EPILEPSY	1.2312833539999999	46.12985009405589
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.72157046490368
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	1.1859649	44.43200086810562
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.1638665397927
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	1.1364273200000001	42.57608270597126
AMOEBIC KERATITIS	1.1	41.211338510031936
SARCOIDOSIS	1.0858456	40.68104599202612
MARFAN SYNDROME	1.0712766	40.13522054588734
MOWAT-WILSON SYNDROME; MOWS	1.0627031089999999	39.81401596423851
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	1.0588235	39.66866698261527
TETRASOMY 9P	1.048663443	39.288021938698705
HEPARIN-INDUCED THROMBOCYTOPENIA	1.0449486	39.14884589107632
BLAU SYNDROME	1.04234231	39.05120161885331
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	1.031564619	38.647417007801025
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	1.02867182	38.53903871795513
AORTA COARCTATION	1.02538772	38.41600039359076
MEVALONIC ACIDURIA; MEVA	1.020065344	38.2165983581238
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	1.0188679	38.17173629445942
FOLATE MALABSORPTION, HEREDITARY	1.014941243	38.02462466642326
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	1.011179719	37.88369972198907
LOWRY-MACLEAN SYNDROME	1.011067719	37.87950365843167
PAROXYSMAL KINESIGENIC DYSKINESIA	1.00980392	37.83215561443382
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	1.006569649	37.71098412623912
PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	1.00342466	37.593157575067
OCULOSKELETODENTAL SYNDROME; OCSKD	1.001197444	37.5097152546025
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	1.001197444	37.5097152546025
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	1.001193309	37.50956033743455
ATRESIA OF SMALL INTESTINE	1.00065189	37.48927615408476
ICHTHYOSIS AND MALE HYPOGONADISM	1.000541419	37.4851373742879
3-METHYLGLUTACONIC ACIDURIA TYPE 7	1.000541419	37.4851373742879
STICKLER SYNDROME, TYPE I	1.0	37.46485319093812
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	1.0	37.46485319093812
LAMBERT-EATON MYASTHENIC SYNDROME	1.0	37.46485319093812
TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD	1.0	37.46485319093812
BARBER-SAY SYNDROME; BBRSAY	1.0	37.46485319093812
ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA	1.0	37.46485319093812
CHROMOSOME 5Q DELETION SYNDROME	1.0	37.46485319093812
MOYAMOYA DISEASE 1; MYMY1	1.0	37.46485319093812
TEMPORAL ARTERITIS	1.0	37.46485319093812
PRIMARY PULMONARY HYPOPLASIA	1.0	37.46485319093812
BNAR SYNDROME	1.0	37.46485319093812
VASCULITIS, LYMPHOCYTIC, NODULAR	1.0	37.46485319093812
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	1.0	37.46485319093812
GRANULOMATOSIS WITH POLYANGIITIS	1.0	37.46485319093812
CHIARI MALFORMATION TYPE II	1.0	37.46485319093812
MYOCLONIC EPILEPSY OF LAFORA	0.96771307	36.25522809850202
LAFORA DISEASE	0.85382841	31.98855603090212
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.871056517926487
FANCONI ANEMIA	0.767400444	28.75054497312073
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	28.045400988084555
CONGENITAL TRACHEAL STENOSIS	0.7442684	27.883906340654413
AGEL AMYLOIDOSIS	0.742857	27.831028446860724
BLAU SYNDROME	0.71528501	26.798047889328707
EARLY MYOCLONIC ENCEPHALOPATHY	0.708728914	26.552424715183008
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.7	26.225397233656683
PHEOCHROMOCYTOMA	0.7	26.225397233656683
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.676035614	25.327575030355714
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.67357727	25.235473533302887
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.6685339199999999	25.046525165962368
DEXTROCARDIA	0.6674628539999999	25.006397835514566
CHILDHOOD DISINTEGRATIVE DISORDER	0.648192429	24.284434191962582
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.6297218	23.5924347881333
PAROXYSMAL HEMICRANIA	0.61322858	22.974518722187455
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6103603	22.86705903307695
ADDISON DISEASE	0.607684319	22.76680379777021
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.6042633789999999	22.6386387828952
ROLANDIC EPILEPSY	0.6004252200000001	22.49484271943673
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59639105	22.34370313263944
INHERITED CREUTZFELDT-JAKOB DISEASE	0.589369229	22.08063163974139
LEUKOCYTE ADHESION DEFICIENCY	0.5865817090000001	21.976197612174587
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.578550119	21.67529527193478
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.57635427	21.59302811152031
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.813808993403544
DILATED CARDIOMYOPATHY WITH ATAXIA	0.553173019	20.724545946023028
SICKLE CELL ANEMIA	0.5476190599999999	20.51646768745953
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5453812	20.432626591097662
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5435606000000001	20.364418079378243
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.541632059	20.292165573940537
CREST SYNDROME	0.5410301599999999	20.26961551626976
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.52623536	19.715330506280473
SITOSTEROLEMIA	0.52223601	19.565495445671292
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.52002806	19.482774923068362
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.52002806	19.482774923068362
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.519075659	19.447093359424457
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.517498954	19.38802233807404
ANEURYSM OF SINUS OF VALSALVA	0.5136986	19.245642633390446
LYMPHOID INTERSTITIAL PNEUMONIA	0.512987	19.21898264385977
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.511183854	19.151428043687947
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.5106383	19.13098894317022
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.5106383	19.13098894317022
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50980392	19.099729018964762
THROMBOCYTOPENIA, CYCLIC	0.50714286	19.000032796732487
CYCLIC NEUTROPENIA	0.50714286	19.000032796732487
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.996263457852947
MATTHEW-WOOD SYNDROME	0.50549451	18.938277605975205
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.504195194	18.889598922786565
MULTIPLE SULFATASE DEFICIENCY	0.501738863	18.797572842483216
PALLISTER-HALL SYNDROME	0.501738863	18.797572842483216
TRIGEMINAL NEURALGIA	0.5	18.73242659546906
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.5	18.73242659546906
BRANCHIOOTORENAL SYNDROME 1	0.5	18.73242659546906
INHALATIONAL ANTHRAX	0.5	18.73242659546906
CLUSTER HEADACHE, FAMILIAL	0.5	18.73242659546906
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.73242659546906
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.5	18.73242659546906
NK-CELL ENTEROPATHY	0.5	18.73242659546906
HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION ISUNKNOWN OR UNCERTAIN	0.5	18.73242659546906
PHOCOMELIA, SCHINZEL TYPE	0.5	18.73242659546906
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.5	18.73242659546906
GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD	0.5	18.73242659546906
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	0.48823819999999996	18.291772485207883
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.46217215999999994	17.315212123338764
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.4586633	17.183753198571207
AORTIC ANEURYSM, FAMILIAL THORACIC 6	0.4429828	16.596285568110705
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.43795096899999997	16.40776875841409
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.4366407	16.358679722688453
WILLIAMS SYNDROME	0.42545858999999997	15.939743613173532
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.420175039	15.741796150631698
THROMBOCYTOPENIA WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA	0.4166663	15.610341759111382
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415131304	15.552833359322705
NEUROMYELITIS OPTICA	0.4102561	15.37018455718683
SPINOCEREBELLAR ATAXIA TYPE 10	0.40889129999999996	15.319052525551836
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.39923477300000004	14.957272159162507
SHEEHAN SYNDROME	0.39560439999999997	14.821260767689159
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.39269791899999995	14.712369883721909
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.3862676400000001	14.471460425010141
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.385638	14.447871054846996
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.38145755000000003	14.29125110932494
FOCAL DERMAL HYPOPLASIA	0.37544414	14.06595958649802
TEMPI SYNDROME	0.37526015	14.05906642815942
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.367208019	13.757394522370218
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.3666667	13.737114085505752
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.3666667	13.737114085505752
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.658183507451616
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.36208931	13.565622841158085
EPIDERMAL NEVUS SYNDROME	0.360194354	13.494628592814795
PGM3-CDG	0.357796809	13.404804921371127
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.394346645067728
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.394346645067728
PLACENTAL INSUFFICIENCY	0.3572261	13.38342339247138
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.35550021	13.318763176997672
CENTRALOPATHIC EPILEPSY	0.3547009	13.288817145193624
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.35463122	13.286206594223279
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.353831473	13.256244190278386
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.35285309	13.219589214818875
MALIGNANT ATROPHIC PAPULOSIS	0.35125443900000003	13.159695989800332
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.350867364	13.145194281751449
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.350541419	13.132982800178128
PARAGANGLIOMAS 1	0.35	13.112698616828341
PARAGANGLIOMAS 3	0.35	13.112698616828341
PARAGANGLIOMAS 4	0.35	13.112698616828341
CARNEY COMPLEX	0.35	13.112698616828341
141700 HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES	0.35	13.112698616828341
HEINZ BODY ANEMIAS	0.35	13.112698616828341
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.34626999	12.972954339777612
COG4-CDG	0.345926754	12.960095053427768
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.345372854	12.939343271245306
CHÉDIAK-HIGASHI SYNDROME	0.34475772299999996	12.916297478637109
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.344263504	12.897781636357939
ESOPHAGEAL ATRESIA	0.3438593	12.88263819283875
MAJEED SYNDROME	0.34354254	12.870770825941987
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34324414999999997	12.859591688398343
HEMOLYTIC ANEMIA DUE TO RED CELL PYRUVATE KINASE DEFICIENCY	0.34285699999999997	12.84508717048547
POTOCKI-SHAFFER SYNDROME	0.341039523	12.776995661502566
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.752108771078863
ZIMMERMANN-LABAND SYNDROME	0.339368929	12.714407102550904
FAMILIAL PSEUDOHYPERKALEMIA	0.33675766	12.616576292823856
MALT LYMPHOMA	0.33652789	12.607967993506172
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.33507186299999997	12.553418155709132
ATAXIA-PANCYTOPENIA SYNDROME	0.33488595	12.546452952457843
KAPOSI SARCOMA	0.334656	12.53783790946659
HEREDITARY ACROKERATOTIC POIKILODERMA	0.33398489	12.512694871841617
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.333874419	12.508556092044762
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.333874419	12.508556092044762
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.33333330000000005	12.488283148150936
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.488271908694976
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.488271908694976
HEREDITARY SPHEROCYTOSIS	0.333333	12.488271908694976
WAGR 11P13 DELETION SYNDROME	0.333333	12.488271908694976
ENCEPHALOMALACIA, MULTILOCULAR	0.333333	12.488271908694976
XK APROSENCEPHALY SYNDROME	0.333333	12.488271908694976
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.488271908694976
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.333333	12.488271908694976
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.333333	12.488271908694976
PULMONARY EDEMA OF MOUNTAINEERS	0.333333	12.488271908694976
FAMILIAL DILATED CARDIOMYOPATHY	0.333333	12.488271908694976
BIRDSHOT CHORIORETINOPATHY	0.333333	12.488271908694976
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.32936450999999994	12.33959301345527
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.32582436	12.20696181343137
PITUITARY APOPLEXY	0.32485326000000003	12.170579694497654
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.31675640000000005	11.867232023290073
ACQUIRED VON WILLEBRAND SYNDROME	0.31610041	11.84265545424535
AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8	0.311111	11.655727941085951
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.303177154	11.35848756545644
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.3026316	11.338048464938709
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.3022207	11.322654156762553
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.30170260000000004	11.303243616324329
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.287463944668248
NON-FUNCTIONING PARAGANGLIOMA	0.30000000000000004	11.239455957281438
SICKLE CELL ANEMIA	0.29888811	11.197799161666964
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.298164554	11.170691242351543
TAKAYASU ARTERITIS	0.297985299	11.1639754800928
ISOLATED AGAMMAGLOBULINEMIA	0.29684689	11.121325154036557
H SYNDROME	0.29495819	11.050565285814834
FAMILIAL AORTIC DISSECTION	0.29256760000000004	10.96100218242511
OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.2884615	10.807167748737797
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.28625975400000003	10.724679658084064
NEUROFIBROMATOSIS TYPE 1	0.283891009	10.635934974412296
MENINGIOMA	0.28315414	10.608328285506339
PEDIATRIC-ONSET GRAVES DISEASE	0.28089331400000006	10.523626771326086
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.28022189000000003	10.498471969737212
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.27723610000000004	10.386609785728242
RHEUMATOID FACTOR-POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.2745725	10.286818402768857
POEMS SYNDROME	0.26778827	10.0326482218053
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.267416194	10.018708449089427
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.26650640000000003	9.984623150445433
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.26424946000000005	9.900067224684678
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.262589619	9.837881525299377
WT LIMB-BLOOD SYNDROME	0.2620482	9.817597341949591
PALLISTER-HALL SYNDROME	0.261723744	9.805441645542672
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.25930812	9.714940647018166
CARTILAGE-HAIR HYPOPLASIA; CHH	0.25899466	9.703196914136933
6P22 MICRODELETION SYNDROME	0.2588235	9.696784429864772
CHILBLAIN LUPUS	0.2567986	9.620921848638442
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.255629954	9.577138697816265
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.25549451	9.572064308240673
KIKUCHI-FUJIMOTO DISEASE	0.25415625	9.521926593809365
USHER SYNDROME	0.25364964	9.502946524534305
TRANSALDOLASE DEFICIENCY	0.25334194400000004	9.49141873906687
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.25185456	9.435694115868316
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.251680264	9.429164141816548
POLYARTERITIS NODOSA	0.25128496	9.41435413549076
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.2511215	9.408230130588167
SCHIZOPHRENIA 1; SCZD1	0.25065189	9.39063626088117
SIX2-RELATED FRONTONASAL DYSPLASIA	0.25065189	9.39063626088117
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.250545554	9.38665239825226
INSULINOMA	0.250541419	9.386497481084314
TUBERCULOSIS	0.25	9.36621329773453
PLEURAL MESOTHELIOMA	0.25	9.36621329773453
ASCITES, CHYLOUS	0.25	9.36621329773453
HYPERPARATHYROIDISM 2	0.25	9.36621329773453
FRONTOMETAPHYSEAL DYSPLASIA	0.25	9.36621329773453
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.25	9.36621329773453
RADIATION PROCTITIS	0.25	9.36621329773453
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.25	9.36621329773453
250700 METHEMOGLOBIN REDUCTASE DEFICIENCY;;NADPH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY;;TPNH-METHEMOGLOBIN REDUCTASE DEFICIENCY	0.25	9.36621329773453
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.25	9.36621329773453
NARCOLEPSY TYPE 1	0.25	9.36621329773453
SCHIZOPHRENIA	0.25	9.36621329773453
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.36621329773453
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.36621329773453
ATR-16 SYNDROME	0.25	9.36621329773453
DYSTONIA 6, TORSION	0.25	9.36621329773453
TAKAYASU ARTERITIS	0.25	9.36621329773453
HYPEREKPLEXIA 1; HKPX1	0.25	9.36621329773453
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.25	9.36621329773453
INFANTILE MYOFIBROMATOSIS	0.2478603	9.28604975136188
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.24709744	9.25746931345664
LENNOX-GASTAUT SYNDROME	0.24461951	9.16463402978922
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.24357002	9.125315041013863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.105651013378948
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.24285720000000002	9.098609344362298
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.239105429	8.95804979464128
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.2381579	8.922550759762123
BENIGN SCHWANNOMA	0.237037	8.8805564058204
GAMMA-HEAVY CHAIN DISEASE	0.23680549999999997	8.871883292306697
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.23661620000000003	8.864791195597654
PERIPARTUM CARDIOMYOPATHY	0.23637521	8.855762540627168
AICARDI-GOUTIÈRES SYNDROME	0.23431311300000002	8.778506379256696
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.23333330000000002	8.741797829057123
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.23327009999999998	8.739430050335455
CRI-DU-CHAT SYNDROME	0.23252151000000001	8.711384235885252
BETA-THALASSEMIA	0.23225810000000002	8.701515618906226
RELAPSING POLYCHONDRITIS	0.23123151000000003	8.66305457526894
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.22961429000000003	8.602465665391493
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.22943254000000002	8.59565642832404
CONGENITAL ENTEROVIRUS INFECTION	0.22920565	8.587156027783546
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.22761426	8.527534835064019
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.464402436303438
ENTHESITIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.225	8.429591967961079
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.223015463	8.355241580604094
COGAN SYNDROME	0.22206309000000002	8.31956106597608
NEUROLEPTIC MALIGNANT SYNDROME	0.22088799999999997	8.275536491639938
WILLIAMS-BEUREN SYNDROME; WBS	0.21945564999999997	8.221873709171899
DIAMOND-BLACKFAN ANEMIA 1	0.21832105	8.179366086741462
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.217498954	8.148566380792603
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.214831554	8.048632631391097
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.2140845	8.020644362955393
MELIOIDOSIS	0.21388890000000002	8.013316237671246
CONGENITAL AORTIC VALVE STENOSIS	0.212987	7.979526686578338
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.2127187	7.969474866467209
MALARIA	0.21222087000000003	7.950823738603166
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.21204820000000002	7.944354682402686
DISTAL TRISOMY 14Q	0.20965852999999998	7.854826046677895
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.20853262900000002	7.812644331005367
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.20832339000000002	7.8048052225885485
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.20714286	7.760576839451049
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.20704225	7.75680750057151
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.206581483	7.73954493256128
NIEMANN-PICK DISEASE, TYPE C2	0.206581483	7.73954493256128
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2061464	7.723244611840407
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.20612591	7.722476956998523
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424821999999998	7.652129576810431
POLYCYSTIC KIDNEYS	0.20342466	7.621275022316502
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.2030294	7.606466664444253
TUBEROUS SCLEROSIS COMPLEX	0.20127066	7.540575728543221
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.201086973	7.533693922055138
STICKLER SYNDROME	0.20065219	7.517404840790223
VASCULAR EHLERS-DANLOS SYNDROME	0.20036530400000002	7.506656698917688
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.492970638187625
ACQUIRED PURPURA FULMINANS	0.2	7.492970638187625
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5	0.2	7.492970638187625
HEREDITARY ELLIPTOCYTOSIS	0.2	7.492970638187625
ANEURYSM, INTRACRANIAL BERRY, 2	0.2	7.492970638187625
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.492970638187625
ANEURYSM, INTRACRANIAL BERRY, 3	0.2	7.492970638187625
JUVENILE HYALINE FIBROMATOSIS	0.2	7.492970638187625
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.2	7.492970638187625
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.492970638187625
HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS	0.2	7.492970638187625
PAROXYSMAL COLD HEMOGLOBINURIA	0.19982114	7.486269674545894
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.1989247	7.45268468155141
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.197917	7.414931348990901
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.197917	7.414931348990901
WALDENSTRÖM MACROGLOBULINEMIA	0.19750813	7.399613094466721
SNEDDON SYNDROME	0.19579720900000003	7.33551369038043
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.19482519	7.299097141246626
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	7.28482715331473
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	7.28482715331473
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	7.28482715331473
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	7.28482715331473
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	7.28482715331473
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	7.28482715331473
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	7.28482715331473
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.193334014	7.243230451324775
MYOCLONIC EPILEPSY OF INFANCY	0.193334014	7.243230451324775
CRISS-CROSS HEART	0.192857	7.2253591918447535
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.19148626000000002	7.174004618981808
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.19087177399999997	7.150982991203919
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.19004364	7.119957072471496
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	0.1888892	7.076706147353749
NEONATAL LUPUS ERYTHEMATOSUS	0.18462666	6.917010712033248
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.18379026	6.885675108824348
REFRACTORY ANEMIA	0.18333336000000003	6.868557417401408
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.855142752067859
UNILATERAL POLYMICROGYRIA	0.1817003	6.807375064249414
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.18162100400000003	6.804404251250787
PANNICULITIS-INDUCED LOCALIZED LIPODYSTROPHY	0.1813185	6.793070983301114
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.18120235999999998	6.788719815251517
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.179894	6.739702299930622
IMMUNODEFICIENCY 16	0.17871520000000002	6.695538730989145
PULMONARY ARTERIOVENOUS MALFORMATION	0.17856649900000002	6.6899676698548
CLASSIC MYCOSIS FUNGOIDES	0.17777769999999998	6.660415431122639
SUPRAVALVULAR AORTIC STENOSIS	0.1773398	6.6440095719103285
FELTY SYNDROME	0.17730796000000001	6.642816690984729
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.17614356300000003	6.599192728323762
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.17315999999999998	6.487413978542844
COWDEN SYNDROME	0.172055503	6.446034160588014
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.17176456	6.435134023806083
SYSTEMIC SCLEROSIS	0.171495509	6.425054067590207
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.171403613	6.421611197441374
MICROSPORIDIOSIS	0.170382719	6.383363553607863
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.17031664000000002	6.38088791357386
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.17030797900000003	6.3805634304803736
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.170082364	6.3721107976277
HYDRANENCEPHALY	0.167753973	6.284877970641597
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.167753973	6.284877970641597
MUCOLIPIDOSIS TYPE II	0.16731889	6.268577649920724
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.264438870123869
PSEUDOXANTHOMA ELASTICUM; PXE	0.16712326000000002	6.261248400690983
CEREBROOCULONASAL SYNDROME	0.166667	6.244154686774085
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.166667	6.244154686774085
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.244154686774085
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2	0.166667	6.244154686774085
DERMATOLEUKODYSTROPHY	0.166667	6.244154686774085
STICKLER SYNDROME TYPE 1	0.166667	6.244154686774085
STICKLER SYNDROME TYPE 2	0.166667	6.244154686774085
ULBRIGHT-HODES SYNDROME	0.166667	6.244154686774085
CAUDAL DUPLICATION	0.166667	6.244154686774085
STICKLER SYNDROME, TYPE II	0.166667	6.244154686774085
CONGENITAL PRIMARY MEGAURETER	0.166667	6.244154686774085
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.1666667	6.244143447318127
FRONTOTEMPORAL DEMENTIA; FTD	0.1666667	6.244143447318127
IMMUNODEFICIENCY 23; IMD23	0.165822954	6.212532627297685
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.164156114	6.150084711404902
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.1634615	6.1240610998705325
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.1634615	6.1240610998705325
PSEUDOXANTHOMA ELASTICUM	0.16139346	6.046582284877545
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.16116350000000002	6.037966867237757
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.16115017	6.037467460744721
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.1607143	6.021137655184386
OGDEN SYNDROME	0.160028354	5.995438788997475
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.975857633617819
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.975857633617819
SANDHOFF DISEASE	0.159364919	5.970583294120745
ACERULOPLASMINEMIA	0.15898980999999998	5.956529890505145
SLC35A2-CDG	0.158977244	5.956059107159948
JEJUNAL NEUROENDOCRINE TUMOR	0.1583333	5.931933839736763
ILEAL NEUROENDOCRINE TUMOR	0.1583333	5.931933839736763
DUODENAL NEUROENDOCRINE TUMOR	0.1583333	5.931933839736763
NEUROENDOCRINE TUMOR OF STOMACH	0.1583333	5.931933839736763
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.15810009	5.923196661324105
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.157504479	5.9008821826501965
VON HIPPEL-LINDAU DISEASE	0.15538538000000002	5.821490449718134
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.1549052	5.803500576512908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.803187894848175
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.719452449372301
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.719452449372301
GITELMAN SYNDROME	0.15220174	5.702215844505335
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.151852749	5.689140947925376
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.6793532924940955
BURKITT LYMPHOMA	0.1513227	5.6692827399563726
ADENOHYPOPHYSITIS	0.15098074	5.656471258759199
PANHYPOPHYSITIS	0.15098074	5.656471258759199
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.15065538299999998	5.644281806519555
MELAS	0.14947458000000002	5.600043195477136
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.14900339999999998	5.582390505950629
STEINERT MYOTONIC DYSTROPHY	0.14835151	5.557967542803988
WOLFRAM-LIKE SYNDROME	0.14835151	5.557967542803988
NORMAL PRESSURE HYDROCEPHALUS	0.14835151	5.557967542803988
GIANT CELL ARTERITIS	0.14822364999999998	5.553177286674995
GRANULOMATOSIS WITH POLYANGIITIS	0.148168719	5.551119304824364
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.1479991	5.54476455389097
RHEUMATOID ARTHRITIS	0.1473416	5.520131412917928
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.14715852999999998	5.513272722244262
ARTERIAL TORTUOSITY SYNDROME	0.146626114	5.493325834967757
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14650664	5.488849759097623
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.14605721	5.472011930128019
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.14605189	5.471812617109043
CHRONIC GRANULOMATOUS DISEASE	0.1458333	5.463623174850037
ACUTE MONOBLASTIC LEUKEMIA	0.1458333	5.463623174850037
COLCHICINE POISONING	0.1438679	5.3899897523885665
AUTOIMMUNE HYPOPARATHYROIDISM	0.1435898	5.379570776716166
JUVENILE POLYPOSIS OF INFANCY	0.14350888999999997	5.376539495444487
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.372555632815576
RHESUS BLOOD GROUP, CCEE ANTIGENS; RHCE	0.14285699999999998	5.352116532297846
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.14285699999999998	5.352116532297846
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.352116532297846
SUPRAVALVULAR AORTIC STENOSIS	0.14285699999999998	5.352116532297846
ERYTHEMA ELEVATUM DIUTINUM	0.14285699999999998	5.352116532297846
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.14285699999999998	5.352116532297846
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.14285699999999998	5.352116532297846
ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY; SIDBA2	0.14285699999999998	5.352116532297846
HEREDITARY MIXED POLYPOSIS SYNDROME	0.14285699999999998	5.352116532297846
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.14285699999999998	5.352116532297846
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.352116532297846
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.14285699999999998	5.352116532297846
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	5.352116532297846
BLACKFAN-DIAMOND ANEMIA	0.14261261	5.342960496826514
ATYPICAL WERNER SYNDROME	0.14255374999999998	5.340755315567694
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.14215680000000003	5.325883642093554
CHOPS SYNDROME; CHOPS	0.142106544	5.324000808431588
ARTERIAL TORTUOSITY SYNDROME	0.14180356	5.312649557352386
OMENN SYNDROME	0.14135269	5.295757778994187
AUTOIMMUNE HEMOLYTIC ANEMIA	0.14127314	5.2927774499228475
TURNER SYNDROME	0.14122625000000003	5.291020722956726
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.14122625000000003	5.291020722956726
MOSAIC MONOSOMY X	0.14122625000000003	5.291020722956726
MONOSOMY X	0.14122625000000003	5.291020722956726
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.141017619	5.283204393170647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089111	5.278464752058314
1P36 DELETION SYNDROME	0.140266963	5.255081176333749
MUCKLE-WELLS SYNDROME	0.13978809	5.237140269691645
BRONCHIAL NEUROENDOCRINE TUMOR	0.1388889	5.203452248350886
LYSOSOMAL ACID LIPASE DEFICIENCY	0.138184614	5.177066276756453
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.15391636932124
CHRONIC GRAFT VERSUS HOST DISEASE	0.13729243	5.143640734177148
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.13705187300000002	5.134628301488097
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.124778079751989
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.136725273	5.122392280435936
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.13617971899999998	5.1019531799182065
NASU-HAKOLA DISEASE	0.13617971899999998	5.1019531799182065
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.13604833400000002	5.097030860181716
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.1359649	5.093905017620583
EVANS SYNDROME	0.1359509	5.09338050967591
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.13589679999999998	5.091353661118279
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.13560496	5.080419918363036
22Q11.2 DELETION SYNDROME	0.13501677299999998	5.0583835787592175
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.13489375000000003	5.053774540125111
BEHCET SYNDROME	0.13400901	5.020627885912959
SECONDARY POLYCYTHEMIA	0.1336106	5.0057015137531575
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.963295046426334
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.13210975	4.949472388841538
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.13036414400000002	4.884073516322317
ALSTRÖM SYNDROME	0.12961112300000002	4.855861695107625
SMITH-MAGENIS SYNDROME; SMS	0.129276773	4.8433353214432335
DIABETIC EMBRYOPATHY	0.1291667	4.839211452657946
CINCA SYNDROME	0.128245564	4.804701227649059
KABUKI SYNDROME 1	0.126571663	4.741988772427895
RAMON SYNDROME	0.126193309	4.727813795363691
DOORS SYNDROME	0.125523904	4.70273463531341
NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE	0.1254902	4.701471919901463
AAPOAIV AMYLOIDOSIS	0.1254902	4.701471919901463
YOUNG-ONSET PARKINSON DISEASE	0.125	4.683106648867265
CARIBBEAN PARKINSONISM	0.125	4.683106648867265
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.12477223900000001	4.674573616439645
PHACE ASSOCIATION	0.12465609300000001	4.67022222360093
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.12456896	4.666957798547844
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.1245155	4.664954927496256
INSULIN-RESISTANCE SYNDROME TYPE B	0.1243201	4.6576342951827465
INTERMEDIATE UVEITIS	0.12272730000000001	4.597960277020221
ZIMMERMANN-LABAND SYNDROME 1	0.12270051900000001	4.596956930786914
BETA-THALASSEMIA INTERMEDIA	0.12251386	4.589963778755147
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.12197415400000002	4.569743772698878
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.121907154	4.567233627535085
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.12180288999999998	4.563327392081985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	4.53009321997278
CHARGE SYNDROME	0.12067794400000001	4.521181455344252
NON-HISTAMINIC ANGIOEDEMA	0.12063480999999998	4.519565446366713
ATRANSFERRINEMIA	0.12037030000000001	4.50965561804918
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.119952919	4.494018500159493
GRAFT VERSUS HOST DISEASE	0.11827941	4.4313207311607785
FAMILIAL BICUSPID AORTIC VALVE	0.11784706	4.415122801883677
AICARDI SYNDROME; AIC	0.1177712	4.412280718120612
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.117647	4.407627583354298
EISENMENGER SYNDROME	0.11745177000000001	4.400313320065831
DOWN SYNDROME	0.11739921	4.398344167382115
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.11712576300000002	4.388099515671613
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.11689349000000002	4.379397441826394
BILATERAL POLYMICROGYRIA	0.116708964	4.372484202326483
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.11667837300000002	4.371338115002519
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.116674229	4.371182860650896
HAMAMY SYNDROME; HMMS	0.11559140000000001	4.330614831135005
HOYERAAL-HREIDARSSON SYNDROME	0.11550333399999999	4.327315451373892
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.11495777999999998	4.306876350856162
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.11491896	4.305421965255291
HOLOPROSENCEPHALY	0.11485561300000001	4.303048679200205
SECKEL SYNDROME 10; SCKL10	0.11453565999999998	4.291061687027203
GOOD SYNDROME	0.11430589	4.282453387709522
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.11384860000000002	4.265321084993839
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.11369860000000001	4.259701357015198
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.11344080000000001	4.250042917862574
AL AMYLOIDOSIS	0.11338956	4.24812321878507
HUGHES-STOVIN SYNDROME	0.11329120000000001	4.244438175825209
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.237098811085104
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.112882339	4.229120258484709
HASHIMOTO THYROIDITIS	0.11263740000000001	4.219943654808974
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.11230430899999999	4.207464449394751
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.1122428	4.20516002373983
SANDHOFF DISEASE	0.11204820000000001	4.1978693633088735
SNEDDON SYNDROME	0.11201231900000001	4.19652508691153
CAREY-FINEMAN-ZITER SYNDROME	0.11176288999999999	4.187180266044966
MICROVILLUS INCLUSION DISEASE	0.11165655399999999	4.183196403416054
JOUBERT SYNDROME 2	0.11165655399999999	4.183196403416054
ACUTE INTERMITTENT PORPHYRIA	0.11165241899999999	4.18304148624811
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.11112849999999999	4.163412937829166
REFSUM DISEASE	0.11111099999999999	4.162757302898325
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	4.162757302898325
LOEYS-DIETZ SYNDROME 3; LDS3	0.11111099999999999	4.162757302898325
WELL-DIFFERENTIATED LIPOSARCOMA	0.11111099999999999	4.162757302898325
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.11111099999999999	4.162757302898325
JESSNER LYMPHOCYTIC INFILTRATION OF THE SKIN	0.11111099999999999	4.162757302898325
NEUTROPHIL CHEMOTACTIC RESPONSE	0.11111099999999999	4.162757302898325
AORTIC ANEURYSM, ABDOMINAL	0.11111099999999999	4.162757302898325
INTERSTITIAL GRANULOMATOUS DERMATITIS WITH ARTHRITIS	0.11111099999999999	4.162757302898325
GREENBERG DYSPLASIA	0.11111099999999999	4.162757302898325
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.11111099999999999	4.162757302898325
SÉZARY SYNDROME	0.11111099999999999	4.162757302898325
RING CHROMOSOME 13 SYNDROME	0.11111099999999999	4.162757302898325
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.11111099999999999	4.162757302898325
PAGOD SYNDROME	0.11077089000000001	4.150015131679556
KAWASAKI DISEASE	0.11040813	4.136424381536011
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.109945	4.119073284077692
YUNIS-VARON SYNDROME	0.109461904	4.100974163360562
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.10918121	4.090458003858985
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.10909864	4.087364530931009
KLIPPEL-TRÉNAUNAY SYNDROME	0.10844860999999999	4.063011252411304
WISKOTT-ALDRICH SYNDROME	0.10797127000000001	4.045127779389142
INSULIN AUTOIMMUNE SYNDROME	0.1072261	4.017210094736851
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000002	3.99970516659133
FONTAINE PROGEROID SYNDROME; FPS	0.10666075	3.9960293399853533
ELLIS VAN CREVELD SYNDROME	0.1064618	3.9885757074430157
SCRUB TYPHUS	0.105917759	3.968193291248165
ALAGILLE SYNDROME 1; ALGS1	0.1052706	3.943947574321971
COMBINED IMMUNODEFICIENCY DUE TO PARTIAL RAG1 DEFICIENCY	0.10470090000000001	3.922603847459094
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.10394717	3.8943654636634877
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.10388836400000001	3.892162305506742
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.10382639	3.889840458695086
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.103574954	3.880420445868169
GAUCHER DISEASE, TYPE II	0.10348826300000001	3.8771725802801944
KINDLER SYNDROME	0.10319489000000001	3.866181403905009
MARFAN SYNDROME; MFS	0.1025266	3.8411440171660365
NEONATAL MARFAN SYNDROME	0.1025266	3.8411440171660365
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.10220120000000002	3.828952953937706
RENPENNING SYNDROME 1; RENS1	0.10119330900000001	3.791192465590238
6Q TERMINAL DELETION SYNDROME	0.10108697300000001	3.7872086029613263
COMMON VARIABLE IMMUNODEFICIENCY	0.10077069999999999	3.775359481448068
9Q31.1Q31.3 MICRODELETION SYNDROME	0.10065189000000001	3.770908282240453
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.10054555400000001	3.7669244196115415
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.100541419	3.766769502443597
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.100232149	3.7551827472972357
GRANGE SYNDROME; GRNG	0.1	3.7464853190938125
CRYPTOSPORIDIOSIS	0.1	3.7464853190938125
ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO	0.1	3.7464853190938125
NEUROTROPHIC KERATOPATHY	0.1	3.7464853190938125
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.1	3.7464853190938125
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.1	3.7464853190938125
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.1	3.7464853190938125
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.1	3.7464853190938125
IMMUNODEFICIENCY 15A; IMD15A	0.1	3.7464853190938125
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.1	3.7464853190938125
ARNOLD-CHIARI MALFORMATION TYPE I	0.1	3.7464853190938125
PEROXISOME BIOGENESIS DISORDER 11B	0.1	3.7464853190938125
KINDLER SYNDROME; KNDLRS	0.1	3.7464853190938125
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.1	3.7464853190938125
MENKES DISEASE	0.09968671900000001	3.734748292421302
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.09957260000000001	3.730472840840006
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.09913806	3.714192863534415
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.707263514147632
ACUTE ADRENAL INSUFFICIENCY	0.098826519	3.7025210257064574
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.09882350000000001	3.7024079193146737
8P23.1 MICRODELETION SYNDROME	0.098721663	3.6985926110602683
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.6863112950006003
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.09814247300000001	3.6768933427406085
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.676120705073252
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.676120705073252
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.676120705073252
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.676120705073252
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.676120705073252
3M SYNDROME	0.09793689	3.6691912058270555
PLAGUE	0.09771865000000002	3.661014876266666
WERNER SYNDROME	0.09738285	3.6484341785651484
STORMORKEN SYNDROME; STRMK	0.09698400000000001	3.633491321869944
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.096945029	3.6320312790762386
TAY-SACHS DISEASE; TSD	0.096945029	3.6320312790762386
FAMILIAL CERVICAL ARTERY DISSECTION	0.09656188000000002	3.6176766580409843
NODULAR NON-SUPPURATIVE PANNICULITIS	0.09649120000000001	3.6150286422174496
MOHR-TRANEBJAERG SYNDROME	0.09640361	3.6117470957264546
MIRAGE SYNDROME; MIRAGE	0.095842853	3.5907384170456638
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.09564571300000001	3.583352595887602
MUCOPOLYSACCHARIDOSIS TYPE 2	0.09544132300000001	3.575695154543906
OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS	0.09496120000000001	3.5577074168353136
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.094875179	3.5544846526989757
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.09474556900000002	3.549628833076899
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.09432294000000002	3.533795099637666
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.0942983	3.5328719656550405
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.09427282000000001	3.5319173611957355
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.09426257900000001	3.5315336836342075
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.09374142999999999	3.5120089128586023
WAARDENBURG SYNDROME TYPE 2	0.09369369999999999	3.510220715415799
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.093527439	3.503991771459421
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.4894072660849864
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.09313722000000002	3.4893722739121067
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.09285711000000002	3.478877993884793
INTESTINAL LYMPHANGIECTASIA	0.09285711000000002	3.478877993884793
PELIZAEUS-MERZBACHER DISEASE	0.09264796300000001	3.4710423322344677
TAY-SACHS DISEASE	0.09199607300000001	3.446619369087827
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.09199607300000001	3.446619369087827
PMM2-CDG	0.09199607300000001	3.446619369087827
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.09199607300000001	3.446619369087827
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.09193871	3.4444702727142347
CHROMOSOME 1P36 DELETION SYNDROME	0.09162207299999998	3.432607513994415
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.09145051900000001	3.4261802685700977
HUNTINGTON DISEASE-LIKE 3	0.09145051900000001	3.4261802685700977
WIEDEMANN-STEINER SYNDROME	0.09145051900000001	3.4261802685700977
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0914352	3.4256063444840654
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.09113168300000002	3.414235124638112
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0910714	3.4119766308932022
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.09104495900000001	3.410986022709981
ALG12-CDG	0.09104454000000001	3.4109703249364935
X-LINKED DYSTONIA-PARKINSONISM	0.0909091	3.4058960852203133
AUTOSOMAL DOMINANT COARCTATION OF AORTA	0.0909091	3.4058960852203133
CLEFT VELUM	0.0909091	3.4058960852203133
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.09063796900000001	3.3957382021098015
KRABBE DISEASE	0.090614919	3.394874637243749
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.090086344	3.3750716524683493
KEARNS-SAYRE SYNDROME; KSS	0.09002111900000001	3.372628007418971
SIALIDOSIS TYPE 2	0.089977573	3.370996562921918
FABRY DISEASE	0.089510609	3.353501825216465
NON-FUNCTIONING PITUITARY ADENOMA	0.08925105900000001	3.343777822570757
X SMALL RINGS	0.088837804	3.3282952846653355
CLASSICAL EHLERS-DANLOS SYNDROME	0.08880671000000001	3.327130352520217
MULTIPLE CARBOXYLASE DEFICIENCY	0.08806991300000001	3.2995263610836933
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.08745101900000002	3.276339588232941
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.08729937900000001	3.270658417895067
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0866013	3.2445049906443897
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.086582199	3.2437893744835895
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.08648031400000002	3.2399722679162317
PLUMMER-VINSON SYNDROME	0.08596490000000001	3.220662358073677
SCHINZEL-GIEDION SYNDROME	0.08551310000000001	3.203735737402011
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.08520094	3.1920407088299276
RFT1-CDG	0.08507216300000002	3.187216097430559
SJÖGREN-LARSSON SYNDROME	0.08452660900000002	3.1667769969128297
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.08449164399999999	3.1654670383210077
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.08442027300000002	3.162793134283918
KEUTEL SYNDROME; KTLS	0.08406617899999999	3.149527054558125
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.08403317	3.1482903772191455
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08398519000000002	3.1464928135630448
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.08387885400000002	3.1425089509341335
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08387471900000001	3.142354033766189
HISTIOCYTOID CARDIOMYOPATHY	0.08387471900000001	3.142354033766189
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08387471900000001	3.142354033766189
603529 DYSERYTHROPOIESIS, CONGENITAL, WITH ULTRASTRUCTURALLY NORMAL ERYTHROBLASTHETEROCHROMATIN	0.08333330000000001	3.122069850416404
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.08333330000000001	3.122069850416404
ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT	0.08333330000000001	3.122069850416404
DPM3-CDG	0.08333330000000001	3.122069850416404
MYCETOMA	0.08333330000000001	3.122069850416404
BULLOUS IMPETIGO	0.08333330000000001	3.122069850416404
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.08333330000000001	3.122069850416404
UVEAL MELANOMA	0.08333330000000001	3.122069850416404
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.08333330000000001	3.122069850416404
BIRDSHOT CHORIORETINOPATHY	0.08333330000000001	3.122069850416404
FAMILIAL MELANOMA	0.08333330000000001	3.122069850416404
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.08333330000000001	3.122069850416404
MARSHALL-SMITH SYNDROME; MRSHSS	0.08311772	3.1139931773655016
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.0830565	3.1116995790531523
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0829801	3.1088372642693645
NOONAN SYNDROME	0.08275369	3.1003548468584046
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.082451209	3.0890224406003557
AMERICAN TRYPANOSOMIASIS	0.08229944	3.0833364372964205
MU-HEAVY CHAIN DISEASE	0.08190979	3.0687382572505713
DENT DISEASE	0.0810457	3.0363652522568136
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0810457	3.0363652522568136
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.08099965	3.0346399957673715
VIPOMA	0.08095241	3.032870156102631
GLUCAGONOMA	0.08095241	3.032870156102631
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.08078009	3.026414212600769
GLYCOGEN STORAGE DISEASE IV	0.08039551	3.0120059793605978
GRANGE SYNDROME	0.08034776	3.0102170326207305
ACQUIRED HEMOPHILIA	0.08011799000000001	3.0016087333030494
IDIOPATHIC BRONCHIECTASIS	0.08010010000000001	3.000938487079463
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.079492954	2.9781918513239978
DUBOWITZ SYNDROME	0.079094119	2.96324955660159
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.961327272449216
PACHYDERMOPERIOSTOSIS	0.0788706	2.9548754500812042
OCULORENOCEREBELLAR SYNDROME	0.0787149	2.949042172439375
KASABACH-MERRITT SYNDROME	0.07857146000000001	2.9436682138976673
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.07841032	2.9376311274544795
MICROSCOPIC POLYANGIITIS	0.07822751	2.930782177642644
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.07810364	2.9261414062778823
GAPO SYNDROME	0.07799389	2.922029638640177
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.07798160000000001	2.9215691955944605
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.07784329000000001	2.916387431749622
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.07774309000000001	2.9126334534598906
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.902351749009582
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.902351749009582
FADD-RELATED IMMUNODEFICIENCY	0.07746451900000001	2.9021968318416373
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.07735301900000001	2.8980195007108476
NIEMANN-PICK DISEASE TYPE B	0.07713028999999999	2.8896749914244824
POTOCKI-LUPSKI SYNDROME	0.077097763	2.888456372144741
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.07703760399999998	2.8862025240416265
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.07692310000000001	2.8819126484918525
PEMPHIGUS VULGARIS, FAMILIAL	0.07692310000000001	2.8819126484918525
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8819126484918525
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.8819126484918525
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.07692310000000001	2.8819126484918525
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.07692310000000001	2.8819126484918525
AUTOIMMUNE DISEASE	0.07692310000000001	2.8819126484918525
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.07688535	2.8804983502838946
JUVENILE XANTHOGRANULOMA	0.07681160000000001	2.877735317361063
HELLP SYNDROME	0.07680494000000002	2.8774858014388114
MEDULLOBLASTOMA	0.076238234	2.8562542443463874
ACQUIRED PARTIAL LIPODYSTROPHY	0.076199319	2.854796299584462
TYROSINEMIA, TYPE I; TYRSN1	0.07619050999999999	2.8544662716927025
ALPHA-THALASSEMIA	0.07610703999999999	2.851339080396855
BUSCHKE-OLLENDORFF SYNDROME	0.07558556	2.8318019087548447
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.07540011	2.824854051730586
RHOMBENCEPHALOSYNAPSIS	0.0753589	2.823310125130587
ALKAPTONURIA	0.07532480999999999	2.8220329482853077
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.07513815400000001	2.8150399086481004
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.07464605	2.796603304533427
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.07461872	2.7955793900957184
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.07454820000000001	2.7929373686486936
MIXED CONNECTIVE TISSUE DISEASE	0.07425668900000001	2.78201595183015
WHIM SYNDROME	0.07380956	2.7652643294877386
REVESZ SYNDROME	0.073777854	2.764076468852467
GRISCELLI SYNDROME	0.073762673	2.7635077149161753
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.07357727	2.7565616187400157
KOOLEN-DE VRIES SYNDROME; KDVS	0.073549173	2.75550896875991
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.073391543	2.7496033839514227
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.07337811	2.7491001185785082
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.07336580000000001	2.7486389262357287
SCLERODERMA	0.07326708900000001	2.7449407331123976
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.730948397207499
CRYPTOCOCCOSIS	0.072796159	2.727297409799189
DERMATOMYOSITIS	0.07276647	2.7261851157728034
OROFACIODIGITAL SYNDROME IX; OFD9	0.07262604400000001	2.7209240762986133
OROFACIODIGITAL SYNDROME VIII; OFD8	0.07262604400000001	2.7209240762986133
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0719814	2.696772583478193
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.07197415400000001	2.6965011131519723
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.6965011131519723
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.6965011131519723
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.071830223	2.6911087593673466
ATYPICAL HEMOLYTIC UREMIC SYNDROME	0.07142860000000001	2.6760620126342434
DIAMOND-BLACKFAN ANEMIA 13; DBA13	0.07142860000000001	2.6760620126342434
OCULOPHARYNGODISTAL MYOPATHY	0.07142860000000001	2.6760620126342434
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.6760620126342434
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.6760620126342434
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.07142860000000001	2.6760620126342434
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07130739999999999	2.671521272427501
BRONCHOPULMONARY DYSPLASIA	0.0712766	2.67036735494922
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.07125146	2.66942548854
MEACHAM SYNDROME	0.07113230000000001	2.664961176633768
CONGENITAL RUBELLA SYNDROME	0.07105489899999999	2.662061359531936
FANCONI-LIKE SYNDROME	0.07087170000000001	2.65519783589221
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6517398299426858
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.07074325	2.6503854754998333
CLASSIC PHENYLKETONURIA	0.070548773	2.643099423245819
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.07054724400000001	2.6430421394852908
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.07051347999999999	2.6417771761821514
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07051347999999999	2.6417771761821514
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.07019114	2.6297007554045844
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.06986159	2.6173542130355107
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.06921141	2.5929953147878266
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.06921141	2.5929953147878266
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.06916125	2.591116077751769
ACROOSTEOLYSIS DOMINANT TYPE	0.06901523	2.5856454598888283
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.573599385642346
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.068405563	2.562804375238469
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.068405563	2.562804375238469
IMMUNODEFICIENCY 52; IMD52	0.06833931	2.5603222163200092
JEUNE SYNDROME	0.06825559	2.5571856588108646
PRIMARY SCLEROSING CHOLANGITIS	0.06806321000000001	2.549978170353992
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.06785990900000001	2.542361528235421
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0677778	2.539285326604766
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.067633514	2.5338796727972586
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.06735561400000001	2.523468190095497
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.06734583	2.5231016339718764
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06731859	2.5220810913709553
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06731859	2.5220810913709553
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.06731859	2.5220810913709553
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.06731859	2.5220810913709553
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.067212254	2.5180972287420436
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.067212254	2.5180972287420436
PETERS PLUS SYNDROME	0.067212254	2.5180972287420436
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.517942311574099
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.06708796	2.513440572279529
ICF SYNDROME	0.066892334	2.5061114729091987
DYSKERATOSIS CONGENITA	0.066892334	2.5061114729091987
SYNDROMIC DIARRHEA	0.06673235400000001	2.500117845695713
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.497658128224314
MANTLE CELL LYMPHOMA	0.0666667	2.497658128224314
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.0666667	2.497658128224314
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.497658128224314
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.497658128224314
CONGENITAL UNILATERAL PULMONARY HYPOPLASIA	0.0666667	2.497658128224314
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0666667	2.497658128224314
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.497658128224314
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.497658128224314
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.497658128224314
DUODENAL ATRESIA	0.0666667	2.497658128224314
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.066466414	2.490154442638114
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.06625974400000001	2.4824115814291434
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.06614964	2.478286551233408
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0660173	2.4733284525621193
BARE LYMPHOCYTE SYNDROME, TYPE II	0.06596636	2.471419992940573
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.06592466	2.4698577085625106
GOODPASTURE SYNDROME	0.0657895	2.464793959005224
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.06571419	2.461972480911414
RETICULAR DYSGENESIS	0.06569489	2.461249409244829
UMBILICAL CORD ULCERATION-INTESTINAL ATRESIA SYNDROME	0.06569489	2.461249409244829
STEVENS-JOHNSON SYNDROME	0.06569489	2.461249409244829
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.06567971	2.4606806927733906
RETT SYNDROME; RTT	0.065511319	2.4543719486797153
NEPHRONOPHTHISIS 1	0.06544305	2.4518142606172235
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.06541155400000001	2.4506342676011217
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.0650623	2.4375495177647735
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.0650623	2.4375495177647735
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.0650623	2.4375495177647735
CAT-EYE SYNDROME	0.0649699	2.434087765329931
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0648604	2.429985363905523
ACROCEPHALOPOLYDACTYLY	0.06467980000000001	2.42321921141924
MONOSOMY 22	0.06467980000000001	2.42321921141924
POLYMYOSITIS	0.06450201	2.4165583351704227
JUVENILE DERMATOMYOSITIS	0.06450201	2.4165583351704227
INIENCEPHALY	0.06431801	2.40966480218329
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.409424652474336
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.0642595	2.407472733623088
MATERNAL PHENYLKETONURIA	0.064244873	2.406924735215464
2Q37 MICRODELETION SYNDROME	0.06423886300000001	2.406699571447787
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.06418444400000001	2.404660771601989
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.06418444400000001	2.404660771601989
CHROMOSOME 18Q DELETION SYNDROME	0.064180309	2.4045058544340447
CYSTIC FIBROSIS	0.0640845	2.4009163843146744
MUCOLIPIDOSIS IV; ML4	0.064037654	2.399161305802091
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.064030564	2.3988956799929677
MYELOPEROXIDASE DEFICIENCY	0.0638946	2.3938018086937145
COMPLEMENT COMPONENT C1R DEFICIENCY	0.06383360999999999	2.391516827297599
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.063703454	2.38664055186568
SHWACHMAN-DIAMOND SYNDROME	0.06370110400000001	2.386552509460681
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.06349210000000001	2.378722205284363
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.06349210000000001	2.378722205284363
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.06345742	2.3774229241757006
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.06345714	2.377412434016807
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.06322340900000001	2.368655736415636
OSLAM SYNDROME	0.06315189	2.3659762875802732
STORM SYNDROME	0.062987	2.3597987079376197
AORTIC VALVE DISEASE 1; AOVD1	0.062987	2.3597987079376197
COCAINE EMBRYOFETOPATHY	0.0627273	2.350069085563933
RECOMBINANT 8 SYNDROME	0.062596773	2.345178910671479
GAUCHER DISEASE, TYPE IIIC	0.062589619	2.3449108871117517
HOLT-ORAM SYNDROME	0.0625	2.3415533244336326
BARTH SYNDROME	0.0625	2.3415533244336326
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.0625	2.3415533244336326
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0625	2.3415533244336326
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.0625	2.3415533244336326
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.0625	2.3415533244336326
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0625	2.3415533244336326
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.062455790000000004	2.3398970032740616
COACH SYNDROME	0.062448133	2.3396101348931784
DISTAL MONOSOMY 15Q	0.062265163000000005	2.3327551907048325
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.062248160000000004	2.332118175806027
ALAGILLE SYNDROME	0.062248160000000004	2.332118175806027
ALAGILLE SYNDROME 2	0.062248160000000004	2.332118175806027
WHITE-SUTTON SYNDROME; WHSUS	0.062247554000000004	2.332095472104993
SOMATOSTATINOMA	0.06215541	2.3286433106725672
NEPHRONOPHTHISIS 4	0.06201839	2.323509876488345
NOONAN SYNDROME 2; NS2	0.061723744000000004	2.3124710073550476
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.061723744000000004	2.3124710073550476
NOONAN SYNDROME 10; NS10	0.06117819000000001	2.292031906837319
ACROCARDIOFACIAL SYNDROME	0.061067719000000006	2.2878931270404625
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.060805453999999995	2.2780674073183413
HEREDITARY FOLATE MALABSORPTION	0.060754173	2.2761461721818566
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.060562363	2.268960038691303
ALSTROM SYNDROME; ALMS	0.060373303999999996	2.261876971011877
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.060360300000000006	2.2613897780609826
ADAMS-OLIVER SYNDROME 1; AOS1	0.060245893	2.2571035366019667
GAUCHER DISEASE	0.060068750000000004	2.2504669001131643
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0600359	2.249236179685842
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.059910473	2.2445370755446623
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.05980392	2.2405450830426084
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.05947539	2.228236754823789
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.05947539	2.228236754823789
CRANIOECTODERMAL DYSPLASIA 3	0.05947539	2.228236754823789
ANE SYNDROME	0.05947539	2.228236754823789
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.059402380000000005	2.225501445892319
ARIMA SYNDROME	0.059369054	2.2242528921948774
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.059369054	2.2242528921948774
OCULOFACIOCARDIODENTAL SYNDROME	0.059369054	2.2242528921948774
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.059364919	2.2240979750269334
TRISOMY 8P	0.059364919	2.2240979750269334
MOYAMOYA DISEASE	0.059364919	2.2240979750269334
ZUNICH NEUROECTODERMAL SYNDROME	0.059364919	2.2240979750269334
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.059364919	2.2240979750269334
GAPO SYNDROME; GAPOS	0.059364919	2.2240979750269334
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.059364919	2.2240979750269334
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.059364919	2.2240979750269334
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.05934724999999999	2.223436008535902
PARTIAL ATRIOVENTRICULAR CANAL	0.059227600000000005	2.218953338851607
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.05917476900000001	2.2169740331926766
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.059027800000000005	2.2114678611840572
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.059027800000000005	2.2114678611840572
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.0588235	2.203813791677149
JUNG SYNDROME	0.0588235	2.203813791677149
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.0588235	2.203813791677149
SPINOCEREBELLAR ATAXIA TYPE 4	0.0588235	2.203813791677149
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0588235	2.203813791677149
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	2.203813791677149
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.0588235	2.203813791677149
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	2.203813791677149
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0588235	2.203813791677149
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0588235	2.203813791677149
AFRICAN IRON OVERLOAD	0.0588235	2.203813791677149
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	2.203813791677149
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	2.203813791677149
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0588235	2.203813791677149
CONGENITAL ANALBUMINEMIA	0.0588235	2.203813791677149
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.0588235	2.203813791677149
LYME DISEASE	0.058356950000000005	2.1863345644209167
NEONATAL ACUTE RESPIRATORY DISTRESS DUE TO SP-B DEFICIENCY	0.058264460000000004	2.1828694401492865
ANTLEY-BIXLER SYNDROME	0.05812611	2.1776861777103202
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.0580808	2.175988645212239
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.164640915829236
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0574407	2.152007392684719
LICHTENSTEIN SYNDROME	0.057332570000000006	2.1479563181091836
FAMILIAL ATRIAL MYXOMA	0.05714281	2.1408469875676706
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056753044	2.126244461598852
LIGNEOUS CONJUNCTIVITIS	0.05629675399999999	2.109149623736358
SCIMITAR SYNDROME	0.055827760000000004	2.0915788323789277
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0557029	2.0869009708095074
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0813823979344823
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0813823979344823
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0813823979344823
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0813823979344823
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0813823979344823
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0813823979344823
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0813823979344823
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0813823979344823
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.0813823979344823
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0813823979344823
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0813823979344823
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0813823979344823
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.055555600000000004	2.0813823979344823
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0813823979344823
JUVENILE IDIOPATHIC ARTHRITIS	0.05550021	2.079307219716236
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.05497831	2.0597543128358855
NIJMEGEN BREAKAGE SYNDROME	0.05456239	2.0441719310967104
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.054437673	2.039499427001296
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.054370463	2.036981414218333
TUFTSIN DEFICIENCY	0.05433041	2.0354808344534767
CUTIS LAXA	0.054328944	2.0354259109786983
COG2-CDG	0.05426045399999999	2.032859943183651
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.054232800000000005	2.0318238901335093
PERIVENTRICULAR NODULAR HETEROTOPIA	0.054093600000000006	2.0266087825693306
PSEUDOTRISOMY 13 SYNDROME	0.0540046	2.0232744106353366
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.053824909000000004	2.0165423137006044
SCHNITZLER SYNDROME	0.053799099999999996	2.015575383304599
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.053718573	2.0125584510716927
MYH9-RELATED DISEASE	0.053714899999999996	2.012420842665922
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	0.053714899999999996	2.012420842665922
NAIL-PATELLA SYNDROME	0.05328349	1.9962581303508198
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.05328349	1.9962581303508198
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.05327356	1.9958861043586333
48,XYYY SYNDROME	0.053177154	1.9922742677219079
KLEEFSTRA SYNDROME	0.053173019	1.9921193505539634
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.053173019	1.9921193505539634
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.053173019	1.9921193505539634
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.05311351	1.9898898546054238
MEGALOBLASTIC ANEMIA 1	0.05311351	1.9898898546054238
GAUCHER DISEASE, PERINATAL LETHAL	0.05308611900000001	1.9888636548116714
INTERNAL CAROTID AGENESIS	0.05299534	1.985462632903851
PULMONARY HEMOSIDEROSIS	0.052941100000000005	1.9834305392667746
BEHÇET DISEASE	0.052719949	1.9751451495187453
MÉNÉTRIER DISEASE	0.0526316	1.971835167204179
CONGENITAL BILATERAL ABSENCE OF VAS DEFERENS	0.0526316	1.971835167204179
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.0526316	1.971835167204179
BETA-THALASSEMIA	0.0526316	1.971835167204179
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.0526316	1.971835167204179
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.0526316	1.971835167204179
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0526316	1.971835167204179
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.0526316	1.971835167204179
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.0526316	1.971835167204179
ACRORENAL SYNDROME	0.0526316	1.971835167204179
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0526316	1.971835167204179
IRON-REFRACTORY IRON DEFICIENCY ANEMIA	0.0526316	1.971835167204179
CONGENITAL MEMBRANOUS NEPHROPATHY DUE TO FETOMATERNAL ANTI-NEUTRAL ENDOPEPTIDASE ALLOIMMUNIZATION	0.0526316	1.971835167204179
GLOMUVENOUS MALFORMATION	0.0526316	1.971835167204179
IMMUNODEFICIENCY 21; IMD21	0.05259736	1.9705523706309211
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.05230499999999999	1.959599146152018
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.05230499999999999	1.959599146152018
PROGRESSIVE NON-FLUENT APHASIA	0.05230499999999999	1.959599146152018
DUBOWITZ SYNDROME	0.05216591	1.954388159721691
AMYLOIDOSIS	0.052139099999999994	1.9533837270076417
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.9212431539630808
CONGENITAL DISORDER OF GLYCOSYLATION	0.051230383000000004	1.9193387780105324
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9174931094829337
POLYCYSTIC KIDNEY DISEASE 3	0.051043660000000005	1.9123432282281607
OSTEOGENESIS IMPERFECTA, TYPE X	0.050651890000000005	1.8976656226935469
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0505747	1.8947737106757383
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.050545554	1.893681760064635
FRAGILE X SYNDROME	0.050541419000000004	1.893526842896691
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.050541419000000004	1.893526842896691
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.050360373	1.8867439810858841
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.05028479	1.8839122750871535
IMMUNODEFICIENCY 57; IMD57	0.05	1.8732426595469063
HYPOPLASTIC LEFT HEART SYNDROME	0.05	1.8732426595469063
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.05	1.8732426595469063
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.05	1.8732426595469063
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.05	1.8732426595469063
BLOOM SYNDROME	0.05	1.8732426595469063
FAMILIAL PAPILLARY OR FOLLICULAR THYROID CARCINOMA	0.05	1.8732426595469063
RESTRICTIVE DERMOPATHY	0.05	1.8732426595469063
FAMILIAL PAPILLARY THYROID CARCINOMA WITH RENAL PAPILLARY NEOPLASIA	0.05	1.8732426595469063
FAMILIAL THROMBOCYTOSIS	0.049896519	1.8693657590738548
CONGENITAL LOBAR EMPHYSEMA	0.049848	1.8675480018618837
NON-DISTAL TRISOMY 10Q	0.04979604	1.8656013280900823
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.049718703	1.8627039087388548
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.04949251	1.8542296212010372
RIDDLE SYNDROME	0.049275094000000005	1.8460841626796762
MCLEOD SYNDROME; MCLDS	0.0490852	1.838969811847836
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8386571301831043
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.04902515	1.8367200474137202
12Q14 MICRODELETION SYNDROME	0.048816444	1.828900907763652
RETINAL VENOUS BEADING	0.048809559999999995	1.8286429997142855
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.048705973	1.824762127966796
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.048705973	1.824762127966796
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.048705973	1.824762127966796
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.8192786596592105
FEINGOLD SYNDROME	0.048270890000000004	1.8084618072459233
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.048270890000000004	1.8084618072459233
LESCH-NYHAN SYNDROME; LNS	0.048270890000000004	1.8084618072459233
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.048164554	1.8044779446170116
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.048160419	1.804323027449067
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.048140339000000004	1.8035707331969932
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.048089099999999996	1.8016510715843421
PRIMARY BILIARY CHOLANGITIS	0.04798531	1.797762594471655
COCKAYNE SYNDROME A; CSA	0.047922089	1.7953940289880708
TRICHOTHIODYSTROPHY	0.047920304	1.7953271542251248
GAUCHER DISEASE, TYPE I	0.047765510000000004	1.7895278197402869
BETA-THALASSEMIA MAJOR	0.04766542	1.7857779625844057
EOSINOPHILOPENIA	0.0476407	1.784851831413526
ANEURYSM, INTRACRANIAL BERRY, 1	0.047619	1.7840388440992825
BODY SKIN HYPERLAXITY DUE TO VITAMIN K-DEPENDENT COAGULATION FACTOR DEFICIENCY	0.047619	1.7840388440992825
CEPHALIN LIPIDOSIS	0.047619	1.7840388440992825
FORMIMINOTRANSFERASE DEFICIENCY	0.047619	1.7840388440992825
PERNICIOUS ANEMIA	0.047619	1.7840388440992825
ACROCEPHALOSYNDACTYLY	0.047619	1.7840388440992825
PANCREATIC COLIPASE DEFICIENCY	0.047619	1.7840388440992825
CEROID STORAGE DISEASE	0.047619	1.7840388440992825
GLYCOGEN STORAGE DISEASE II	0.047619	1.7840388440992825
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.047619	1.7840388440992825
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.047619	1.7840388440992825
MEESTER-LOEYS SYNDROME; MRLS	0.047619	1.7840388440992825
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0475924	1.7830422790044036
AUTOSOMAL DOMINANT CUTIS LAXA	0.0475924	1.7830422790044036
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.0474093	1.776182464385143
OCULOECTODERMAL SYNDROME; OES	0.047327573000000005	1.7731205743284069
X-LINKED AGAMMAGLOBULINEMIA	0.04724105	1.7698790028357674
JUVENILE POLYPOSIS SYNDROME	0.047173650000000004	1.7673538717306985
INCONTINENTIA PIGMENTI	0.046986263	1.760333445285808
KLEEFSTRA SYNDROME	0.046747963	1.7514055707704073
TRISOMY 12P	0.046691954	1.7493072018080362
OVARIAN HYPERSTIMULATION SYNDROME	0.04656081	1.7443939111011635
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.04656081	1.7443939111011635
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.046363313999999996	1.7369947524553662
AMISH INFANTILE EPILEPSY SYNDROME	0.046314350000000004	1.7351603233837252
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.04631204	1.735073779572854
PRIMARY MYELOFIBROSIS	0.04615919	1.7293472767626192
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.04611745	1.727783493790429
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.04611745	1.727783493790429
ACETOPHENETIDIN SENSITIVITY	0.046110700000000004	1.7275306060313906
WHIPPLE DISEASE	0.046078619	1.726328696076172
GALLOWAY-MOWAT SYNDROME	0.046008103	1.72368682448856
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.046000054	1.723385269885226
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.04594215	1.7212159050260578
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.0454545	1.702946169367497
CHLORAMPHENICOL TOXICITY	0.0454545	1.702946169367497
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.0454545	1.702946169367497
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0454545	1.702946169367497
DERMATITIS HERPETIFORMIS	0.045416	1.7015037725196458
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.04528169900000001	1.69647220527125
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.045238110000000005	1.6948391497855102
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.04509136	1.6893411825797395
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.04509136	1.6893411825797395
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.04509136	1.6893411825797395
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.04509136	1.6893411825797395
ALPORT SYNDROME, X-LINKED; ATS	0.04509136	1.6893411825797395
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.045090873	1.6893229371962355
HARDIKAR SYNDROME	0.045009099999999996	1.686259323756253
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6831276366780223
FAMILIAL MEDITERRANEAN FEVER	0.044840729	1.6799513289596417
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.044607900000000006	1.6712284246560487
KEUTEL SYNDROME	0.044486122999999995	1.6666660672290157
HYPERLYSINEMIA, TYPE I	0.044422949	1.6642992625935316
MASP2 DEFICIENCY	0.044387499999999996	1.6629711710127657
PINEOBLASTOMA	0.044333859	1.6609615188227507
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.65961634326893
SLC39A8-CDG	0.044289829	1.6593119413367539
AORTIC VALVE DISEASE 3; AOVD3	0.044237	1.6573327106075297
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.04413019000000001	1.6533310896382059
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.04413019000000001	1.6533310896382059
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04413019000000001	1.6533310896382059
CHOREOACANTHOCYTOSIS	0.044082719	1.6515525955923784
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.044076550000000006	1.651321474913044
HYDROXYKYNURENINURIA	0.044023854	1.649347227009294
CADASIL	0.04398730900000001	1.6479780739494316
BETA-THALASSEMIA ASSOCIATED WITH ANOTHER HEMOGLOBIN ANOMALY	0.043885999999999994	1.6441825471375102
PREPAPILLARY VASCULAR LOOPS	0.0435606	1.6319914839091791
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	1.6289081264915652
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	1.6289081264915652
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	1.6289081264915652
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.6289081264915652
HYPOPLASMINOGENEMIA	0.043478300000000004	1.6289081264915652
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.6289081264915652
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	1.6289081264915652
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.043424660000000004	1.6268985117664032
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.04335084	1.624132856303848
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.6209829613069664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.6203082193009977
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.04320929	1.6188297063346706
BRAIN-LUNG-THYROID SYNDROME	0.043154204	1.6167659174317945
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.042933072999999995	1.608481276980829
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.042923214	1.60811191099322
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04292174000000001	1.6080566877996167
DISTAL MONOSOMY 12Q	0.04286414399999999	1.605898862115231
PHACE SYNDROME	0.042863273	1.6058662302281017
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.6018678687010055
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.6018678687010055
ADULT-ONSET DYSTONIA-PARKINSONISM	0.04275367299999999	1.6017600823183746
YUNIS-VARON SYNDROME	0.04274726	1.6015198202148615
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042673844	1.598769300552996
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.042627203	1.5970219023353172
MYASTHENIA GRAVIS; MG	0.0425697	1.5948675608822787
NIJMEGEN BREAKAGE SYNDROME	0.04251419	1.5927878868816499
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.042425710000000005	1.5894729966713157
OGDEN SYNDROME; OGDNS	0.042391653999999994	1.5881970936310446
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.042318589999999996	1.585459761597502
THYROCEREBRORENAL SYNDROME	0.042208118999999995	1.581320981800646
THYROCEREBRORETINAL SYNDROME	0.042208118999999995	1.581320981800646
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.042208118999999995	1.581320981800646
IMMUNOGLOBULIN A VASCULITIS	0.042081649	1.576582801817588
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.04192304399999999	1.5706406887772388
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.041761160000000005	1.5645757284832778
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.041735629	1.5636192133164597
ALG1-CDG	0.041706573	1.5625306345421437
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.041666699999999994	1.561036798450861
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.041666699999999994	1.561036798450861
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.041666699999999994	1.561036798450861
AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22	0.041666699999999994	1.561036798450861
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.041666699999999994	1.561036798450861
DYSCHONDROSTEOSIS AND NEPHRITIS	0.041666699999999994	1.561036798450861
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.041666699999999994	1.561036798450861
PERRY SYNDROME	0.041666699999999994	1.561036798450861
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.041666699999999994	1.561036798450861
FECHTNER SYNDROME	0.041666699999999994	1.561036798450861
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.041666699999999994	1.561036798450861
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.041666699999999994	1.561036798450861
CONGENITAL ATRANSFERRINEMIA	0.04164261	1.5601342701374916
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.0415952	1.5583580614477093
LETTERER-SIWE DISEASE	0.04125385	1.5455694338109827
ACUTE PROMYELOCYTIC LEUKEMIA	0.04125385	1.5455694338109827
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.041232194	1.5447580949502797
PELIZAEUS-MERZBACHER DISEASE	0.041193309	1.54330127413395
DIAMOND-BLACKFAN ANEMIA 8	0.041128050000000006	1.5408563552795629
DIAMOND-BLACKFAN ANEMIA 4	0.041128050000000006	1.5408563552795629
NOCARDIOSIS	0.041083259000000004	1.5391782670402876
MONOSOMY 18Q	0.041041663	1.537619879006957
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.04103016	1.5371889208007017
ANTISYNTHETASE SYNDROME	0.04103016	1.5371889208007017
HURLER SYNDROME	0.041023444000000006	1.5369373068466716
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04065189	1.5230170907841658
KAPUR-TORIELLO SYNDROME	0.040541419	1.5188783109873096
7Q11.23 MICRODUPLICATION SYNDROME	0.040496109	1.517180778489228
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.040476160000000004	1.516433392132922
NEPHROSIALIDOSIS	0.04043991	1.5150752912047505
RECURRENT ACUTE PANCREATITIS	0.040368229	1.5123897730631708
GASTROINTESTINAL STROMAL TUMOR	0.04023189	1.5072818524439715
APOLIPOPROTEIN A-I DEFICIENCY	0.04023189	1.5072818524439715
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0400144	1.4991336215234745
OSTEOGENESIS IMPERFECTA, TYPE V	0.040003689999999995	1.4987323729457993
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.498594127637525
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.04	1.498594127637525
3Q13 MICRODELETION SYNDROME	0.04	1.498594127637525
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04	1.498594127637525
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	1.498594127637525
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.498594127637525
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.498594127637525
MECKEL SYNDROME, TYPE 5	0.04	1.498594127637525
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.039826	1.4920752431823017
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.03979085	1.4907583535926403
LINEAR VERRUCOUS NEVUS SYNDROME	0.039616619	1.48423081475633
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.03940096	1.4761511819820252
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.03940096	1.4761511819820252
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.039369229000000006	1.4749623847254238
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.0393028	1.4724736319928027
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.4723818431024849
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4723818431024849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.039272100000000004	1.4713234609998411
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.039113390000000005	1.4653774141499074
CRANIOFACIOFRONTODIGITAL SYNDROME	0.039113390000000005	1.4653774141499074
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.039113390000000005	1.4653774141499074
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.039113390000000005	1.4653774141499074
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.039007054	1.4613935515209957
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.039002919000000004	1.4612386343530512
NORRIE DISEASE	0.038916739	1.4580099133050561
SRD5A3-CDG	0.038839583	1.455119275092256
HALLERMANN-STREIFF SYNDROME	0.038827810000000004	1.4546782013756392
ADIPOSIS DOLOROSA	0.038722968999999996	1.4507503487022477
LEPTOSPIROSIS	0.038709640000000003	1.4502509796740661
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.038709640000000003	1.4502509796740661
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.038674700000000006	1.448941957703575
GANGLIOCYTOMA	0.03864865000000001	1.447965998277951
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4431948492240845
THORACOLARYNGOPELVIC DYSPLASIA	0.0384615	1.4409544510032668
KNIEST DYSPLASIA	0.0384615	1.4409544510032668
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.0384615	1.4409544510032668
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0384615	1.4409544510032668
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.0384615	1.4409544510032668
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0384615	1.4409544510032668
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.0384615	1.4409544510032668
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.0384615	1.4409544510032668
FACIOCARDIOMELIC SYNDROME	0.0384615	1.4409544510032668
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.0384615	1.4409544510032668
CHILBLAIN LUPUS 1	0.0384615	1.4409544510032668
GAUCHER DISEASE TYPE 3	0.03826132	1.4334547366915047
TETRASOMY X	0.038261104	1.4334466442832152
16P13.11 MICRODELETION SYNDROME	0.038234444	1.432447831297145
NEONATAL ADRENOLEUKODYSTROPHY	0.038230309000000004	1.4322929141292007
NAIL-PATELLA SYNDROME	0.03820016	1.4311633862703466
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.426463045789012
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.037907460000000004	1.4201974237413593
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4192907742941383
TRANSALDOLASE DEFICIENCY	0.037817590000000005	1.4168304573850898
INFANTILE LIVER FAILURE SYNDROME 1	0.037615163	1.4092465595482075
LISSENCEPHALY 2; LIS2	0.037582554	1.408024868150504
300270 ADRENOMYODYSTROPHY	0.037582554	1.408024868150504
VISCERAL STEATOSIS, CONGENITAL	0.037578419	1.4078699509825598
SCHWARTZ-JAMPEL SYNDROME	0.03748775	1.4044730502085905
DIAMOND-BLACKFAN ANEMIA 10	0.037180080000000004	1.3929462388273348
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3875857676327752
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.3875857676327752
CHRISTIANSON SYNDROME	0.037037	1.3875857676327752
RHYNS SYNDROME	0.037037	1.3875857676327752
ADENOMYOSIS	0.037037	1.3875857676327752
TESTICULAR TORSION	0.037037	1.3875857676327752
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.3875857676327752
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.3875857676327752
PEYRONIE DISEASE	0.037037	1.3875857676327752
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.3875857676327752
GALACTORRHEA	0.037037	1.3875857676327752
NATHALIE SYNDROME	0.037037	1.3875857676327752
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.3875857676327752
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.3875857676327752
DK PHOCOMELIA SYNDROME	0.037037	1.3875857676327752
URINARY BLADDER, ATONY OF	0.037037	1.3875857676327752
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.3875857676327752
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.3875857676327752
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.037037	1.3875857676327752
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3875857676327752
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.3875857676327752
CANAVAN DISEASE	0.037037	1.3875857676327752
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.3875857676327752
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.3875857676327752
GENITOURINARY TRACT ANOMALIES	0.037037	1.3875857676327752
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.3875857676327752
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3875857676327752
POLAND SYNDROME	0.037037	1.3875857676327752
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	1.3875857676327752
MYOCLONUS AND ATAXIA	0.037037	1.3875857676327752
FIBROSCLEROSIS, MULTIFOCAL	0.037037	1.3875857676327752
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.3875857676327752
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.036933299999999995	1.3837006623568748
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.036911744	1.3828930699814912
AORTIC VALVE DISEASE 2; AOVD2	0.0368421	1.3802838677458615
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.036801273	1.378754290184635
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036765932999999994	1.377430282272867
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.036646299	1.3729482120262224
MUSCULAR HYPERTONIA, LETHAL	0.0366162	1.3718205574100286
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.036559629999999996	1.3697011706650168
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.03636619000000001	1.3624539694637623
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.03636619000000001	1.3624539694637623
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.036259854	1.3584701068348506
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.036255719000000006	1.3583151896669061
THUMBS, CONGENITAL CLASPED	0.0361093	1.3528296233275419
ALG13-CDG	0.03590774	1.3452782075183765
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.035832879	1.3424735511436496
PRIMARY HYPEROXALURIA TYPE 1	0.03576139	1.3397952262538826
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	1.3380310063171217
COWDEN SYNDROME 7; CWS7	0.035714300000000004	1.3380310063171217
HYPOALPHALIPOPROTEINEMIA	0.035714300000000004	1.3380310063171217
THYROID LYMPHOMA	0.035714300000000004	1.3380310063171217
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.035714300000000004	1.3380310063171217
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.3380310063171217
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.3380310063171217
219400 CYANOSIS AND HEPATIC DISEASE	0.035714300000000004	1.3380310063171217
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.035714300000000004	1.3380310063171217
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.035714300000000004	1.3380310063171217
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.3380310063171217
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.3380310063171217
GASTRIC SNEEZING	0.035714300000000004	1.3380310063171217
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.3380310063171217
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.3380310063171217
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1	0.035714300000000004	1.3380310063171217
TERATOMA, PINEAL	0.035714300000000004	1.3380310063171217
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.035714300000000004	1.3380310063171217
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.3380310063171217
METHANE PRODUCTION	0.035714300000000004	1.3380310063171217
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.3380310063171217
BLUE DIAPER SYNDROME	0.035714300000000004	1.3380310063171217
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.3380310063171217
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.035714300000000004	1.3380310063171217
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.3380310063171217
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.035714300000000004	1.3380310063171217
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.035676109	1.336600186108906
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.035676109	1.336600186108906
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3362308201212967
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3362308201212967
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03566625	1.3362308201212967
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3362308201212967
IMMUNODEFICIENCY 49; IMD49	0.035569773	1.3326163234799948
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.324967161868854
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.035357373000000004	1.3246587886622396
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.035326550000000005	1.3235040094923354
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.035326550000000005	1.3235040094923354
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.035326550000000005	1.3235040094923354
MILLER-DIEKER SYNDROME	0.035316919	1.3231431854912534
C SYNDROME	0.035259219	1.3209814634621362
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0352092	1.3191075089703785
COCKAYNE SYNDROME	0.03518466900000001	1.318188458656752
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0351655	1.3174702948859347
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.03513469	1.3163160027591219
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.035108763999999994	1.315344688975293
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.035024219	1.3121772229622657
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.035024219	1.3121772229622657
LYMPHANGIOLEIOMYOMATOSIS	0.034991469	1.3109502490202622
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.034931199999999996	1.3086922797832976
CHROMOSOME 16P13.3 DELETION SYNDROME	0.034825383	1.3047278614131923
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3045280613511252
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.034803472999999994	1.3039070064797784
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.03467466	1.2990810463456948
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03461480399999999	1.2968385500930975
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.034594454	1.296076140330662
CHROMOSOME 15Q25 DELETION SYNDROME	0.034530744	1.2936892545338676
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.034530744	1.2936892545338676
DIAMOND-BLACKFAN ANEMIA 5	0.034530744	1.2936892545338676
INCONTINENTIA PIGMENTI; IP	0.034526609	1.293534337365923
PANNER DISEASE	0.0344828	1.2918930396124813
FLOOD FACTOR DEFICIENCY	0.0344828	1.2918930396124813
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.0344828	1.2918930396124813
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.0344828	1.2918930396124813
COUMARIN RESISTANCE	0.0344828	1.2918930396124813
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.0344828	1.2918930396124813
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.0344828	1.2918930396124813
CHANARIN-DORFMAN SYNDROME	0.0344828	1.2918930396124813
HEMOPOIETIC PROLIFERATION	0.0344828	1.2918930396124813
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.0344828	1.2918930396124813
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0344828	1.2918930396124813
MACROCYTOSIS, FAMILIAL	0.0344828	1.2918930396124813
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.0344828	1.2918930396124813
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.0344828	1.2918930396124813
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.0344828	1.2918930396124813
MYELOMA, MULTIPLE	0.0344828	1.2918930396124813
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0344828	1.2918930396124813
OMODYSPLASIA 1; OMOD1	0.0344828	1.2918930396124813
GIANT NEUTROPHIL LEUKOCYTES	0.0344828	1.2918930396124813
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.0344828	1.2918930396124813
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.0344828	1.2918930396124813
SULFHEMOGLOBINEMIA, CONGENITAL	0.0344828	1.2918930396124813
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.034420273	1.2895504747370115
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.034270400000000006	1.283935504794726
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.03411099	1.2779632325475585
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.03401585	1.2743988264149726
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.03391132	1.2704826253109238
TRANSKETOLASE DEFICIENCY	0.033878854	1.2692662913872268
JERVELL AND LANGE-NIELSEN SYNDROME	0.033874719000000005	1.2691113742192826
HYPERCALCEMIA, INFANTILE, 1	0.0338203	1.2670725743734845
TRICHOHEPATOENTERIC SYNDROME 1	0.03371333	1.26306495902765
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.033695559	1.2623991711215938
BOHRING-OPITZ SYNDROME	0.033608483	1.2591368815651398
NIEMANN-PICK DISEASE, TYPE A	0.033455544	1.2534070443829708
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.033451409	1.253252127215026
GLYCOGEN STORAGE DISEASE IB	0.03344161	1.2528850091186081
FETAL ALCOHOL SYNDROME	0.033418484	1.2520185969237145
PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A	0.0333333	1.248827190869498
GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS; GURDP	0.0333333	1.248827190869498
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0333333	1.248827190869498
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.0333333	1.248827190869498
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.0333333	1.248827190869498
BREATH-HOLDING SPELLS	0.0333333	1.248827190869498
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0333333	1.248827190869498
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.0333333	1.248827190869498
PROTOPORPHYRIA, ERYTHROPOIETIC, 2; EPP2	0.0333333	1.248827190869498
PEUTZ-JEGHERS SYNDROME	0.0333333	1.248827190869498
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q) CHROMOSOME ABNORMALITY	0.0333333	1.248827190869498
DIAMOND-BLACKFAN ANEMIA 3	0.0333333	1.248827190869498
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.0333333	1.248827190869498
RETINOBLASTOMA	0.0333333	1.248827190869498
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0333333	1.248827190869498
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.03327231	1.2465422094733825
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.03327231	1.2465422094733825
HYPER-IGD SYNDROME	0.03325325	1.245828129371563
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.03319991	1.2438297541023584
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.03315414	1.2421149877718092
GAUCHER DISEASE TYPE 1	0.03303136	1.2375150530970258
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.032988863	1.2359229092309707
TRACHEOPATHIA OSTEOPLASTICA	0.0329524	1.2345568282890693
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.03290999	1.2329679438652419
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.03286473299999999	1.231272397004379
HALLERMANN-STREIFF SYNDROME; HSS	0.03281587	1.2294417518829104
PEHO SYNDROME	0.032803653999999995	1.22898408123633
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.22898408123633
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2288291640683855
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2288291640683855
TUBEROUS SCLEROSIS-1	0.032799519	1.2288291640683855
MECKEL SYNDROME, TYPE 1; MKS1	0.0327485	1.226917744723437
ROIFMAN-CHITAYAT SYNDROME	0.032702724	1.2252027536037688
THYMOMA	0.03268511	1.2245428476796636
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.032490420000000006	1.21724881541192
BENIGN OCCIPITAL EPILEPSY	0.03240334	1.213986375996053
REACTIVE ARTHRITIS	0.03226645	1.2088578122427454
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.0322581	1.2085449807186008
DOMINANT BETA-THALASSEMIA	0.0322581	1.2085449807186008
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2085449807186008
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0322581	1.2085449807186008
HEMOGLOBIN C-BETA-THALASSEMIA SYNDROME	0.0322581	1.2085449807186008
WEST SYNDROME	0.0322581	1.2085449807186008
ACATALASEMIA	0.0322581	1.2085449807186008
DELTA-BETA-THALASSEMIA	0.0322581	1.2085449807186008
NAKAJO-NISHIMURA SYNDROME	0.0322581	1.2085449807186008
AICARDI SYNDROME	0.0322581	1.2085449807186008
MAJEED SYNDROME	0.0322581	1.2085449807186008
BLUE RUBBER BLEB NEVUS	0.0322581	1.2085449807186008
HEMORRHAGIC FEVER-RENAL SYNDROME	0.03209648	1.2024899111458816
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0320258	1.199841895322346
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.031972994000000005	1.1978635262847457
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.03190189	1.1951996253634571
EHLERS-DANLOS SYNDROME, TYPE I	0.03190189	1.1951996253634571
THANATOPHORIC DYSPLASIA TYPE 2	0.031869949	1.1940029604876854
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.031795554	1.1912157627345452
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.031791419	1.191060845566601
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.03173631	1.1889961949721013
SAPHO SYNDROME	0.03173631	1.1889961949721013
CRYOGLOBULINEMIC VASCULITIS	0.03173631	1.1889961949721013
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.031656000000000004	1.1859873926123374
LIG4 SYNDROME	0.031461654000000006	1.1787062482540913
MARFANOID HABITUS WITH SITUS INVERSUS	0.03125	1.1707766622168163
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.03125	1.1707766622168163
AORTO-VENTRICULAR TUNNEL	0.03125	1.1707766622168163
IMMUNODEFICIENCY 62; IMD62	0.03125	1.1707766622168163
CAP MYOPATHY	0.03125	1.1707766622168163
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.03125	1.1707766622168163
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.1699115987566373
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1699115987566373
ENCEPHALITIS LETHARGICA	0.031123859000000004	1.1660508081704584
BARDET-BIEDL SYNDROME 1; BBS1	0.030997214	1.1613060718380919
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.030916100000000002	1.1582671477363622
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.030676639999999998	1.14929581399126
BARDET-BIEDL SYNDROME 12; BBS12	0.030676639999999998	1.14929581399126
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.030617329999999998	1.1470737735485055
NAVAJO NEUROHEPATOPATHY	0.030609243999999997	1.1467708327456034
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.030498773	1.1426320529487475
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.030310263	1.1355695534737238
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.030302999999999997	1.1352974462449978
COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF	0.030302999999999997	1.1352974462449978
COMPLEMENT COMPONENT 2 DEFICIENCY	0.030302999999999997	1.1352974462449978
SUBCORNEAL PUSTULAR DERMATOSIS	0.030302999999999997	1.1352974462449978
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.030302999999999997	1.1352974462449978
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.030294804	1.1349903843082452
COLD AGGLUTININ DISEASE	0.03016214	1.1300201470245224
RIN2 SYNDROME	0.02996544	1.1226508104018647
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.029957354	1.1223478695989628
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.02990553	1.1204062910471957
ABETA AMYLOIDOSIS, IOWA TYPE	0.02983141	1.1176293961286834
PENTASOMY X	0.029768844	1.1152853701239391
COFS SYNDROME	0.029764709	1.1151304529559947
DISTAL MONOSOMY 7Q36	0.029764709	1.1151304529559947
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1131172416049262
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.029674063999999997	1.111734451338502
22Q11.2 MICRODUPLICATION SYNDROME	0.029658373000000002	1.111146590327083
SOTOS SYNDROME	0.029658373000000002	1.111146590327083
ABETAL34V AMYLOIDOSIS	0.029542584	1.1068085724409575
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.02954106	1.1067514760046946
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.029538449	1.106653655273013
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.101908769081234
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.101908769081234
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	1.101908769081234
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.101908769081234
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	1.101908769081234
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.101908769081234
IMMUNE SUPPRESSION	0.0294118	1.101908769081234
MONOMELIC AMYOTROPHY	0.0294118	1.101908769081234
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	1.101908769081234
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.101908769081234
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.101908769081234
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.101908769081234
RAGWEED SENSITIVITY	0.0294118	1.101908769081234
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.101908769081234
SHORT SYNDROME	0.0294118	1.101908769081234
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.101908769081234
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.101908769081234
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.101908769081234
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	1.101908769081234
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.101908769081234
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.02922329	1.09484626960621
ACRODYSOSTOSIS	0.02922329	1.09484626960621
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.02922329	1.09484626960621
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.02922329	1.09484626960621
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.02917146	1.0929044662653238
PROPIONIC ACIDEMIA	0.029116954	1.0908624069772985
IDIOPATHIC APLASTIC ANEMIA	0.029097360000000003	1.0901283206438754
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.029077904	1.0893994044601925
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.028933610000000002	1.0839934509338593
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.028864773000000003	1.0814144828347547
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.028864773000000003	1.0814144828347547
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.028864773000000003	1.0814144828347547
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.028864773000000003	1.0814144828347547
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.028864773000000003	1.0814144828347547
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.028864773000000003	1.0814144828347547
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.028864773000000003	1.0814144828347547
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.028864773000000003	1.0814144828347547
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.02884175	1.0805519295197397
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.028784944	1.0784237010693751
WYBURN-MASON SYNDROME	0.028685513000000003	1.0746985332517471
MYHRE SYNDROME	0.028676823	1.074372963677518
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0723939577374129
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0723939577374129
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.0704233064595696
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0704233064595696
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.0704233064595696
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0285714	1.0704233064595696
CHEILITIS GLANDULARIS	0.0285714	1.0704233064595696
COG7-CDG	0.0285714	1.0704233064595696
FANCONI ANEMIA	0.02853235	1.0689603039424633
BRADDOCK SYNDROME	0.02852415	1.0686530921462978
CYSTINOSIS, NEPHROPATHIC; CTNS	0.02842969	1.0651141621138818
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.02840099	1.0640389208273018
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0618050414909386
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	1.0618050414909386
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.028323354000000002	1.06113029948497
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.06113029948497
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.028319219000000003	1.0609753823170256
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.028319219000000003	1.0609753823170256
GRISCELLI SYNDROME, TYPE 2; GS2	0.028319219000000003	1.0609753823170256
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.028319219000000003	1.0609753823170256
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.028319219000000003	1.0609753823170256
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.028319219000000003	1.0609753823170256
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.028319219000000003	1.0609753823170256
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.028224443999999998	1.0574246508558542
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.028220309	1.0572697336879098
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.028181010000000003	1.0557974024223593
WOLF-HIRSCHHORN SYNDROME	0.028113973	1.053285871058998
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.028113973	1.053285871058998
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.028054663	1.0510638306162436
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.027973400000000002	1.0480193242513887
FAMILIAL MEDITERRANEAN FEVER; FMF	0.027876909999999998	1.0444043405669947
ADULT-ONSET STILL DISEASE	0.027876909999999998	1.0444043405669947
TRIMETHYLAMINURIA	0.02784691	1.0432803949712668
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0406911989672412
KOSAKI OVERGROWTH SYNDROME; KOGS	0.027777800000000002	1.0406911989672412
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.027777800000000002	1.0406911989672412
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.027777800000000002	1.0406911989672412
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.027777800000000002	1.0406911989672412
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0406911989672412
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0406911989672412
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.027678889999999998	1.0369855503381253
CHROMOSOME 17Q12 DELETION SYNDROME	0.027678889999999998	1.0369855503381253
7P22.1 MICRODUPLICATION SYNDROME	0.027572554	1.0330016877092136
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0330016877092136
THANATOPHORIC DYSPLASIA	0.027568419	1.0328467705412692
THANATOPHORIC DYSPLASIA TYPE 1	0.027568419	1.0328467705412692
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0328467705412692
9Q33.3Q34.11 MICRODELETION SYNDROME	0.027568419	1.0328467705412692
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.027568419	1.0328467705412692
SCLEROSTEOSIS 1; SOST1	0.02754448	1.0319498994207315
RELAPSING FEVER	0.02743913	1.028002977137066
TEMTAMY SYNDROME; TEMTYS	0.027402773000000002	1.026640867469603
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.027301940000000004	1.0228631739278011
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0272424	1.0206325165688126
LIPOSARCOMA	0.027027	1.0125625871914847
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.027027	1.0125625871914847
BARDET-BIEDL SYNDROME 11; BBS11	0.027027	1.0125625871914847
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0125625871914847
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0125625871914847
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	1.0125625871914847
NIPPLES, SUPERNUMERARY	0.027027	1.0125625871914847
ROTHMUND-THOMSON SYNDROME	0.027008054000000004	1.0118527780829292
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.02696769	1.01034054674873
TEMTAMY SYNDROME	0.026861354	1.0063566841198186
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.026861354	1.0063566841198186
OROFACIODIGITAL SYNDROME I; OFD1	0.026840169	1.0055629912049686
ROIFMAN SYNDROME	0.026784590000000004	1.0034807321294696
CRANIOECTODERMAL DYSPLASIA 4	0.026784590000000004	1.0034807321294696
HERMANSKY-PUDLAK SYNDROME	0.026750660000000002	1.0022095496607009
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.026674119000000003	0.9993419523326132
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.026445404000000002	0.9907731784350479
OSTEOGENESIS IMPERFECTA, TYPE I	0.0263158	0.9859175836020895
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.0263158	0.9859175836020895
LOEYS-DIETZ SYNDROME	0.0263158	0.9859175836020895
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.0263158	0.9859175836020895
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0263158	0.9859175836020895
MARFANOID HYPERMOBILITY SYNDROME	0.0263158	0.9859175836020895
GLYCOGEN STORAGE DISEASE IA	0.02629875	0.985278807855184
OROFACIODIGITAL SYNDROME TYPE 1	0.026188279000000002	0.9811400280583279
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.026132700000000002	0.9790577689828288
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.026132700000000002	0.9790577689828288
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.025962644	0.9726866459085906
GALACTOSEMIA	0.025888323	0.9699022205545869
ROWLEY-ROSENBERG SYNDROME	0.025773619999999997	0.9656048894990265
HYPOPHOSPHATASIA	0.025664799	0.9615279267099356
FRASIER SYNDROME	0.02564686	0.9608558447085432
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.02564686	0.9608558447085432
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.025467659	0.9541421055518741
JACOBSEN SYNDROME	0.025252162999999998	0.9460685795486395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.025123323	0.9412416078635191
ABETA AMYLOIDOSIS, DUTCH TYPE	0.025110869	0.9407750205818792
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.024967804	0.9354151113601177
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.024739944000000003	0.9268783699120307
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9265138368904826
AREGENERATIVE ANEMIA	0.024685570000000004	0.9248412559846266
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.024637819000000005	0.9230522717799061
BEEMER LETHAL MALFORMATION SYNDROME	0.02436241	0.9127341140274428
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.02432799	0.9114445737806108
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.02424424	0.9083068923258697
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.024221654000000002	0.9074607111516992
PROPIONIC ACIDEMIA	0.024124813000000002	0.9038325773038356
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.024088054	0.9024554067653898
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.024058854	0.9013614330522144
PALLISTER-KILLIAN SYNDROME	0.024054719	0.9012065158842699
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.02401301	0.899643894322529
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.02401301	0.899643894322529
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.023961063	0.8976977075938194
FETAL HYDANTOIN SYNDROME	0.023924743999999998	0.8963370215907775
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.02389484	0.8952166726209558
AICARDI-GOUTIERES SYNDROME 7	0.023814273	0.8921982417939216
KAGAMI-OGATA SYNDROME	0.023814273	0.8921982417939216
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.023811553	0.8920963373932422
SIALURIA	0.023773473000000003	0.8906696757837315
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4	0.0235133	0.8809223325344853
HYPOPLASTIC LEFT HEART SYNDROME	0.0235133	0.8809223325344853
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.023507550000000002	0.8807069096286375
METHYLMALONIC ACIDURIA, CBLA TYPE	0.023472923000000003	0.879409614157195
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02344437	0.878339880204034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.023419644	0.8774135242440348
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.023419644	0.8774135242440348
SILVER-RUSSELL SYNDROME	0.023379189999999998	0.8758979210730485
FATCO SYNDROME	0.023379189999999998	0.8758979210730485
LARSEN SYNDROME	0.023379189999999998	0.8758979210730485
WATSON SYNDROME	0.023379189999999998	0.8758979210730485
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.023309173000000002	0.8732747444471788
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.023309173000000002	0.8732747444471788
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.023309173000000002	0.8732747444471788
MONOSOMY 18P	0.023274514	0.8719762501004339
SILVER-RUSSELL SYNDROME; SRS	0.023272854	0.871914058444137
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.8717591412761926
COWDEN SYNDROME 6; CWS6	0.023268719	0.8717591412761926
COWDEN SYNDROME 5; CWS5	0.023268719	0.8717591412761926
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.023041473000000003	0.8632454032479647
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.02303246	0.8629077325261547
NETHERTON SYNDROME	0.023015463	0.8622709424164684
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.02295997	0.8601919053183437
METHYLMALONIC ACIDURIA, CBLB TYPE	0.022931504000000002	0.8591254308074104
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.02289791	0.8578668365293138
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.022890379	0.857584688719933
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.02287409	0.8569744237263057
JOHANSON-BLIZZARD SYNDROME; JBS	0.02287409	0.8569744237263057
MULTIPLE OSTEOCHONDROMAS	0.02287409	0.8569744237263057
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.02287409	0.8569744237263057
BETA-KETOTHIOLASE DEFICIENCY	0.022833979	0.8554716709999641
ERDHEIM-CHESTER DISEASE	0.02280269	0.8542994332084728
CURRARINO SYNDROME	0.022767754	0.8529905610973942
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.022767754	0.8529905610973942
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.022767754	0.8529905610973942
OCCIPITAL HORN SYNDROME	0.022767754	0.8529905610973942
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.022767754	0.8529905610973942
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.022763619000000002	0.8528356439294498
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.022763619000000002	0.8528356439294498
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.022763619000000002	0.8528356439294498
BUERGER DISEASE	0.0227273	0.8514749579264079
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.8514749579264079
BETHLEM MYOPATHY 1	0.0227273	0.8514749579264079
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.8514749579264079
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8514749579264079
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8514749579264079
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.0227273	0.8514749579264079
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	0.8514749579264079
THUMB DEFORMITY	0.0227273	0.8514749579264079
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.8514749579264079
CHILBLAIN LUPUS 2; CHBL2	0.0227273	0.8514749579264079
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.0227273	0.8514749579264079
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8514749579264079
ARTERIES, ANOMALIES OF	0.0227273	0.8514749579264079
PRIMARY ERYTHROMELALGIA	0.0227273	0.8514749579264079
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8514749579264079
CUTANEOUS SMALL VESSEL VASCULITIS	0.0227273	0.8514749579264079
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8514749579264079
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8514749579264079
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8514749579264079
SIRENOMELIA	0.0227273	0.8514749579264079
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.8514749579264079
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	0.8514749579264079
TRISOMY 13	0.022709559	0.8508102939659475
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.022686500000000002	0.8499463919162178
SPINOCEREBELLAR ATAXIA 14	0.022686500000000002	0.8499463919162178
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.022686500000000002	0.8499463919162178
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.022686500000000002	0.8499463919162178
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.022686500000000002	0.8499463919162178
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.022658983	0.8489154715509628
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.022604209	0.8468633716822823
COPPER DEFICIENCY, FAMILIAL BENIGN	0.022604209	0.8468633716822823
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8434538827176409
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8434538827176409
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8434538827176409
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8434538827176409
19P13.3 MICRODUPLICATION SYNDROME	0.022508613999999996	0.8432819190414944
POLYCYTHEMIA VERA	0.022499599999999998	0.8429442108548313
THROMBOCYTHEMIA, ESSENTIAL	0.02229256	0.8351874876501795
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.0222222	0.8325514605796651
NEPHROTIC SYNDROME, TYPE 18; NPHS18	0.0222222	0.8325514605796651
CARDIOMYOPATHY, DILATED, 1B; CMD1B	0.0222222	0.8325514605796651
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.0222222	0.8325514605796651
NEPHROTIC SYNDROME, TYPE 4	0.0222222	0.8325514605796651
NEPHROTIC SYNDROME, TYPE 19; NPHS19	0.0222222	0.8325514605796651
NEPHROTIC SYNDROME, TYPE 20; NPHS20	0.0222222	0.8325514605796651
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.0222222	0.8325514605796651
TELANGIECTASIA, HEREDITARY BENIGN	0.0222222	0.8325514605796651
VASCULAR HYALINOSIS	0.0222222	0.8325514605796651
CAROLI DISEASE, ISOLATED	0.0222222	0.8325514605796651
FRASIER SYNDROME	0.0222222	0.8325514605796651
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8	0.0222222	0.8325514605796651
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7	0.0222222	0.8325514605796651
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0222222	0.8325514605796651
GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	0.0222222	0.8325514605796651
DUANE-RADIAL RAY SYNDROME; DRRS	0.0222222	0.8325514605796651
NEPHROTIC SYNDROME, TYPE 12	0.0222222	0.8325514605796651
NEPHROTIC SYNDROME, TYPE 13	0.0222222	0.8325514605796651
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.0222222	0.8325514605796651
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9	0.0222222	0.8325514605796651
CHEILITIS GLANDULARIS	0.0222222	0.8325514605796651
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0222222	0.8325514605796651
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.0222222	0.8325514605796651
ANEURYSM OF INTERVENTRICULAR SEPTUM	0.0222222	0.8325514605796651
ISOLATED POLYCYSTIC LIVER DISEASE	0.0222222	0.8325514605796651
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.021977374	0.8233790904323406
PREECLAMPSIA	0.0219589	0.8226869647344912
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021920273	0.8212398098502848
WHIM SYNDROME	0.021768779	0.8155641093809767
CAMURATI-ENGELMANN DISEASE	0.02171339	0.8134889686275839
TIMOTHY SYNDROME; TS	0.021687283	0.8125108737053282
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.021607453999999998	0.8095200919399486
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.021572010000000003	0.8081921876834491
CARNEY TRIAD	0.0215197	0.8062324012130312
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.021485189999999998	0.8049394891294118
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.8008007093325556
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.8008007093325556
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299113999999997	0.7979681791070549
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.02129822	0.7979346855283022
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7974920008229979
WOLFRAM SYNDROME	0.021279019000000003	0.797215322882183
CUTIS LAXA-MARFANOID SYNDROME	0.0212766	0.7971246954023141
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.0212766	0.7971246954023141
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4	0.0212766	0.7971246954023141
EMPHYSEMA, HEREDITARY PULMONARY	0.0212766	0.7971246954023141
MEIER-GORLIN SYNDROME 6; MGORS6	0.0212766	0.7971246954023141
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.0212766	0.7971246954023141
ALPHA-1-ANTITRYPSIN DEFICIENCY	0.0212766	0.7971246954023141
BIRT-HOGG-DUBÉ SYNDROME	0.0212766	0.7971246954023141
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0212766	0.7971246954023141
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.0212766	0.7971246954023141
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.02125146	0.7961828289930939
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.021192350000000002	0.7939682815209776
PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	0.02105721	0.7889052812607541
SLC35A1-CDG	0.02103176	0.7879518007470449
BENIGN FAMILIAL INFANTILE EPILEPSY	0.020983639000000002	0.7861489545466437
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.020983639	0.7861489545466436
LYNCH SYNDROME	0.020983639	0.7861489545466436
FAMILIAL COLORECTAL CANCER TYPE X	0.020983639	0.7861489545466436
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.020951429	0.7849422116253635
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.7805165259827712
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7805165259827712
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7805165259827712
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7805165259827712
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.7805165259827712
PUPIL, EGG-SHAPED	0.0208333	0.7805165259827712
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7805165259827712
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7805165259827712
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7805165259827712
CRANDALL SYNDROME	0.0208333	0.7805165259827712
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7805165259827712
IMINOGLYCINURIA	0.0208333	0.7805165259827712
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7805165259827712
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7805165259827712
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7805165259827712
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7805165259827712
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7805165259827712
DERMOIDS OF CORNEA	0.0208333	0.7805165259827712
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7805165259827712
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7805165259827712
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7805165259827712
STICKLER SYNDROME, TYPE III	0.0208333	0.7805165259827712
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7805165259827712
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7805165259827712
611426 TENTED EYEBROWS	0.0208333	0.7805165259827712
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7805165259827712
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.7805165259827712
UNIQUE GREEN PHENOMENON	0.0208333	0.7805165259827712
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7805165259827712
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7805165259827712
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.7805165259827712
FARBER DISEASE	0.020805244	0.7794654120616463
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.020772319	0.7782318817703346
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.777052900305269
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.777052900305269
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.020740849999999998	0.777052900305269
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.777052900305269
FG SYNDROME TYPE 1	0.020529623	0.7691393117603067
WOLCOTT-RALLISON SYNDROME	0.020384369000000003	0.7636973919749103
YELLOW NAIL SYNDROME	0.020312660000000003	0.7610108248174412
LYSOSOMAL ACID LIPASE DEFICIENCY	0.020312660000000003	0.7610108248174412
COG1-CDG	0.020312660000000003	0.7610108248174412
46,XX GONADAL DYSGENESIS	0.02025969	0.7590263115439172
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.020153354000000002	0.7550424489150056
BAND HETEROTOPIA; BH	0.019954873	0.747606387388815
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.01995115	0.7474669057403851
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.01986931	0.7444007821552387
BULLOUS PEMPHIGOID	0.01986931	0.7444007821552387
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.01986931	0.7444007821552387
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.01986931	0.7444007821552387
STIFF-PERSON SYNDROME; SPS	0.01977745	0.7409592607411192
GRISCELLI SYNDROME TYPE 2	0.019732479	0.7392744288282695
15Q OVERGROWTH SYNDROME	0.019676728999999997	0.7371857632628747
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.019616359	0.7349240100757377
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.0196078	0.7346033483972766
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.0196078	0.7346033483972766
IDIOPATHIC PULMONARY FIBROSIS	0.0196078	0.7346033483972766
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4	0.0196078	0.7346033483972766
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3	0.0196078	0.7346033483972766
CYSTIC FIBROSIS	0.0196078	0.7346033483972766
IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS	0.0196078	0.7346033483972766
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.0196078	0.7346033483972766
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0196078	0.7346033483972766
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.0196078	0.7346033483972766
PETERS-PLUS SYNDROME; PTRPLS	0.019605473	0.7345161676839013
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.01955747	0.7327177423361766
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.019544620000000002	0.732236318972673
HHHH SYNDROME	0.019409319	0.727167286871086
HEMOCHROMATOSIS, TYPE 3; HFE3	0.01934676	0.7248235231203141
GLUTATHIONE SYNTHETASE DEFICIENCY	0.019312179	0.7235279510321182
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.019276923999999997	0.7222071276328716
PRIMARY CILIARY DYSKINESIA	0.019265240000000003	0.7217693882881889
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.019264509	0.7217420014805062
AMYLOIDOSIS VI	0.01919311	0.7190670484275263
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.01919311	0.7190670484275263
TRANSCOBALAMIN DEFICIENCY	0.019191060000000003	0.7189902454784851
GRANT SYNDROME	0.01917039	0.7182158469630283
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.01917039	0.7182158469630283
PYCNODYSOSTOSIS	0.01917039	0.7182158469630283
AREDYLD SYNDROME	0.01917039	0.7182158469630283
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.01917039	0.7182158469630283
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.01917039	0.7182158469630283
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.01917039	0.7182158469630283
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.019147764	0.7173681671947301
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.019082104	0.714908224934213
SALT-AND-PEPPER SYNDROME	0.019082104	0.714908224934213
HARROD SYNDROME	0.019059919	0.7140770671661723
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.018915309999999998	0.7086593122110837
VAN DEN BOSCH SYNDROME	0.0188679	0.7068831035213015
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0188679	0.7068831035213015
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7068831035213015
HEREDITARY CHRONIC PANCREATITIS	0.0188679	0.7068831035213015
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7068831035213015
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7068831035213015
CARPAL DISPLACEMENT	0.0188679	0.7068831035213015
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7068831035213015
VESICOURETERAL REFLUX 1	0.0188679	0.7068831035213015
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7068831035213015
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7068831035213015
RAYNAUD DISEASE	0.0188679	0.7068831035213015
TRACHEOBRONCHOMEGALY	0.0188679	0.7068831035213015
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7068831035213015
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7068831035213015
OSTEOPETROSIS AND RELATED DISORDERS	0.0188679	0.7068831035213015
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7068831035213015
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7068831035213015
IVIC SYNDROME	0.0188679	0.7068831035213015
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7068831035213015
TOE, MISSHAPEN	0.0188679	0.7068831035213015
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.7068831035213015
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0188679	0.7068831035213015
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7068831035213015
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7068831035213015
PUBIC BONE DYSPLASIA	0.0188679	0.7068831035213015
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7068831035213015
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0188679	0.7068831035213015
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0188679	0.7068831035213015
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7068831035213015
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7068831035213015
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7068831035213015
KNUCKLE PADS	0.0188679	0.7068831035213015
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7068831035213015
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	0.0188679	0.7068831035213015
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7068831035213015
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	0.0188679	0.7068831035213015
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7068831035213015
THROMBOCYTOPENIA 3	0.0188679	0.7068831035213015
PYOMYOSITIS	0.0188679	0.7068831035213015
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7068831035213015
SPINAL ARACHNOIDITIS	0.0188679	0.7068831035213015
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7068831035213015
IVIC SYNDROME	0.0188679	0.7068831035213015
CHRONIC MYELOID LEUKEMIA	0.0188679	0.7068831035213015
MONOPHALANGY OF GREAT TOE	0.0188679	0.7068831035213015
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7068831035213015
RHEUMATIC FEVER	0.01881293	0.7048236605413954
PFAPA SYNDROME	0.01881293	0.7048236605413954
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.01877076	0.7032437676823337
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.018636459	0.6982122004339375
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.018629683	0.6979583385887157
JOUBERT SYNDROME WITH RENAL DEFECT	0.018629683	0.6979583385887157
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.694469124416484
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.694469124416484
THYMIC TUMOR	0.01853424	0.694382580605613
REYNOLDS SYNDROME	0.01853282	0.6943293805140818
SHORT RIB-POLYDACTYLY SYNDROME	0.0185185	0.6937928838163876
OSTEOARTHRITIS	0.0185185	0.6937928838163876
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.0185185	0.6937928838163876
EXSTROPHY OF BLADDER	0.0185185	0.6937928838163876
THORACOMELIC DYSPLASIA	0.0185185	0.6937928838163876
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.0185185	0.6937928838163876
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0185185	0.6937928838163876
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0185185	0.6937928838163876
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0185185	0.6937928838163876
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0185185	0.6937928838163876
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.0185185	0.6937928838163876
MEIER-GORLIN SYNDROME 1; MGORS1	0.0185185	0.6937928838163876
ISOLATED EPISPADIAS	0.0185185	0.6937928838163876
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.0185185	0.6937928838163876
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0185185	0.6937928838163876
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0185185	0.6937928838163876
MOEBIUS SYNDROME; MBS	0.0185185	0.6937928838163876
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.0185185	0.6937928838163876
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0185185	0.6937928838163876
ATELOSTEOGENESIS, TYPE II	0.0185185	0.6937928838163876
HYPOCHONDROPLASIA	0.0185185	0.6937928838163876
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.0185185	0.6937928838163876
HYPOCHONDROPLASIA	0.0185185	0.6937928838163876
OSTEOPATHIA STRIATA-PIGMENTARY DERMOPATHY-WHITE FORELOCK SYNDROME	0.0185185	0.6937928838163876
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.018435154	0.6906703381623356
KABUKI SYNDROME	0.018431019	0.6905154209943911
ADAMS-OLIVER SYNDROME	0.018329689	0.6867191074205534
PRADER-WILLI SYNDROME	0.018316568999999998	0.6862275685466882
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.018246604	0.6836063400931843
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01820571	0.6820742523867941
SYSTEMIC MASTOCYTOSIS	0.01809504	0.677928017084153
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.017893793999999998	0.6703883652388893
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01789329	0.6703694829528811
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.0178896	0.6702312376446066
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.017788270000000002	0.666434924070769
APPARENT MINERALOCORTICOID EXCESS	0.01777515	0.6659433851969038
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.017594714	0.6591833769465437
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.017542710000000003	0.6572350547212022
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.017542710000000003	0.6572350547212022
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.01750916	0.6559781088966461
CONGENITAL TOXOPLASMOSIS	0.017455313000000004	0.6539607389468738
YELLOW FEVER	0.017424540000000002	0.652807833019629
MYOPATHY, CONGENITAL	0.0172414	0.6459465198062406
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6459465198062406
269800 SENILE PLAQUE FORMATION	0.0172414	0.6459465198062406
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6459465198062406
PALMOMENTAL REFLEX	0.0172414	0.6459465198062406
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6459465198062406
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6459465198062406
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6459465198062406
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6459465198062406
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6459465198062406
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6459465198062406
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6459465198062406
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6459465198062406
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6459465198062406
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6459465198062406
TRANSSEXUALITY	0.0172414	0.6459465198062406
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6459465198062406
CARDIAC ARRHYTHMIA	0.0172414	0.6459465198062406
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6459465198062406
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6459465198062406
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6459465198062406
DIASTEMATOMYELIA	0.0172414	0.6459465198062406
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6459465198062406
MOSAIC TRISOMY 15	0.0172414	0.6459465198062406
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6459465198062406
ERYTHERMALGIA, PRIMARY	0.0172414	0.6459465198062406
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6459465198062406
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6459465198062406
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6459465198062406
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6459465198062406
ALCOHOL DEPENDENCE	0.0172414	0.6459465198062406
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6459465198062406
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6459465198062406
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6459465198062406
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6459465198062406
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6459465198062406
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6459465198062406
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6459465198062406
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6459465198062406
MOTION SICKNESS	0.0172414	0.6459465198062406
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6459465198062406
CERVICAL RIB	0.0172414	0.6459465198062406
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.017123259999999998	0.6415204220502629
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.017123259999999998	0.6415204220502629
WILSON DISEASE	0.01712241	0.6414885769250508
BABESIOSIS	0.01700424	0.6370613552234777
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064	0.6311727794583387
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064	0.6311727794583387
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.016674229	0.624697541557083
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.016674229	0.624697541557083
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.016674229	0.624697541557083
HUNTINGTON DISEASE-LIKE 1	0.016674229	0.624697541557083
ALZHEIMER DISEASE 3; AD	0.016674229	0.624697541557083
ACQUIRED GENERALIZED LIPODYSTROPHY	0.01658256	0.6212631759299229
GLIOBLASTOMA	0.016556059	0.6202703198555098
SAETHRE-CHOTZEN SYNDROME	0.016491739000000002	0.6178605804982688
CERNUNNOS-XLF DEFICIENCY	0.01635279	0.612654876612241
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.016330063000000002	0.6118034128937706
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6107336789406097
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6107336789406097
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6107336789406097
AUTOSOMAL AGAMMAGLOBULINEMIA	0.01615187	0.6051274383091176
PROGRESSIVE SUPRANUCLEAR PALSY	0.01613281	0.6044133582072985
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.01613281	0.6044133582072985
ALZHEIMER DISEASE 4	0.01613281	0.6044133582072985
CORTICOBASAL SYNDROME	0.01613281	0.6044133582072985
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.01613281	0.6044133582072985
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.01613281	0.6044133582072985
ALZHEIMER DISEASE 10	0.01613281	0.6044133582072985
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.01613281	0.6044133582072985
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.01613281	0.6044133582072985
CREUTZFELDT-JAKOB DISEASE; CJD	0.01613281	0.6044133582072985
HUNTINGTON DISEASE-LIKE 2	0.01613281	0.6044133582072985
MANGANESE POISONING	0.01601464	0.5999861365057253
PITUICYTOMA	0.01601464	0.5999861365057253
PINEOCYTOMA	0.01601464	0.5999861365057253
PAPILLARY TUMOR OF THE PINEAL REGION	0.01601464	0.5999861365057253
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.015894980000000003	0.5955030921728978
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.015894980000000003	0.5955030921728978
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.015894980000000003	0.5955030921728978
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.015823363	0.5928199717819221
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.015784509000000002	0.5913643123760416
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.015472860000000001	0.5796884283439389
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.015472860000000001	0.5796884283439389
AMYLOIDOSIS, FAMILIAL VISCERAL	0.015472860000000001	0.5796884283439389
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.015472860000000001	0.5796884283439389
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.015472860000000001	0.5796884283439389
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.015472860000000001	0.5796884283439389
DENYS-DRASH SYNDROME	0.015472860000000001	0.5796884283439389
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.015472860000000001	0.5796884283439389
LIDDLE SYNDROME	0.015472860000000001	0.5796884283439389
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.015470953999999999	0.5796170203337568
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.5796170203337568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5796170203337568
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5796170203337568
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5796170203337568
CEDNIK SYNDROME	0.015437462999999998	0.5783622849355391
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.015298430000000002	0.5731534340018436
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.015298430000000002	0.5731534340018436
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.015295189	0.5730320104126517
ROIFMAN SYNDROME; RFMN	0.015281944	0.5725357884321377
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.015243090000000003	0.571080129026257
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.015243090000000003	0.571080129026257
LEISHMANIASIS	0.015243090000000003	0.571080129026257
KAPOSIFORM LYMPHANGIOMATOSIS	0.015243090000000003	0.571080129026257
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.015243090000000003	0.571080129026257
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.015243090000000003	0.571080129026257
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.015243090000000003	0.571080129026257
TANGIER DISEASE	0.015243090000000003	0.571080129026257
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.015243090000000003	0.571080129026257
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.015243090000000003	0.571080129026257
RETICULOENDOTHELIOSIS, X-LINKED	0.015243090000000003	0.571080129026257
MULTIPLE MYELOMA	0.015243090000000003	0.571080129026257
INTERMEDIATE OSTEOPETROSIS	0.015243090000000003	0.571080129026257
ACUTE ERYTHROID LEUKEMIA	0.015243090000000003	0.571080129026257
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.015234744	0.5707674473615254
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.015180260000000001	0.5687262123002703
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.015171473	0.5683970086352815
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.015171473	0.5683970086352815
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.015171473	0.5683970086352815
HENNEKAM-BEEMER SYNDROME	0.015082209000000001	0.5650527459800457
CORNELIA DE LANGE SYNDROME 1	0.015082209000000001	0.5650527459800457
LCAT DEFICIENCY	0.01505256	0.5639419505477875
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.014975873	0.561068883351134
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.014941243	0.5597714754851318
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.014941243	0.5597714754851318
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5591779198160278
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5591779198160278
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5591779198160278
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5591779198160278
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.014918959999999998	0.5589366461614781
FUNCTIONING GONADOTROPIC ADENOMA	0.014900150000000001	0.5582319322729566
DENGUE FEVER	0.014900150000000001	0.5582319322729566
AYMÉ-GRIPP SYNDROME	0.014896043999999999	0.5580781015857547
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.014891908999999998	0.5579231844178101
FLOATING-HARBOR SYNDROME	0.014827829999999998	0.555522474090188
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014785572999999998	0.5539393217888985
CITRULLINEMIA, CLASSIC	0.014785572999999998	0.5539393217888985
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01475377	0.5527478270628671
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.01475377	0.5527478270628671
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.01475377	0.5527478270628671
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.01473639	0.5520966879144086
PELGER-HUET ANOMALY; PHA	0.014730664000000001	0.5518821641650373
MEND SYNDROME; MEND	0.014725863	0.5517022954048677
MEND SYNDROME	0.014725863	0.5517022954048677
BARAITSER-WINTER SYNDROME 1; BRWS1	0.014725863	0.5517022954048677
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.014725863	0.5517022954048677
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.014630054	0.5481128252854971
KEPPEN-LUBINSKY SYNDROME	0.014625919	0.5479579081175525
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.014540790000000001	0.5447685626302612
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.014540790000000001	0.5447685626302612
CASPASE 8 DEFICIENCY	0.014540790000000001	0.5447685626302612
IMMUNODEFICIENCY 55; IMD55	0.01450616	0.543471154764259
RIGID SPINE SYNDROME	0.014434454000000001	0.5407847000013496
TENORIO SYNDROME; TNORS	0.014430319	0.540629782833405
FAMILIAL COLD URTICARIA	0.01438535	0.5389450258502617
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.01438535	0.5389450258502617
NIEMANN-PICK DISEASE TYPE C	0.014260423000000001	0.5342646541356774
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5336551384391139
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5336551384391139
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.5336551384391139
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5336551384391139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5336551384391139
STURGE-WEBER SYNDROME	0.014240018999999998	0.5335002212711694
TRISOMY 17P	0.014184444000000001	0.5314181120550832
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.014184444000000001	0.5314181120550832
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.014184444000000001	0.5314181120550832
3C SYNDROME	0.014184444000000001	0.5314181120550832
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.014180309	0.5312631948871386
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0140845	0.527673724767768
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.0140845	0.527673724767768
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.0140845	0.527673724767768
EHLERS-DANLOS SYNDROME, TYPE VI	0.0140845	0.527673724767768
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.0140845	0.527673724767768
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.0140845	0.527673724767768
LEPTIN DEFICIENCY OR DYSFUNCTION	0.0140845	0.527673724767768
MEIER-GORLIN SYNDROME 3; MGORS3	0.0140845	0.527673724767768
PULMONARY BLASTOMA	0.0140845	0.527673724767768
CILIARY DYSKINESIA, PRIMARY, 33	0.0140845	0.527673724767768
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.0140845	0.527673724767768
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.0140845	0.527673724767768
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0140845	0.527673724767768
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.0140845	0.527673724767768
EMANUEL SYNDROME	0.014073973	0.527279332258227
EMANUEL SYNDROME	0.014073973	0.527279332258227
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.014073973	0.527279332258227
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.014073973	0.527279332258227
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.013999114	0.5244747508132065
CYCLIC VOMITING SYNDROME	0.013994979000000001	0.524319833645262
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.013994979000000001	0.524319833645262
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.013994979000000001	0.524319833645262
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.013994979000000001	0.524319833645262
CARTILAGE-HAIR HYPOPLASIA	0.013987389999999999	0.524035512874396
WITTEVEEN-KOLK SYNDROME	0.013944783	0.5224392478744897
COFFIN-SIRIS SYNDROME 2; CSS2	0.013944783	0.5224392478744897
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.013888900000000001	0.5203455994836206
MOUNIER-KÜHN SYNDROME	0.013888900000000001	0.5203455994836206
215030 CHOLESTEROL PNEUMONIA	0.013888900000000001	0.5203455994836206
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.013888900000000001	0.5203455994836206
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.013888900000000001	0.5203455994836206
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.013888900000000001	0.5203455994836206
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.013888900000000001	0.5203455994836206
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.013888900000000001	0.5203455994836206
IMMUNODEFICIENCY 32B; IMD32B	0.013888900000000001	0.5203455994836206
IMMUNODEFICIENCY 13; IMD13	0.013888900000000001	0.5203455994836206
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.013888900000000001	0.5203455994836206
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.013888900000000001	0.5203455994836206
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.013888900000000001	0.5203455994836206
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.013888900000000001	0.5203455994836206
LAZY LEUKOCYTE SYNDROME	0.01385427	0.5190481916176183
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.01385427	0.5190481916176183
IMMUNODEFICIENCY 36; IMD36	0.01380979	0.5173817549476853
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.5132160379213849
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.5132160379213849
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.5132160379213849
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.5132160379213849
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5132160379213849
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.5132160379213849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5132160379213849
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	0.5132160379213849
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5132160379213849
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.5132160379213849
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5132160379213849
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5132160379213849
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5132160379213849
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.013698599999999998	0.5132160379213849
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.5132160379213849
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.5132160379213849
ACYS AMYLOIDOSIS	0.013698599999999998	0.5132160379213849
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5132160379213849
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5132160379213849
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5132160379213849
STROKE, ISCHEMIC	0.013698599999999998	0.5132160379213849
WEILL-MARCHESANI SYNDROME	0.01363889	0.5109790115373541
MCDONOUGH SYNDROME	0.01363889	0.5109790115373541
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.01363889	0.5109790115373541
PFEIFFER-PALM-TELLER SYNDROME	0.01363889	0.5109790115373541
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.01363889	0.5109790115373541
MUCOLIPIDOSIS III GAMMA	0.01363889	0.5109790115373541
WEILL-MARCHESANI SYNDROME 3	0.01363889	0.5109790115373541
TEEBI-SHALTOUT SYNDROME; TBSH	0.01363889	0.5109790115373541
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.01363889	0.5109790115373541
WILLIAMS-BEUREN SYNDROME (WBS)	0.01363889	0.5109790115373541
WEILL-MARCHESANI SYNDROME 1; WMS1	0.01363889	0.5109790115373541
POLYVALVULAR HEART DISEASE SYNDROME	0.01363889	0.5109790115373541
MERRF	0.013560790000000001	0.5080530065031419
RITSCHER-SCHINZEL SYNDROME 1	0.013532554	0.5069951489084424
OKAMOTO SYNDROME	0.013532554	0.5069951489084424
EPISODIC ATAXIA TYPE 7	0.01345356	0.5040356502954775
OCULOCEREBRORENAL SYNDROME OF LOWE	0.013397209	0.501924468353315
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.013366763	0.5007838134330637
8P11.2 DELETION SYNDROME	0.013366763	0.5007838134330637
WOLMAN DISEASE	0.013264254000000001	0.4969433287973138
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.013245644000000003	0.49624610787943046
BANGSTAD SYNDROME	0.013241509000000002	0.4960911907114859
COG5-CDG	0.013241509000000002	0.4960911907114859
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.013241509000000002	0.4960911907114859
ACROMEGALY	0.01322858	0.4956068076245802
SOMATOMAMMOTROPINOMA	0.01322858	0.4956068076245802
CRANIOPHARYNGIOMA	0.013174723	0.49358906302627586
ACQUIRED ICHTHYOSIS	0.0131579	0.49295879180104474
MUCOUS MEMBRANE PEMPHIGOID	0.0131579	0.49295879180104474
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0131579	0.49295879180104474
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0131579	0.49295879180104474
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.0131579	0.49295879180104474
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.0131579	0.49295879180104474
INCLUSION BODY MYOSITIS	0.0131579	0.49295879180104474
PEMPHIGUS VULGARIS	0.0131579	0.49295879180104474
ALOPECIA AREATA 1	0.0131579	0.49295879180104474
LINEAR IGA DERMATOSIS	0.0131579	0.49295879180104474
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2	0.0131579	0.49295879180104474
IMMUNODEFICIENCY 22; IMD22	0.0131579	0.49295879180104474
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.013135173000000002	0.49210732808257435
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.013135173000000002	0.49210732808257435
MELANOSIS, NEUROCUTANEOUS; NCMS	0.013135173000000002	0.49210732808257435
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.013135173000000002	0.49210732808257435
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.013135173000000002	0.49210732808257435
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.013135173000000002	0.49210732808257435
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.013135173000000002	0.49210732808257435
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.013135173000000002	0.49210732808257435
CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL	0.012987	0.48655604839071337
ATRIAL SEPTAL DEFECT 1	0.012987	0.48655604839071337
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.012987	0.48655604839071337
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.012987	0.48655604839071337
WEILL-MARCHESANI SYNDROME 2; WMS2	0.012987	0.48655604839071337
ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13	0.012987	0.48655604839071337
ISOTRETINOIN-LIKE SYNDROME	0.012987	0.48655604839071337
SCHEIE SYNDROME	0.012987	0.48655604839071337
XFE PROGEROID SYNDROME; XFEPS	0.01294847	0.48511252759726653
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012908900000000001	0.48363004335650117
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.012718700000000001	0.4765042282795847
ALPHA-HEAVY CHAIN DISEASE	0.012718700000000001	0.4765042282795847
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.012718700000000001	0.4765042282795847
FETAL PARVOVIRUS SYNDROME	0.012718700000000001	0.4765042282795847
EOSINOPHILIC GASTROENTERITIS	0.012718700000000001	0.4765042282795847
HEPATOCELLULAR CARCINOMA	0.012718700000000001	0.4765042282795847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.012718700000000001	0.4765042282795847
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.012700090000000002	0.4758070073617014
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.012700090000000002	0.4758070073617014
DAHLBERG-BORER-NEWCOMER SYNDROME	0.012700090000000002	0.4758070073617014
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.012700090000000002	0.4758070073617014
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.012700090000000002	0.4758070073617014
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.012700090000000002	0.4758070073617014
CYSTINOSIS	0.012700090000000002	0.4758070073617014
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012691744	0.47549432569696976
WRINKLY SKIN SYNDROME	0.012691744	0.47549432569696976
NARP SYNDROME	0.012609713	0.4724210463248639
SPINOCEREBELLAR ATAXIA TYPE 7	0.012593754000000002	0.47182314473278986
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.012593754000000002	0.47182314473278986
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.012593754000000002	0.47182314473278986
LIG4 SYNDROME	0.012593754000000002	0.47182314473278986
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.012593754000000002	0.47182314473278986
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.012593754000000002	0.47182314473278986
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.012593754000000002	0.47182314473278986
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.012593754000000002	0.47182314473278986
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.012589619000000002	0.4716682275648453
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.012589619000000002	0.4716682275648453
SECKEL SYNDROME 1; SCKL1	0.012589619000000002	0.4716682275648453
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.012589619000000002	0.4716682275648453
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.012589619000000002	0.4716682275648453
METACHROMATIC LEUKODYSTROPHY	0.012589619000000002	0.4716682275648453
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.012589619000000002	0.4716682275648453
HYPERPROLINEMIA TYPE 1	0.012589619000000002	0.4716682275648453
KNOBLOCH SYNDROME 1; KNO1	0.012589619000000002	0.4716682275648453
NEURONAL CEROID LIPOFUSCINOSIS	0.012589619000000002	0.4716682275648453
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.012589619000000002	0.4716682275648453
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.012589619000000002	0.4716682275648453
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.012589619000000002	0.4716682275648453
EARLY-ONSET LAFORA BODY DISEASE	0.012589619000000002	0.4716682275648453
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.012589619000000002	0.4716682275648453
FETAL GAUCHER DISEASE	0.012589619000000002	0.4716682275648453
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.012589619000000002	0.4716682275648453
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.012589619000000002	0.4716682275648453
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.012589619000000002	0.4716682275648453
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.012589619000000002	0.4716682275648453
LATHOSTEROLOSIS	0.012589619000000002	0.4716682275648453
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4713555459001136
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.012536760000000001	0.46968787289002545
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.01241859	0.4652606511884523
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.01234101	0.4623541278778992
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.01234101	0.4623541278778992
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.01227979	0.4600605295655501
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.012265162999999999	0.4595125311579262
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.012234674	0.45837026524898766
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.012234674	0.45837026524898766
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.012234674	0.45837026524898766
WILSON DISEASE	0.0122039	0.4572173218568898
AICARDI-GOUTIERES SYNDROME 6	0.012173454	0.45607666693663845
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.012169319	0.45592174976869393
ACUTE BILIRUBIN ENCEPHALOPATHY	0.012169319	0.45592174976869393
LOWE-KOHN-COHEN SYNDROME	0.012048200000000002	0.4513840442150608
AA AMYLOIDOSIS	0.012048200000000002	0.4513840442150608
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.012048200000000002	0.4513840442150608
MODY	0.012048200000000002	0.4513840442150608
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.012048200000000002	0.4513840442150608
FGFR2-RELATED BENT BONE DYSPLASIA	0.012048200000000002	0.4513840442150608
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.012048200000000002	0.4513840442150608
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.012048200000000002	0.4513840442150608
KURU, SUSCEPTIBILITY TO	0.012048200000000002	0.4513840442150608
WILD TYPE ATTR AMYLOIDOSIS	0.012048200000000002	0.4513840442150608
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.012048200000000002	0.4513840442150608
RENAL TUBULAR DYSGENESIS	0.012048200000000002	0.4513840442150608
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.012048200000000002	0.4513840442150608
FAMILIAL PANCREATIC CARCINOMA	0.012048200000000002	0.4513840442150608
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.012048200000000002	0.4513840442150608
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.012048200000000002	0.4513840442150608
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.012048200000000002	0.4513840442150608
WOODHOUSE-SAKATI SYNDROME	0.012048200000000002	0.4513840442150608
HYPERLIPOPROTEINEMIA, TYPE I	0.012048200000000002	0.4513840442150608
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.012048200000000002	0.4513840442150608
NEUTROPHILIA, HEREDITARY	0.012048200000000002	0.4513840442150608
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.012048200000000002	0.4513840442150608
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.012048200000000002	0.4513840442150608
DE SANCTIS-CACCHIONE SYNDROME	0.012048200000000002	0.4513840442150608
%614227 HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3	0.012048200000000002	0.4513840442150608
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.012048200000000002	0.4513840442150608
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.012048200000000002	0.4513840442150608
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.012048200000000002	0.4513840442150608
ATAXIA WITH VITAMIN E DEFICIENCY	0.012048200000000002	0.4513840442150608
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.012048200000000002	0.4513840442150608
DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY	0.012048200000000002	0.4513840442150608
PENDRED SYNDROME	0.012048200000000002	0.4513840442150608
ENAMEL-RENAL SYNDROME	0.012048200000000002	0.4513840442150608
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.012048200000000002	0.4513840442150608
ATTRV30M AMYLOIDOSIS	0.012048200000000002	0.4513840442150608
INDOMETHACIN EMBRYOFETOPATHY	0.012048200000000002	0.4513840442150608
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.012048200000000002	0.4513840442150608
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.012048200000000002	0.4513840442150608
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.012048200000000002	0.4513840442150608
RICHARDS-RUNDLE SYNDROME	0.012048200000000002	0.4513840442150608
BENT BONE DYSPLASIA SYNDROME; BBDS	0.012048200000000002	0.4513840442150608
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.012048200000000002	0.4513840442150608
OPTICOCOCHLEODENTATE DEGENERATION	0.012048200000000002	0.4513840442150608
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.012048200000000002	0.4513840442150608
SPINOCEREBELLAR ATAXIA TYPE 17	0.012048200000000002	0.4513840442150608
BECKWITH-WIEDEMANN SYNDROME	0.012048200000000002	0.4513840442150608
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.012048200000000002	0.4513840442150608
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.012048200000000002	0.4513840442150608
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.012048200000000002	0.4513840442150608
MADELUNG DEFORMITY	0.012048200000000002	0.4513840442150608
IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13	0.012048200000000002	0.4513840442150608
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012039854	0.4510713625503291
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.4510713625503291
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.4510713625503291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.4510713625503291
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.4510713625503291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.4510713625503291
FUMARASE DEFICIENCY; FMRD	0.012039854	0.4510713625503291
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.4510713625503291
PEHO-LIKE SYNDROME; PEHOL	0.012039854	0.4510713625503291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.4510713625503291
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.4510713625503291
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.4510713625503291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.4510713625503291
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.012039854	0.4510713625503291
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.4510713625503291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.4510713625503291
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.012039854	0.4510713625503291
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.4510713625503291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.4510713625503291
PERLMAN SYNDROME	0.012039854	0.4510713625503291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.4510713625503291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.4510713625503291
RING CHROMOSOME 14 SYNDROME	0.012039854	0.4510713625503291
RHABDOID TUMOR	0.01199589	0.44942425774464273
CITRULLINEMIA TYPE II	0.011725273	0.43928563156867056
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.011723744	0.4392283478081417
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.011723744	0.4392283478081417
NOONAN SYNDROME 9; NS9	0.011723744	0.4392283478081417
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.011723744	0.4392283478081417
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.011719608999999999	0.4390734306401971
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.011719608999999999	0.4390734306401971
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.011689119999999999	0.4379311647312586
CIRRHOSIS, FAMILIAL	0.011689119999999999	0.4379311647312586
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.011689119999999999	0.4379311647312586
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.0116279	0.43563756641890944
GLYCOGEN STORAGE DISEASE VII	0.0116279	0.43563756641890944
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.0116279	0.43563756641890944
SPHEROCYTOSIS, TYPE 2	0.0116279	0.43563756641890944
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.0116279	0.43563756641890944
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0116279	0.43563756641890944
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.0116279	0.43563756641890944
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.0116279	0.43563756641890944
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0116279	0.43563756641890944
ELLIPTOCYTOSIS 1; EL1	0.0116279	0.43563756641890944
SPECTRIN, BETA, ERYTHROCYTIC	0.0116279	0.43563756641890944
HEPATOERYTHROPOIETIC PORPHYRIA	0.0116279	0.43563756641890944
SPHEROCYTOSIS, AUTOSOMAL RECESSIVE	0.0116279	0.43563756641890944
GALACTOSEMIA	0.0116279	0.43563756641890944
OVALOCYTOSIS, HEREDITARY HEMOLYTIC	0.0116279	0.43563756641890944
URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIADUE TO	0.0116279	0.43563756641890944
GLUTATHIONE REDUCTASE	0.0116279	0.43563756641890944
6-@PHOSPHOGLUCONOLACTONASE DEFICIENCY	0.0116279	0.43563756641890944
SPHEROCYTOSIS, TYPE 1; SPH1	0.0116279	0.43563756641890944
PORPHYRIA, ACUTE HEPATIC	0.0116279	0.43563756641890944
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.0116279	0.43563756641890944
OVERHYDRATED HEREDITARY STOMATOCYTOSIS	0.0116279	0.43563756641890944
ELLIPTOCYTOSIS 2; EL2	0.0116279	0.43563756641890944
PYROPOIKILOCYTOSIS, HEREDITARY	0.0116279	0.43563756641890944
GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIADUE TO	0.0116279	0.43563756641890944
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0116279	0.43563756641890944
ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO	0.0116279	0.43563756641890944
RH-NULL, REGULATOR TYPE; RHNR	0.0116279	0.43563756641890944
CATEL-MANZKE SYNDROME; CATMANS	0.011613272999999999	0.43508956801128545
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.011613272999999999	0.43508956801128545
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.011613272999999999	0.43508956801128545
8Q24.3 MICRODELETION SYNDROME	0.011613272999999999	0.43508956801128545
HARTNUP DISEASE	0.011542783000000001	0.43244867050985636
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.4306322620326
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4306322620326
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4306322620326
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4306322620326
DESMOSTEROLOSIS	0.011494299999999999	0.4306322620326
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4306322620326
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4306322620326
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.01145935	0.4293228654135768
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.011424723000000001	0.4280255699421342
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.011424723000000001	0.4280255699421342
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.011424723000000001	0.4280255699421342
GRACILE BONE DYSPLASIA; GCLEB	0.011262673	0.42195439048254263
OBESITY DUE TO SIM1 DEFICIENCY	0.011183854	0.4190014482188861
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.011179719	0.41884653105094155
CRIGLER-NAJJAR SYNDROME TYPE 1	0.011179719	0.41884653105094155
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.011179719	0.41884653105094155
CRIGLER-NAJJAR SYNDROME	0.011179719	0.41884653105094155
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.011179719	0.41884653105094155
SIFRIM-HITZ-WEISS SYNDROME	0.01117819	0.4187892472904126
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01117819	0.4187892472904126
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01117819	0.4187892472904126
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.01117819	0.4187892472904126
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01117819	0.4187892472904126
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.01117819	0.4187892472904126
DOUBLE OUTLET RIGHT VENTRICLE	0.01117819	0.4187892472904126
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.011071853999999999	0.41480538466150096
16P13.11 MICRODUPLICATION SYNDROME	0.011071853999999999	0.41480538466150096
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.011067718999999998	0.41465046749355644
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.011067718999999998	0.41465046749355644
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.010998123	0.41204306357087994
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.01098964	0.4117252492212613
DISTAL 16P11.2 MICRODELETION SYNDROME	0.010890893	0.4080257073632157
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.010883304	0.40774138659234965
X-LINKED ADRENOLEUKODYSTROPHY	0.010870850000000001	0.4072747993107097
LYMPHEDEMA, HEREDITARY, III	0.010721254000000001	0.40167020713275814
NEURAMINIDASE DEFICIENCY	0.010717119	0.40151528996481356
MYXEDEMA	0.0106383	0.39856234770115706
POSTERIOR CORTICAL ATROPHY	0.0106383	0.39856234770115706
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.0106383	0.39856234770115706
MACHADO-JOSEPH DISEASE TYPE 2	0.0106383	0.39856234770115706
MACHADO-JOSEPH DISEASE TYPE 3	0.0106383	0.39856234770115706
MACHADO-JOSEPH DISEASE TYPE 1	0.0106383	0.39856234770115706
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0106383	0.39856234770115706
SPINOCEREBELLAR ATAXIA TYPE 1	0.0106383	0.39856234770115706
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.0106383	0.39856234770115706
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0106383	0.39856234770115706
SPINOCEREBELLAR ATAXIA TYPE 27	0.0106383	0.39856234770115706
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.0106383	0.39856234770115706
SPINOCEREBELLAR ATAXIA TYPE 28	0.0106383	0.39856234770115706
SPASTIC PARAPLEGIA TYPE 7	0.0106383	0.39856234770115706
WERNICKE-KORSAKOFF SYNDROME	0.0106383	0.39856234770115706
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.0106383	0.39856234770115706
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0106383	0.39856234770115706
INFANTILE SIALIC ACID STORAGE DISEASE	0.010610783	0.397531427335902
FREE SIALIC ACID STORAGE DISEASE	0.010610783	0.397531427335902
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6	0.010526299999999999	0.39436628414377195
OTOMANDIBULAR SYNDROME	0.010526299999999999	0.39436628414377195
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.010526299999999999	0.39436628414377195
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	0.010526299999999999	0.39436628414377195
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.010526299999999999	0.39436628414377195
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.010526299999999999	0.39436628414377195
MOSAIC TRISOMY 1	0.010526299999999999	0.39436628414377195
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.010526299999999999	0.39436628414377195
PHAVER SYNDROME	0.010526299999999999	0.39436628414377195
TRICUSPID ATRESIA	0.010526299999999999	0.39436628414377195
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.010526299999999999	0.39436628414377195
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.010526299999999999	0.39436628414377195
CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA	0.010526299999999999	0.39436628414377195
METHIMAZOLE EMBRYOFETOPATHY	0.010526299999999999	0.39436628414377195
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.010526299999999999	0.39436628414377195
COARCTATION OF AORTA	0.010526299999999999	0.39436628414377195
HEMIFACIAL MICROSOMIA	0.010526299999999999	0.39436628414377195
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.010451854	0.39157717568311934
BERNARD-SOULIER SYNDROME	0.010345339	0.3875866068454866
SUBEPENDYMOMA	0.010345339	0.3875866068454866
CITRULLINEMIA TYPE I	0.010345339	0.3875866068454866
ATYPICAL TERATOID RHABDOID TUMOR	0.010345339	0.3875866068454866
EPISODIC ATAXIA TYPE 6	0.010345339	0.3875866068454866
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.010345339	0.3875866068454866
EPENDYMOMA	0.010345339	0.3875866068454866
RABIES	0.010345339	0.3875866068454866
VIRAL HEMORRHAGIC FEVER	0.010345339	0.3875866068454866
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.010345339	0.3875866068454866
EPISODIC ATAXIA, TYPE 6	0.010345339	0.3875866068454866
MALAN OVERGROWTH SYNDROME	0.010345339	0.3875866068454866
AARSKOG-SCOTT SYNDROME	0.010341593999999999	0.38744630097028654
CYCLIC NEUTROPENIA	0.01033775	0.3873022860746205
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.01033775	0.3873022860746205
TOXIC EPIDERMAL NECROLYSIS	0.01033775	0.3873022860746205
THROMBOCYTOPENIA 5; THC5	0.01033775	0.3873022860746205
IMMUNODEFICIENCY 46; IMD46	0.01033775	0.3873022860746205
ROTHMUND-THOMSON SYNDROME TYPE 2	0.01033775	0.3873022860746205
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.010231123000000002	0.3833075211734305
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.010175700000000001	0.3812311066150291
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010065229	0.37709232681817295
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.010065229	0.37709232681817295
HENNEKAM SYNDROME	0.010065229	0.37709232681817295
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.010065229	0.37709232681817295
PSEUDO-TORCH SYNDROME 2	0.010065229	0.37709232681817295
MICROHYDRANENCEPHALY; MHAC	0.00991115	0.3713197797033664
XQ12-Q13.3 DUPLICATION SYNDROME	0.00991115	0.3713197797033664
BIOTINIDASE DEFICIENCY	0.009804814	0.3673359170744548
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.3673359170744548
KRABBE DISEASE	0.009804814	0.3673359170744548
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.3673359170744548
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3673359170744548
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.3673359170744548
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3673359170744548
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.3673359170744548
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.3673359170744548
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3673359170744548
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3673359170744548
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3673359170744548
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3673359170744548
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3673359170744548
ARACHNOIDITIS	0.00980392	0.3673024234957021
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.3673024234957021
EPISODIC ATAXIA, TYPE 2	0.00980392	0.3673024234957021
CLASSIC HODGKIN LYMPHOMA	0.00980392	0.3673024234957021
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.3673024234957021
KERION CELSI	0.00980392	0.3673024234957021
LEGIONELLOSIS	0.00980392	0.3673024234957021
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00980392	0.3673024234957021
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.3673024234957021
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.3673024234957021
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.3673024234957021
FAMILIAL PAROXYSMAL ATAXIA	0.00980392	0.3673024234957021
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.3673024234957021
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3671809999065102
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00979604	0.3670072004525575
KEIPERT SYNDROME	0.009796039999999999	0.3670072004525574
TRISOMY 4P	0.009796039999999999	0.3670072004525574
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.009796039999999999	0.3670072004525574
DISTAL TRISOMY 18Q	0.009689704	0.36302333782364593
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.009685569000000002	0.3628684206557014
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.0096609	0.3619442001923341
ENG-STROM SYNDROME	0.0096609	0.3619442001923341
KID SYNDROME	0.0096609	0.3619442001923341
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.009567399	0.35844119895412824
ALPHA-MANNOSIDOSIS	0.009554564	0.3579603375634225
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.009554564	0.3579603375634225
ASPARTYLGLUCOSAMINURIA	0.009550429	0.35780542039547797
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.009550429	0.35780542039547797
OVARIAN FIBROMA	0.00952381	0.3568081434683884
MALIGNANT PERITONEAL MESOTHELIOMA	0.00952381	0.3568081434683884
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00952381	0.3568081434683884
OVARIAN FIBROTHECOMA	0.00952381	0.3568081434683884
GRFOMA	0.00952381	0.3568081434683884
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00952381	0.3568081434683884
HEMOCHROMATOSIS, TYPE 1	0.00952381	0.3568081434683884
GALLBLADDER NEUROENDOCRINE TUMOR	0.00952381	0.3568081434683884
HEREDITARY ANGIOEDEMA	0.00952381	0.3568081434683884
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00952381	0.3568081434683884
CHYLOUS ASCITES	0.00952381	0.3568081434683884
ACQUIRED ANGIOEDEMA	0.00952381	0.3568081434683884
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00952381	0.3568081434683884
SPLENOPORTAL VASCULAR ANOMALIES	0.00952381	0.3568081434683884
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00952381	0.3568081434683884
ADENOCARCINOMA OF OVARY	0.00952381	0.3568081434683884
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00952381	0.3568081434683884
PPOMA	0.00952381	0.3568081434683884
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00952381	0.3568081434683884
BUDD-CHIARI SYNDROME	0.00952381	0.3568081434683884
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00952381	0.3568081434683884
PULMONARY ARTERIAL HYPERTENSION	0.00952381	0.3568081434683884
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00952381	0.3568081434683884
PSEUDOMYXOMA PERITONEI	0.00952381	0.3568081434683884
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00952381	0.3568081434683884
HEPATIC VENO-OCCLUSIVE DISEASE	0.00952381	0.3568081434683884
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00952381	0.3568081434683884
OVARIAN HYPERSTIMULATION SYNDROME	0.00952381	0.3568081434683884
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.009461904	0.3544888442667502
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.009351433	0.35035006446989403
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.009351433	0.35035006446989403
TETRASOMY 5P	0.009351433	0.35035006446989403
KAGAMI-OGATA SYNDROME	0.009351433	0.35035006446989403
TSH-SECRETING PITUITARY ADENOMA	0.009342419	0.3500123562832309
PAINE SYNDROME	0.00925926	0.3468968165567257
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3468968165567257
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3468968165567257
CARNOSINEMIA	0.00925926	0.3468968165567257
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3468968165567257
GAUCHER DISEASE TYPE 2	0.00925926	0.3468968165567257
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3468968165567257
HYDROXYLYSINURIA	0.00925926	0.3468968165567257
GLYCINE ENCEPHALOPATHY	0.00925926	0.3468968165567257
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3468968165567257
CARNOSINASE DEFICIENCY	0.00925926	0.3468968165567257
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3468968165567257
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3468968165567257
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3468968165567257
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.009223120000000001	0.34554283676240527
TRISOMY 20P	0.00914415	0.3425842373059168
ROSAÏ-DORFMAN DISEASE	0.009112649	0.3414040569655491
SUSAC SYNDROME	0.00902598	0.33815701560434364
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.00900901	0.3375212370456934
PSORIASIS 1, SUSCEPTIBILITY TO	0.00900901	0.3375212370456934
WILD TYPE ABETA2M AMYLOIDOSIS	0.00900901	0.3375212370456934
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.00900901	0.3375212370456934
YAO SYNDROME	0.00900901	0.3375212370456934
EOSINOPHILIC FASCIITIS	0.00900901	0.3375212370456934
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00900901	0.3375212370456934
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.00900901	0.3375212370456934
VERTICAL TALUS, CONGENITAL	0.00900901	0.3375212370456934
HEMOCHROMATOSIS, TYPE 2A	0.00900901	0.3375212370456934
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00900901	0.3375212370456934
MELORHEOSTOSIS	0.00900901	0.3375212370456934
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00900901	0.3375212370456934
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.00900901	0.3375212370456934
CINCA SYNDROME; CINCA	0.00900901	0.3375212370456934
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.00900901	0.3375212370456934
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	0.00900901	0.3375212370456934
IMMUNODEFICIENCY 61; IMD61	0.00900901	0.3375212370456934
DRACUNCULIASIS	0.00900901	0.3375212370456934
CAUDAL REGRESSION SEQUENCE	0.00891917	0.3341553946350196
APERT SYNDROME	0.00891917	0.3341553946350196
PRIMARY PROGRESSIVE FREEZING GAIT	0.00891917	0.3341553946350196
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00891635	0.33404974374902113
HURLER-SCHEIE SYNDROME	0.00891635	0.33404974374902113
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00891635	0.33404974374902113
STUVE-WIEDEMANN SYNDROME	0.00891635	0.33404974374902113
COHEN SYNDROME	0.008881723000000001	0.33275244827757855
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.008881723000000001	0.33275244827757855
3Q29 MICRODELETION SYNDROME	0.008810014	0.33006588112010954
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.008810014	0.33006588112010954
ADAMS-OLIVER SYNDROME 5; AOS5	0.008805878999999999	0.32991096395216496
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.008805878999999999	0.32991096395216496
FAMILIAL HYPERALDOSTERONISM TYPE III	0.008801	0.3297281729334464
ALPORT SYNDROME	0.008801	0.3297281729334464
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.008801	0.3297281729334464
FAMILIAL HYPERALDOSTERONISM TYPE II	0.008801	0.3297281729334464
FAMILIAL HYPERALDOSTERONISM TYPE I	0.008801	0.3297281729334464
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.008801	0.3297281729334464
POSTORGASMIC ILLNESS SYNDROME	0.008801	0.3297281729334464
CUSHING DISEASE	0.008801	0.3297281729334464
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.008801	0.3297281729334464
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.008801	0.3297281729334464
ACERULOPLASMINEMIA	0.0086894	0.3255470953173377
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0086894	0.3255470953173377
RAT-BITE FEVER	0.00857123	0.3211198736157646
CAMURATI-ENGELMANN DISEASE	0.00857123	0.3211198736157646
SEVERE HEMOPHILIA A	0.00857123	0.3211198736157646
DIGEORGE SYNDROME; DGS	0.008450273000000001	0.3165882373683483
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.008450273000000001	0.3165882373683483
HELSMOORTEL-VAN DER AA SYNDROME	0.008450273000000001	0.3165882373683483
COFFIN-SIRIS SYNDROME 5	0.008450273000000001	0.3165882373683483
DISTAL MONOSOMY 10Q	0.008450273	0.31658823736834824
SAUL-WILSON SYNDROME; SWILS	0.008340304	0.31246826492779395
COHEN SYNDROME	0.008336169000000001	0.3123133477598495
ASPARTYLGLUCOSAMINURIA; AGU	0.008336169000000001	0.3123133477598495
CARDIOMYOPATHY, DILATED, 2C; CMD2C	0.00826446	0.30962678060238047
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.00826446	0.30962678060238047
PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT	0.00826446	0.30962678060238047
CONGENITAL TRICUSPID STENOSIS	0.00826446	0.30962678060238047
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.00826446	0.30962678060238047
PULMONARY HYPERTENSION, PRIMARY, 4	0.00826446	0.30962678060238047
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.00826446	0.30962678060238047
MELNICK-NEEDLES SYNDROME	0.00826446	0.30962678060238047
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00826446	0.30962678060238047
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.00826446	0.30962678060238047
OROFACIODIGITAL SYNDROME TYPE 2	0.008239694	0.3086989260482537
1Q44 MICRODELETION SYNDROME	0.008239694	0.3086989260482537
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.008229833	0.3083294851309379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.008229833	0.3083294851309379
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.008041974	0.30129137527534144
RABSON-MENDENHALL SYNDROME	0.007908854	0.29630405401856375
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.007908854	0.29630405401856375
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.007798383000000001	0.2921652742217076
PHELAN-MCDERMID SYNDROME	0.007798383000000001	0.2921652742217076
SMITH-LEMLI-OPITZ SYNDROME	0.007798383000000001	0.2921652742217076
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.007798383000000001	0.2921652742217076
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.007798383000000001	0.2921652742217076
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.007798383000000001	0.2921652742217076
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.007798383000000001	0.2921652742217076
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00779475	0.29202916441006493
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00779475	0.29202916441006493
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00779475	0.29202916441006493
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00769414	0.28825982553052465
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00769414	0.28825982553052465
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0076842790000000005	0.2878903846132088
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0076842790000000005	0.2878903846132088
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.28427596290161306
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.28427596290161306
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28427596290161306
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.007587804	0.28427596290161306
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.28427596290161306
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.28427596290161306
W SYNDROME	0.007587804	0.28427596290161306
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28427596290161306
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28427596290161306
SARCOSINEMIA	0.007587804	0.28427596290161306
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.28427596290161306
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2841210457336685
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2841210457336685
PYCNODYSOSTOSIS	0.00749642	0.2808522747576124
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.0073633	0.2758649535008347
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.0073633	0.2758649535008347
VELOCARDIOFACIAL SYNDROME	0.0073633	0.2758649535008347
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0072714400000000005	0.27242343208671516
MACROCEPHALY/AUTISM SYNDROME	0.007256964	0.2718810908719231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007256964	0.2718810908719231
NETHERTON SYNDROME; NETH	0.007256964	0.2718810908719231
JOUBERT SYNDROME 10	0.007256964	0.2718810908719231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.007256964	0.2718810908719231
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.007256964	0.2718810908719231
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.007256964	0.2718810908719231
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.007256964	0.2718810908719231
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.007256964	0.2718810908719231
224250 DYSMYELINATION WITH JAUNDICE	0.007252829000000001	0.2717261737039786
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.007252829000000001	0.2717261737039786
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.007252829000000001	0.2717261737039786
PROTEUS SYNDROME	0.007252829000000001	0.2717261737039786
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.007252829000000001	0.2717261737039786
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.007252829000000001	0.2717261737039786
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.007252829000000001	0.2717261737039786
QAZI-MARKOUIZOS SYNDROME	0.007252829000000001	0.2717261737039786
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.007252829000000001	0.2717261737039786
IMMUNODEFICIENCY 37; IMD37	0.007252829000000001	0.2717261737039786
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.007252829000000001	0.2717261737039786
6Q25 MICRODELETION SYNDROME	0.007233373000000001	0.2709972575202957
COFFIN-SIRIS SYNDROME	0.007233373000000001	0.2709972575202957
COFFIN-SIRIS SYNDROME 4; CSS4	0.007233373000000001	0.2709972575202957
15Q11Q13 MICRODUPLICATION SYNDROME	0.007233373000000001	0.2709972575202957
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007233373000000001	0.2709972575202957
49,XXXXY SYNDROME	0.007233373000000001	0.2709972575202957
COFFIN-SIRIS SYNDROME 3; CSS3	0.007233373000000001	0.2709972575202957
SMITH-MAGENIS SYNDROME	0.007233373000000001	0.2709972575202957
15Q13.3 MICRODELETION SYNDROME	0.007233373000000001	0.2709972575202957
ZTTK SYNDROME; ZTTKS	0.007233373000000001	0.2709972575202957
RUBINSTEIN-TAYBI SYNDROME	0.007233373000000001	0.2709972575202957
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3	0.00714286	0.26760620126342427
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00714286	0.26760620126342427
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00714286	0.26760620126342427
ADULT IDIOPATHIC NEUTROPENIA	0.00714286	0.26760620126342427
%162700 NEUTROPENIA, CHRONIC FAMILIAL;;LEUKOPENIA, BENIGN FAMILIAL	0.00714286	0.26760620126342427
IMMUNODEFICIENCY 50; IMD50	0.00714286	0.26760620126342427
BARTH SYNDROME; BTHS	0.00714286	0.26760620126342427
X-LINKED SEVERE CONGENITAL NEUTROPENIA	0.00714286	0.26760620126342427
NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA	0.00714286	0.26760620126342427
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.00714286	0.26760620126342427
IMMUNODEFICIENCY DUE TO INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE-4 DEFICIENCY	0.00714286	0.26760620126342427
DIAMOND-BLACKFAN ANEMIA 18; DBA18	0.00714286	0.26760620126342427
FELTY SYNDROME	0.00714286	0.26760620126342427
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00714286	0.26760620126342427
ISOLATED ECTOPIA LENTIS	0.0070743	0.2650376109286536
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.263836862383884
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.263836862383884
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.263836862383884
AMISH LETHAL MICROCEPHALY	0.00704225	0.263836862383884
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.263836862383884
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.263836862383884
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.263836862383884
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.263836862383884
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.263836862383884
OLIVER SYNDROME	0.00704225	0.263836862383884
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.263836862383884
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.263836862383884
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.263836862383884
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.263836862383884
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.263836862383884
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.263836862383884
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.263836862383884
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.263836862383884
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00684453	0.2564293116109717
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00684453	0.2564293116109717
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00671141	0.25144199035419407
HISTIOCYTOSIS, FAMILIAL LIPOCHROME	0.00671141	0.25144199035419407
UROCANIC ACIDURIA	0.00671141	0.25144199035419407
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.00671141	0.25144199035419407
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.00671141	0.25144199035419407
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00671141	0.25144199035419407
PSEUDODIASTROPHIC DYSPLASIA	0.00671141	0.25144199035419407
GABRIELE-DE VRIES SYNDROME	0.00671141	0.25144199035419407
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.00671141	0.25144199035419407
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00671141	0.25144199035419407
IMMUNODEFICIENCY 32A	0.00671141	0.25144199035419407
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00671141	0.25144199035419407
IMMUNE DEFICIENCY, FAMILIAL VARIABLE	0.00671141	0.25144199035419407
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00671141	0.25144199035419407
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00671141	0.25144199035419407
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00671141	0.25144199035419407
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00671141	0.25144199035419407
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00671141	0.25144199035419407
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00671141	0.25144199035419407
CYSTIC DISEASE OF LUNG	0.00671141	0.25144199035419407
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00671141	0.25144199035419407
IMMUNODEFICIENCY 9; IMD9	0.00671141	0.25144199035419407
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00671141	0.25144199035419407
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.00671141	0.25144199035419407
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00671141	0.25144199035419407
6Q16 MICRODELETION SYNDROME	0.006691954	0.25071307417051114
DISTAL TRISOMY 6P	0.006691954	0.25071307417051114
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.006691954	0.25071307417051114
17P11.2 MICRODUPLICATION SYNDROME	0.006691954	0.25071307417051114
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.006691954	0.25071307417051114
FLOATING-HARBOR SYNDROME	0.006691954	0.25071307417051114
OHDO SYNDROME	0.006687819000000001	0.2505581570025667
MICROPHTHALMIA, LENZ TYPE	0.006687819000000001	0.2505581570025667
BARAITSER-WINTER SYNDROME 2; BRWS2	0.006687819000000001	0.2505581570025667
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.006687819000000001	0.2505581570025667
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.006687819000000001	0.2505581570025667
BOWEN-CONRADI SYNDROME	0.006687819000000001	0.2505581570025667
ISOLATED SPINA BIFIDA	0.006687819000000001	0.2505581570025667
ADNP SYNDROME	0.006687819000000001	0.2505581570025667
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00661955	0.24800046894007444
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.006581483000000001	0.24657429437365502
DUANE RETRACTION SYNDROME	0.006581483000000001	0.24657429437365502
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.006581483000000001	0.24657429437365502
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.006581483000000001	0.24657429437365502
48,XXYY SYNDROME	0.006581483000000001	0.24657429437365502
MONOSOMY 9P	0.006581483000000001	0.24657429437365502
GM2-GANGLIOSIDOSIS, AB VARIANT	0.006581483000000001	0.24657429437365502
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.006581483000000001	0.24657429437365502
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.006581483000000001	0.24657429437365502
MOSAIC TRISOMY 14	0.006581483000000001	0.24657429437365502
48,XXXY SYNDROME	0.006581483000000001	0.24657429437365502
WAISMAN SYNDROME; WSMN	0.006581483000000001	0.24657429437365502
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.006581483000000001	0.24657429437365502
L1 SYNDROME	0.006463313	0.24214707267208188
OPTIC PATHWAY GLIOMA	0.006463313	0.24214707267208188
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0061464	0.23027397365278207
MONOSOMY 5P	0.0061464	0.23027397365278207
FRONTONASAL DYSPLASIA	0.0061464	0.23027397365278207
MOSAIC TRISOMY 8	0.0061464	0.23027397365278207
ACROCRANIOFACIAL DYSOSTOSIS	0.0061464	0.23027397365278207
MESOMELIA-SYNOSTOSES SYNDROME	0.0061464	0.23027397365278207
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.0061464	0.23027397365278207
NEUROFACIODIGITORENAL SYNDROME	0.0061464	0.23027397365278207
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.0061464	0.23027397365278207
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.0061464	0.23027397365278207
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.0061464	0.23027397365278207
MCDONOUGH SYNDROME	0.0061464	0.23027397365278207
CAMPOMELIC DYSPLASIA	0.0061464	0.23027397365278207
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0061464	0.23027397365278207
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0061464	0.23027397365278207
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.0061464	0.23027397365278207
LAURENCE-MOON SYNDROME	0.0061464	0.23027397365278207
THALIDOMIDE EMBRYOPATHY	0.0061464	0.23027397365278207
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0061464	0.23027397365278207
TRISOMY 18P	0.0061464	0.23027397365278207
ERYTHROKERATODERMIA VARIABILIS	0.0061464	0.23027397365278207
DISTAL MONOSOMY 10P	0.0061464	0.23027397365278207
MONOSOMY 13Q14	0.0061464	0.23027397365278207
FEMORAL-FACIAL SYNDROME	0.0061464	0.23027397365278207
X-LINKED EHLERS-DANLOS SYNDROME	0.0061464	0.23027397365278207
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.0061464	0.23027397365278207
LARYNX ATRESIA	0.0061464	0.23027397365278207
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0061464	0.23027397365278207
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.006040064	0.22629011102387048
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.006040064	0.22629011102387048
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.006040064	0.22629011102387048
ROBERTS SYNDROME	0.006040064	0.22629011102387048
TARP SYNDROME; TARPS	0.006040064	0.22629011102387048
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.006040064	0.22629011102387048
DISTAL MONOSOMY 9P	0.006040064	0.22629011102387048
HYDROCEPHALUS, NORMAL-PRESSURE	0.006040064	0.22629011102387048
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.006040064	0.22629011102387048
TRISOMY 8Q	0.006040064	0.22629011102387048
OROFACIODIGITAL SYNDROME TYPE 4	0.006040064	0.22629011102387048
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.006040064	0.22629011102387048
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.006040064	0.22629011102387048
WEAVER SYNDROME	0.006040064	0.22629011102387048
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.006035929000000001	0.22613519385592598
FLYNN-AIRD SYNDROME	0.006035929000000001	0.22613519385592598
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.006035929000000001	0.22613519385592598
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.006035929000000001	0.22613519385592598
FLYNN-AIRD SYNDROME	0.006035929000000001	0.22613519385592598
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.006035929000000001	0.22613519385592598
HUNTINGTON DISEASE; HD	0.006035929000000001	0.22613519385592598
KALLMANN SYNDROME	0.006035929000000001	0.22613519385592598
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.006035929000000001	0.22613519385592598
DISTAL TRISOMY 15Q	0.006035929000000001	0.22613519385592598
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.006035929000000001	0.22613519385592598
KUFOR-RAKEB SYNDROME	0.006035929000000001	0.22613519385592598
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.006035929000000001	0.22613519385592598
JUVENILE HUNTINGTON DISEASE	0.006035929000000001	0.22613519385592598
ACROCALLOSAL SYNDROME; ACLS	0.006035929000000001	0.22613519385592598
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.006035929000000001	0.22613519385592598
ADRENOLEUKODYSTROPHY	0.006035929000000001	0.22613519385592598
CHOREOATHETOSIS, FAMILIAL INVERTED	0.006035929000000001	0.22613519385592598
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.006035929000000001	0.22613519385592598
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006035929000000001	0.22613519385592598
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006035929000000001	0.22613519385592598
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.006028230000000001	0.22584675195120893
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0059218940000000005	0.22186288932229734
HYDROXYKYNURENINURIA	0.0059218940000000005	0.22186288932229734
LHERMITTE-DUCLOS DISEASE	0.005917759	0.22170797215435278
LUJO HEMORRHAGIC FEVER	0.005917759	0.22170797215435278
PARIETAL FORAMINA	0.005917759	0.22170797215435278
CENTRAL DIABETES INSIPIDUS	0.005917759	0.22170797215435278
EBOLA HEMORRHAGIC FEVER	0.005917759	0.22170797215435278
PAPILLOMA OF CHOROID PLEXUS	0.005917759	0.22170797215435278
RIFT VALLEY FEVER	0.005917759	0.22170797215435278
NIPAH VIRUS DISEASE	0.005917759	0.22170797215435278
CRANIOSYNOSTOSIS 2	0.005917759	0.22170797215435278
PROLACTINOMA	0.005917759	0.22170797215435278
ACQUIRED METHEMOGLOBINEMIA	0.005917759	0.22170797215435278
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.005917759	0.22170797215435278
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.005917759	0.22170797215435278
POSTENCEPHALITIC PARKINSONISM	0.005917759	0.22170797215435278
NEUROFIBROMATOSIS, TYPE II	0.005917759	0.22170797215435278
LASSA FEVER	0.005917759	0.22170797215435278
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00549451	0.20585101050614144
DEMENTIA, LEWY BODY; DLB	0.00549451	0.20585101050614144
PHENYLKETONURIA	0.00549451	0.20585101050614144
DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	0.00549451	0.20585101050614144
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.20585101050614144
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00549451	0.20585101050614144
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00549451	0.20585101050614144
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00549451	0.20585101050614144
SCHISIS ASSOCIATION	0.00549451	0.20585101050614144
CAMPOMELIA, CUMMING TYPE	0.00549451	0.20585101050614144
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00549451	0.20585101050614144
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00549451	0.20585101050614144
HEART-HAND SYNDROME TYPE 2	0.00549451	0.20585101050614144
184705 STEINFELD SYNDROME	0.00549451	0.20585101050614144
BEEMER-ERTBRUGGEN SYNDROME	0.00549451	0.20585101050614144
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00549451	0.20585101050614144
BARTSOCAS-PAPAS SYNDROME	0.00549451	0.20585101050614144
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00549451	0.20585101050614144
NAGER SYNDROME	0.00549451	0.20585101050614144
HUNTINGTON DISEASE	0.00549451	0.20585101050614144
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.00549451	0.20585101050614144
46,XY PARTIAL GONADAL DYSGENESIS	0.00549451	0.20585101050614144
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00549451	0.20585101050614144
MARSHALL-SMITH SYNDROME	0.00549451	0.20585101050614144
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00549451	0.20585101050614144
NEUROFERRITINOPATHY	0.00549451	0.20585101050614144
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00549451	0.20585101050614144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00549451	0.20585101050614144
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00549451	0.20585101050614144
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00549451	0.20585101050614144
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.00549451	0.20585101050614144
ALZHEIMER DISEASE 2	0.00549451	0.20585101050614144
ALZHEIMER DISEASE	0.00549451	0.20585101050614144
ACHONDROGENESIS	0.00549451	0.20585101050614144
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00549451	0.20585101050614144
ACHONDROGENESIS TYPE 2	0.00549451	0.20585101050614144
ACHONDROGENESIS TYPE 1B	0.00549451	0.20585101050614144
ACHONDROGENESIS TYPE 1A	0.00549451	0.20585101050614144
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00549451	0.20585101050614144
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.00549451	0.20585101050614144
ACALVARIA	0.00549451	0.20585101050614144
HYDROLETHALUS	0.00549451	0.20585101050614144
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00549451	0.20585101050614144
HOLZGREVE SYNDROME	0.00549451	0.20585101050614144
15Q26 OVERGROWTH SYNDROME	0.00549451	0.20585101050614144
SPINOCEREBELLAR ATAXIA TYPE 2	0.00549451	0.20585101050614144
SPINOCEREBELLAR ATAXIA TYPE 12	0.00549451	0.20585101050614144
CONGENITAL DIAPHRAGMATIC HERNIA	0.00549451	0.20585101050614144
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00549451	0.20585101050614144
PRIMARY DYSTONIA, DYT4 TYPE	0.00549451	0.20585101050614144
EARLY-ONSET ALZHEIMER DISEASE WITH CEREBRAL AMYLOID ANGIOPATHY	0.00549451	0.20585101050614144
FRANK-TER HAAR SYNDROME; FTHS	0.00549451	0.20585101050614144
ISOLATED HEMIHYPERPLASIA	0.00549451	0.20585101050614144
FRASER SYNDROME	0.00549451	0.20585101050614144
MAST SYNDROME	0.00549451	0.20585101050614144
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00549451	0.20585101050614144
ADULT POLYGLUCOSAN BODY DISEASE	0.00549451	0.20585101050614144
RENAL AGENESIS, BILATERAL	0.00549451	0.20585101050614144
AUROCEPHALOSYNDACTYLY	0.00549451	0.20585101050614144
WAARDENBURG SYNDROME TYPE 1	0.00549451	0.20585101050614144
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00549451	0.20585101050614144
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.00549451	0.20585101050614144
HUNTINGTON DISEASE-LIKE 2	0.00549451	0.20585101050614144
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00549451	0.20585101050614144
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00549451	0.20585101050614144
AXENFELD-RIEGER SYNDROME	0.00549451	0.20585101050614144
SPINOCEREBELLAR ATAXIA 12	0.00549451	0.20585101050614144
HUNTINGTON DISEASE-LIKE 1	0.00549451	0.20585101050614144
PARKINSONIAN-PYRAMIDAL SYNDROME	0.00549451	0.20585101050614144
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00549451	0.20585101050614144
POPLITEAL PTERYGIUM SYNDROME	0.00549451	0.20585101050614144
TRISOMY 18-LIKE SYNDROME	0.00549451	0.20585101050614144
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00549451	0.20585101050614144
DEMENTIA, FAMILIAL DANISH	0.00549451	0.20585101050614144
MACHADO-JOSEPH DISEASE; MJD	0.00549451	0.20585101050614144
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00549451	0.20585101050614144
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00549451	0.20585101050614144
PERRY SYNDROME	0.00549451	0.20585101050614144
ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL	0.00549451	0.20585101050614144
AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA	0.00549451	0.20585101050614144
LEBER OPTIC ATROPHY AND DYSTONIA	0.00549451	0.20585101050614144
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00549451	0.20585101050614144
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00549451	0.20585101050614144
PSEUDODIASTROPHIC DYSPLASIA	0.00549451	0.20585101050614144
CAMPOMELIC DYSPLASIA	0.00549451	0.20585101050614144
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00549451	0.20585101050614144
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00549451	0.20585101050614144
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00549451	0.20585101050614144
INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	0.00549451	0.20585101050614144
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00549451	0.20585101050614144
SEMANTIC DEMENTIA	0.00549451	0.20585101050614144
VACTERL WITH HYDROCEPHALUS	0.00549451	0.20585101050614144
PRESENILE DEMENTIA, KRAEPELIN TYPE	0.00549451	0.20585101050614144
NEU-LAXOVA SYNDROME	0.00549451	0.20585101050614144
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00549451	0.20585101050614144
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.00549451	0.20585101050614144
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00549451	0.20585101050614144
CHST3-RELATED SKELETAL DYSPLASIA	0.00549451	0.20585101050614144
KUFOR-RAKEB SYNDROME	0.00549451	0.20585101050614144
UNVERRICHT-LUNDBORG DISEASE	0.00549451	0.20585101050614144
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00549451	0.20585101050614144
FACIOSCAPULOHUMERAL DYSTROPHY	0.00549451	0.20585101050614144
FAMILIAL VISCERAL MYOPATHY	0.00549451	0.20585101050614144
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.00549451	0.20585101050614144
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00549451	0.20585101050614144
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00549451	0.20585101050614144
PARKINSON DISEASE, LATE-ONSET; PD	0.00549451	0.20585101050614144
MYOPATHY AND DIABETES MELLITUS	0.00549451	0.20585101050614144
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.00549451	0.20585101050614144
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005388503	0.20187947381392965
CORNELIA DE LANGE SYNDROME 3	0.005388503	0.20187947381392965
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005388503	0.20187947381392965
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.005388503	0.20187947381392965
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.2014237888045683
BRUNNER SYNDROME; BRNRS	0.00537634	0.2014237888045683
CUTANEOUS MASTOCYTOSIS	0.00537634	0.2014237888045683
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00537634	0.2014237888045683
PITUITARY CARCINOMA	0.00537634	0.2014237888045683
MARSILI SYNDROME; MARSIS	0.00537634	0.2014237888045683
EPISODIC ATAXIA, TYPE 3	0.00537634	0.2014237888045683
IDIOPATHIC PANUVEITIS	0.00537634	0.2014237888045683
SOLAR URTICARIA	0.00537634	0.2014237888045683
PARKES WEBER SYNDROME	0.00537634	0.2014237888045683
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.2014237888045683
PRIMARY FAMILIAL POLYCYTHEMIA	0.00537634	0.2014237888045683
PARATHYROID CARCINOMA	0.00537634	0.2014237888045683
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.2014237888045683
SYDENHAM CHOREA	0.00537634	0.2014237888045683
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.2014237888045683
HODGKIN LYMPHOMA	0.00537634	0.2014237888045683
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.2014237888045683
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00537634	0.2014237888045683
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.2014237888045683
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00537634	0.2014237888045683
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.2014237888045683
PERINEURAL CYST	0.00537634	0.2014237888045683
CHIARI MALFORMATION TYPE I	0.00537634	0.2014237888045683
CUTANEOUS MASTOCYTOMA	0.00537634	0.2014237888045683
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.2014237888045683
CENTRAL NEUROCYTOMA	0.00537634	0.2014237888045683
HEMANGIOBLASTOMA	0.00537634	0.2014237888045683
TYPHOID	0.00537634	0.2014237888045683
MARBURG HEMORRHAGIC FEVER	0.00537634	0.2014237888045683
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.2014237888045683
CROUZON DISEASE	0.00537634	0.2014237888045683
TURCOT SYNDROME WITH POLYPOSIS	0.00537634	0.2014237888045683
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00537634	0.2014237888045683
EPISODIC ATAXIA TYPE 1	0.00537634	0.2014237888045683
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.2014237888045683
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00537634	0.2014237888045683
PONTIAC FEVER	0.00537634	0.2014237888045683
PRIMARY PARATHYROID HYPERPLASIA	0.00537634	0.2014237888045683
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.004933753000000001	0.18484233182535056
TRISOMY 18	0.004847084	0.18159529046414513
DYSTONIA 28, CHILDHOOD-ONSET	0.004847084	0.18159529046414513
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.004847084	0.18159529046414513
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.004847084	0.18159529046414513
NOONAN SYNDROME 7; NS7	0.004842949	0.1814403732962006
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.004842949	0.1814403732962006
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.004842949	0.1814403732962006
GM2 GANGLIOSIDOSIS, AB VARIANT	0.004842949	0.1814403732962006
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.004842949	0.1814403732962006
ZELLWEGER SYNDROME	0.004842949	0.1814403732962006
XERODERMA PIGMENTOSUM	0.004842949	0.1814403732962006
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.004842949	0.1814403732962006
ATAXIA-TELANGIECTASIA	0.004842949	0.1814403732962006
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.004842949	0.1814403732962006
DISTAL MONOSOMY 3P	0.004842949	0.1814403732962006
CANAVAN DISEASE	0.004736613000000001	0.177456510667289
TRISOMY X	0.004736613000000001	0.177456510667289
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004736613000000001	0.177456510667289
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.004736613000000001	0.177456510667289
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.004736613000000001	0.177456510667289
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.004736613000000001	0.177456510667289
FOIX-CHAVANY-MARIE SYNDROME	0.004736613000000001	0.177456510667289
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004736613000000001	0.177456510667289
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.004736613000000001	0.177456510667289
DYSTONIA-APHONIA SYNDROME	0.004736613000000001	0.177456510667289
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.004736613000000001	0.177456510667289
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.004736613	0.17745651066728899
CONGENITAL HYPOTHYROIDISM	0.004622104	0.17316644779324786
POPOV-CHANG SYNDROME; POPCHAS	0.004622104	0.17316644779324786
SENIOR-LOKEN SYNDROME	0.004622104	0.17316644779324786
HURLER SYNDROME	0.004622104	0.17316644779324786
NEUROFIBROMATOSIS, TYPE I	0.0046179689999999995	0.1730115306253033
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.004511633	0.16902766799639174
XQ21 MICRODELETION SYNDROME	0.004511633	0.16902766799639174
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.004392334	0.16455814847556602
FAMILIAL BENIGN COPPER DEFICIENCY	0.004388199000000001	0.1644032313076215
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.004388199000000001	0.1644032313076215
21Q22.11Q22.12 MICRODELETION SYNDROME	0.004388199000000001	0.1644032313076215
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.004388199000000001	0.1644032313076215
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00430153	0.16115618994641606
HIDROTIC ECTODERMAL DYSPLASIA	0.00430153	0.16115618994641606
CONGENITAL SHORT BOWEL SYNDROME	0.00430153	0.16115618994641606
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00430153	0.16115618994641606
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00430153	0.16115618994641606
SECKEL SYNDROME 4	0.00430153	0.16115618994641606
LEPRECHAUNISM	0.00430153	0.16115618994641606
DISTAL MONOSOMY 13Q	0.00430153	0.16115618994641606
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00430153	0.16115618994641606
VOGT-KOYANAGI-HARADA DISEASE	0.00430153	0.16115618994641606
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00430153	0.16115618994641606
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00430153	0.16115618994641606
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00430153	0.16115618994641606
SECKEL SYNDROME	0.00430153	0.16115618994641606
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00430153	0.16115618994641606
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00430153	0.16115618994641606
LAMELLAR ICHTHYOSIS	0.00430153	0.16115618994641606
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00430153	0.16115618994641606
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00430153	0.16115618994641606
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00430153	0.16115618994641606
MUCOLIPIDOSIS TYPE III	0.00430153	0.16115618994641606
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00430153	0.16115618994641606
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004281863	0.1604193686787099
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.004281863	0.1604193686787099
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.004281863	0.1604193686787099
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.004281863	0.1604193686787099
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.004281863	0.1604193686787099
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.004281863	0.1604193686787099
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.004281863	0.1604193686787099
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.004281863	0.1604193686787099
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.004195194	0.15717232731750447
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.004195194	0.15717232731750447
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA 5; SCA5	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.004195194	0.15717232731750447
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.004195194	0.15717232731750447
DUCHENNE MUSCULAR DYSTROPHY	0.004195194	0.15717232731750447
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.004195194	0.15717232731750447
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.004195194	0.15717232731750447
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.004195194	0.15717232731750447
BARDET-BIEDL SYNDROME 17; BBS17	0.004195194	0.15717232731750447
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.004195194	0.15717232731750447
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA TYPE 29	0.004195194	0.15717232731750447
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004195194	0.15717232731750447
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.004195194	0.15717232731750447
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.004195194	0.15717232731750447
BARDET-BIEDL SYNDROME 8; BBS8	0.004195194	0.15717232731750447
JOUBERT SYNDROME 31; JBTS31	0.004195194	0.15717232731750447
BARDET-BIEDL SYNDROME 16; BBS16	0.004195194	0.15717232731750447
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.004195194	0.15717232731750447
ENDOCARDIAL FIBROELASTOSIS	0.0041910590000000005	0.15701741014955997
CRISPONI SYNDROME	0.0041910590000000005	0.15701741014955997
PHAKOMATOSIS PIGMENTOVASCULARIS	0.0041910590000000005	0.15701741014955997
BENIGN FAMILIAL NEONATAL EPILEPSY	0.0041910590000000005	0.15701741014955997
MUSCLE-EYE-BRAIN DISEASE	0.0041910590000000005	0.15701741014955997
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0041910590000000005	0.15701741014955997
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.0041910590000000005	0.15701741014955997
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.0041910590000000005	0.15701741014955997
SYMMETRICAL THALAMIC CALCIFICATIONS	0.0041910590000000005	0.15701741014955997
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0041910590000000005	0.15701741014955997
ONDINE SYNDROME	0.0041910590000000005	0.15701741014955997
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0041910590000000005	0.15701741014955997
WORSTER-DROUGHT SYNDROME	0.0041910590000000005	0.15701741014955997
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.0041910590000000005	0.15701741014955997
PAPILLOMA OF CHOROID PLEXUS	0.0041910590000000005	0.15701741014955997
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0041910590000000005	0.15701741014955997
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0041910590000000005	0.15701741014955997
ALG2-CDG	0.0041910590000000005	0.15701741014955997
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0041910590000000005	0.15701741014955997
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0041910590000000005	0.15701741014955997
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.0041910590000000005	0.15701741014955997
MPDU1-CDG	0.0041910590000000005	0.15701741014955997
LEIGH SYNDROME	0.0041910590000000005	0.15701741014955997
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0041910590000000005	0.15701741014955997
ALG9-CDG	0.0041910590000000005	0.15701741014955997
NAIL-PATELLA-LIKE RENAL DISEASE	0.00407655	0.15272734727551882
JUVENILE PAGET DISEASE	0.00407655	0.15272734727551882
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00407655	0.15272734727551882
BARDET-BIEDL SYNDROME	0.00407655	0.15272734727551882
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00407655	0.15272734727551882
STIFF SKIN SYNDROME	0.00407655	0.15272734727551882
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00407655	0.15272734727551882
HUNTER-MACDONALD SYNDROME	0.00407655	0.15272734727551882
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.003970214	0.1487434846466072
JOUBERT SYNDROME 14	0.003970214	0.1487434846466072
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003970214	0.1487434846466072
MERCURY POISONING	0.003966079	0.14858856747866267
FAMILIAL DYSAUTONOMIA	0.003966079	0.14858856747866267
ALEXANDER DISEASE	0.003966079	0.14858856747866267
CLASSIC HOMOCYSTINURIA	0.003966079	0.14858856747866267
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.003966079	0.14858856747866267
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003966079	0.14858856747866267
PORPHYRIA	0.003966079	0.14858856747866267
PREECLAMPSIA/ECLAMPSIA 1	0.003966079	0.14858856747866267
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.003966079	0.14858856747866267
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00384678	0.14411904795783695
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00384678	0.14411904795783695
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00384678	0.14411904795783695
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00384678	0.14411904795783695
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00384678	0.14411904795783695
JOHANSON-BLIZZARD SYNDROME	0.00384678	0.14411904795783695
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003740444	0.14013518532892535
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.003740444	0.14013518532892535
HEREDITARY OROTIC ACIDURIA	0.003740444	0.14013518532892535
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.003740444	0.14013518532892535
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.003740444	0.14013518532892535
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.003740444	0.14013518532892535
NEPHRONOPHTHISIS 11; NPHP11	0.003740444	0.14013518532892535
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.003740444	0.14013518532892535
DERMOTRICHIC SYNDROME	0.003736309	0.13998026816098083
CRONKHITE-CANADA SYNDROME	0.003736309	0.13998026816098083
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.003736309	0.13998026816098083
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.003736309	0.13998026816098083
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.003736309	0.13998026816098083
HYPOPHOSPHATASIA, INFANTILE	0.003736309	0.13998026816098083
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00364964	0.13673322679977543
EARLY-ONSET SCHIZOPHRENIA	0.00364964	0.13673322679977543
PRUNE BELLY SYNDROME	0.00364964	0.13673322679977543
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00364964	0.13673322679977543
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00364964	0.13673322679977543
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00364964	0.13673322679977543
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00364964	0.13673322679977543
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00364964	0.13673322679977543
SPINOCEREBELLAR ATAXIA TYPE 21	0.00364964	0.13673322679977543
SPINOCEREBELLAR ATAXIA TYPE 14	0.00364964	0.13673322679977543
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00364964	0.13673322679977543
SCHIZOPHRENIA 19; SCZD19	0.00364964	0.13673322679977543
DK1-CDG	0.00364964	0.13673322679977543
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00364964	0.13673322679977543
NON-DISTAL TRISOMY 13Q	0.00364964	0.13673322679977543
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00364964	0.13673322679977543
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00364964	0.13673322679977543
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00364964	0.13673322679977543
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.13673322679977543
COWCHOCK SYNDROME; COWCK	0.00364964	0.13673322679977543
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.00364964	0.13673322679977543
MONOAMINE OXIDASE A DEFICIENCY	0.00364964	0.13673322679977543
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00364964	0.13673322679977543
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00364964	0.13673322679977543
RHIZOMELIC SYNDROME, URBACH TYPE	0.00364964	0.13673322679977543
DEAFNESS-HYPOGONADISM SYNDROME	0.00364964	0.13673322679977543
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00364964	0.13673322679977543
SPINOCEREBELLAR ATAXIA TYPE 32	0.00364964	0.13673322679977543
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00364964	0.13673322679977543
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00364964	0.13673322679977543
JOUBERT SYNDROME 4	0.00364964	0.13673322679977543
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00364964	0.13673322679977543
NON-DISTAL MONOSOMY 10Q	0.00364964	0.13673322679977543
SPINOCEREBELLAR ATAXIA 1	0.00364964	0.13673322679977543
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00364964	0.13673322679977543
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00364964	0.13673322679977543
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00364964	0.13673322679977543
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00364964	0.13673322679977543
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00364964	0.13673322679977543
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00364964	0.13673322679977543
MONILETHRIX	0.00364964	0.13673322679977543
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00364964	0.13673322679977543
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00364964	0.13673322679977543
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00364964	0.13673322679977543
KERATODERMA HEREDITARIUM MUTILANS	0.00364964	0.13673322679977543
DYSTONIA 16; DYT16	0.00364964	0.13673322679977543
SPINOCEREBELLAR ATAXIA 42	0.00364964	0.13673322679977543
SPINOCEREBELLAR ATAXIA 32; SCA32	0.00364964	0.13673322679977543
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00364964	0.13673322679977543
RING CHROMOSOME 1 SYNDROME	0.00364964	0.13673322679977543
ISOLATED CLOVERLEAF SKULL SYNDROME	0.00364964	0.13673322679977543
ISOLATED KLIPPEL-FEIL SYNDROME	0.00364964	0.13673322679977543
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00364964	0.13673322679977543
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.13673322679977543
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00364964	0.13673322679977543
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.00364964	0.13673322679977543
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00364964	0.13673322679977543
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00364964	0.13673322679977543
PACHYONYCHIA CONGENITA	0.00364964	0.13673322679977543
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00364964	0.13673322679977543
BARDET-BIEDL SYNDROME 5; BBS5	0.00364964	0.13673322679977543
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00364964	0.13673322679977543
BARDET-BIEDL SYNDROME 10; BBS10	0.00364964	0.13673322679977543
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.13673322679977543
ISOTRETINOIN SYNDROME	0.00364964	0.13673322679977543
BARDET-BIEDL SYNDROME 18; BBS18	0.00364964	0.13673322679977543
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00342466	0.12830438412887815
POSTERIOR URETHRAL VALVE	0.00342466	0.12830438412887815
POLYCYSTIC KIDNEY DISEASE 2	0.00342466	0.12830438412887815
LIDDLE SYNDROME 3; LIDLS3	0.00342466	0.12830438412887815
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00342466	0.12830438412887815
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00342466	0.12830438412887815
ACTH-DEPENDENT CUSHING SYNDROME	0.00342466	0.12830438412887815
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00342466	0.12830438412887815
ACTH-INDEPENDENT CUSHING SYNDROME	0.00342466	0.12830438412887815
PRIMARY LIPODYSTROPHY	0.00342466	0.12830438412887815
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00342466	0.12830438412887815
LONG QT SYNDROME 13; LQT13	0.00342466	0.12830438412887815
GANGLIONEUROMA	0.00342466	0.12830438412887815
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00342466	0.12830438412887815
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12830438412887815
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00342466	0.12830438412887815
SCALP-EAR-NIPPLE SYNDROME	0.00342466	0.12830438412887815
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00342466	0.12830438412887815
OCHOA SYNDROME	0.00342466	0.12830438412887815
RENAL AGENESIS	0.00342466	0.12830438412887815
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12830438412887815
CONGENITAL ADRENAL HYPERPLASIA	0.00342466	0.12830438412887815
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00342466	0.12830438412887815
NELSON SYNDROME	0.00342466	0.12830438412887815
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00342466	0.12830438412887815
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.00342466	0.12830438412887815
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00342466	0.12830438412887815
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12830438412887815
LIDDLE SYNDROME 1; LIDLS1	0.00342466	0.12830438412887815
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00342466	0.12830438412887815
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00342466	0.12830438412887815
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00342466	0.12830438412887815
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00342466	0.12830438412887815
LIDDLE SYNDROME 2; LIDLS2	0.00342466	0.12830438412887815
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00342466	0.12830438412887815
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00342466	0.12830438412887815
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.00342466	0.12830438412887815
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12830438412887815
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00342466	0.12830438412887815
FIBRONECTIN GLOMERULOPATHY	0.00342466	0.12830438412887815
INFANT BOTULISM	0.00342466	0.12830438412887815
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00342466	0.12830438412887815
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00342466	0.12830438412887815
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00342466	0.12830438412887815
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00342466	0.12830438412887815
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00342466	0.12830438412887815
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00342466	0.12830438412887815
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00342466	0.12830438412887815
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00342466	0.12830438412887815
TETANUS	0.00342466	0.12830438412887815
NEPHROBLASTOMA	0.00342466	0.12830438412887815
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.00342466	0.12830438412887815
CATECHOLAMINE-PRODUCING TUMOR	0.00342466	0.12830438412887815
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00342466	0.12830438412887815
PARAGANGLIOMAS 6	0.00342466	0.12830438412887815
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.00342466	0.12830438412887815
ALKAPTONURIA	0.00342466	0.12830438412887815
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00342466	0.12830438412887815
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00342466	0.12830438412887815
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00342466	0.12830438412887815
ADRENOCORTICAL CARCINOMA	0.00342466	0.12830438412887815
CUSHING SYNDROME	0.00342466	0.12830438412887815
DIAMOND-BLACKFAN ANEMIA-LIKE; DBAL	0.00319489	0.1196960848111963
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00319489	0.1196960848111963
SENIOR-LOKEN SYNDROME 1	0.00319489	0.1196960848111963
DIAMOND-BLACKFAN ANEMIA 9	0.00319489	0.1196960848111963
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00319489	0.1196960848111963
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00319489	0.1196960848111963
BAZEX SYNDROME	0.00319489	0.1196960848111963
NEPHRONOPHTHISIS	0.00319489	0.1196960848111963
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00319489	0.1196960848111963
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY	0.00319489	0.1196960848111963
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.00319489	0.1196960848111963
HEMOGLOBIN E-BETA-THALASSEMIA SYNDROME	0.00319489	0.1196960848111963
X-LINKED SIDEROBLASTIC ANEMIA	0.00319489	0.1196960848111963
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.00319489	0.1196960848111963
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.00319489	0.1196960848111963
EOSINOPHILIA, FAMILIAL	0.00319489	0.1196960848111963
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00319489	0.1196960848111963
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00319489	0.1196960848111963
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.00319489	0.1196960848111963
CASTLEMAN DISEASE	0.00319489	0.1196960848111963
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00319489	0.1196960848111963
CONGENITAL FACTOR II DEFICIENCY	0.00319489	0.1196960848111963
PEARSON SYNDROME	0.00319489	0.1196960848111963
HYDATIDIFORM MOLE	0.00319489	0.1196960848111963
HB BART'S HYDROPS FETALIS	0.00319489	0.1196960848111963
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00319489	0.1196960848111963
TUFTED ANGIOMA	0.00319489	0.1196960848111963
SANDIFER SYNDROME	0.00319489	0.1196960848111963
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.00319489	0.1196960848111963
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.00319489	0.1196960848111963
LYMPHATIC MALFORMATION 7; LMPHM7	0.00319489	0.1196960848111963
HEMOCHROMATOSIS, TYPE 2B	0.00319489	0.1196960848111963
PEUTZ-JEGHERS SYNDROME	0.00319489	0.1196960848111963
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00319489	0.1196960848111963
DIAMOND-BLACKFAN ANEMIA 20; DBA20	0.00319489	0.1196960848111963
DIAMOND-BLACKFAN ANEMIA 16	0.00319489	0.1196960848111963
HYDROPS FETALIS, NONIMMUNE	0.00319489	0.1196960848111963
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00319489	0.1196960848111963
WEISMANN-NETTER SYNDROME	0.00319489	0.1196960848111963
SENIOR-LOKEN SYNDROME 4; SLSN4	0.00319489	0.1196960848111963
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00319489	0.1196960848111963
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00319489	0.1196960848111963
FAMILIAL LONG QT SYNDROME	0.00319489	0.1196960848111963
HEMOGLOBIN--DELTA LOCUS	0.00319489	0.1196960848111963
DIAMOND-BLACKFAN ANEMIA 17	0.00319489	0.1196960848111963
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00319489	0.1196960848111963
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00319489	0.1196960848111963
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00319489	0.1196960848111963
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00319489	0.1196960848111963
OLLIER DISEASE	0.00319489	0.1196960848111963
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00319489	0.1196960848111963
GENERALIZED DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00319489	0.1196960848111963
LESCH-NYHAN SYNDROME	0.00319489	0.1196960848111963
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00319489	0.1196960848111963
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00319489	0.1196960848111963
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00319489	0.1196960848111963
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00319489	0.1196960848111963
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00319489	0.1196960848111963
FETAL CYTOMEGALOVIRUS SYNDROME	0.00319489	0.1196960848111963
DOHLE BODIES AND LEUKEMIA	0.00319489	0.1196960848111963
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00319489	0.1196960848111963
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001738863	0.06514624701415424
DISTAL MONOSOMY 1Q	0.001738863	0.06514624701415424
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001738863	0.06514624701415424
INFANTILE REFSUM DISEASE	0.001738863	0.06514624701415424
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001738863	0.06514624701415424
PRADER-WILLI-LIKE SYNDROME	0.001738863	0.06514624701415424
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001738863	0.06514624701415424
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.001738863	0.06514624701415424
OROFACIODIGITAL SYNDROME TYPE 6	0.001738863	0.06514624701415424
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.001738863	0.06514624701415424
15Q14 MICRODELETION SYNDROME	0.001738863	0.06514624701415424
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001738863	0.06514624701415424
SPINOCEREBELLAR ATAXIA TYPE 13	0.001738863	0.06514624701415424
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001738863	0.06514624701415424
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001738863	0.06514624701415424
COFFIN-SIRIS SYNDROME 1; CSS1	0.001738863	0.06514624701415424
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.001738863	0.06514624701415424
KBG SYNDROME	0.001738863	0.06514624701415424
16P13.2 MICRODELETION SYNDROME	0.001738863	0.06514624701415424
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001738863	0.06514624701415424
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001738863	0.06514624701415424
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.001738863	0.06514624701415424
NEPHROGENIC DIABETES INSIPIDUS	0.001738863	0.06514624701415424
XQ25 MICRODUPLICATION SYNDROME	0.001738863	0.06514624701415424
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001738863	0.06514624701415424
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001738863	0.06514624701415424
GENITOPATELLAR SYNDROME	0.001738863	0.06514624701415424
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001738863	0.06514624701415424
MEVALONIC ACIDURIA	0.001738863	0.06514624701415424
PRADER-WILLI SYNDROME; PWS	0.001738863	0.06514624701415424
15Q24 MICRODELETION SYNDROME	0.001738863	0.06514624701415424
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001738863	0.06514624701415424
PITUITARY STALK INTERRUPTION SYNDROME	0.001738863	0.06514624701415424
KOOLEN-DE VRIES SYNDROME	0.001738863	0.06514624701415424
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001738863	0.06514624701415424
20P12.3 MICRODELETION SYNDROME	0.001738863	0.06514624701415424
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.001738863	0.06514624701415424
WILSON-TURNER SYNDROME	0.001738863	0.06514624701415424
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001738863	0.06514624701415424
1Q21.1 MICRODELETION SYNDROME	0.001738863	0.06514624701415424
MICRO SYNDROME	0.001738863	0.06514624701415424
2Q31.1 MICRODELETION SYNDROME	0.001738863	0.06514624701415424
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001738863	0.06514624701415424
17Q12 MICRODELETION SYNDROME	0.001738863	0.06514624701415424
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001738863	0.06514624701415424
KBG SYNDROME	0.001738863	0.06514624701415424
C SYNDROME	0.001738863	0.06514624701415424
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001738863	0.06514624701415424
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001738863	0.06514624701415424
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001738863	0.06514624701415424
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001738863	0.06514624701415424
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001738863	0.06514624701415424
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001738863	0.06514624701415424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001738863	0.06514624701415424
VICI SYNDROME	0.001738863	0.06514624701415424
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001738863	0.06514624701415424
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001738863	0.06514624701415424
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001738863	0.06514624701415424
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001738863	0.06514624701415424
PIERPONT SYNDROME	0.001738863	0.06514624701415424
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.001738863	0.06514624701415424
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001738863	0.06514624701415424
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001738863	0.06514624701415424
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001738863	0.06514624701415424
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001738863	0.06514624701415424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001738863	0.06514624701415424
LUSCAN-LUMISH SYNDROME; LLS	0.001738863	0.06514624701415424
BOHRING-OPITZ SYNDROME	0.001738863	0.06514624701415424
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001738863	0.06514624701415424
CHROMOSOME 1P35 DELETION SYNDROME	0.001738863	0.06514624701415424
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001738863	0.06514624701415424
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001738863	0.06514624701415424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001738863	0.06514624701415424
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.001738863	0.06514624701415424
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001738863	0.06514624701415424
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001738863	0.06514624701415424
SCHAAF-YANG SYNDROME; SHFYNG	0.001738863	0.06514624701415424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001738863	0.06514624701415424
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001738863	0.06514624701415424
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001738863	0.06514624701415424
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001738863	0.06514624701415424
HOLOPROSENCEPHALY 1; HPE1	0.001738863	0.06514624701415424
GLYCEROL KINASE DEFICIENCY; GKD	0.001738863	0.06514624701415424
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001738863	0.06514624701415424
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001738863	0.06514624701415424
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001738863	0.06514624701415424
WIEACKER-WOLFF SYNDROME	0.001738863	0.06514624701415424
HARTNUP DISORDER	0.001738863	0.06514624701415424
CODAS SYNDROME	0.001738863	0.06514624701415424
CHROMOSOME 2Q37 DELETION SYNDROME	0.001738863	0.06514624701415424
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.001738863	0.06514624701415424
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.001738863	0.06514624701415424
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001738863	0.06514624701415424
XQ25 DUPLICATION SYNDROME	0.001738863	0.06514624701415424
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001738863	0.06514624701415424
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001738863	0.06514624701415424
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001738863	0.06514624701415424
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001738863	0.06514624701415424
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001738863	0.06514624701415424
LISSENCEPHALY 4	0.001738863	0.06514624701415424
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001738863	0.06514624701415424
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001738863	0.06514624701415424
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001738863	0.06514624701415424
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001738863	0.06514624701415424
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001738863	0.06514624701415424
GLASS SYNDROME	0.001738863	0.06514624701415424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001738863	0.06514624701415424
CHROMOSOME 10Q26 DELETION SYNDROME	0.001738863	0.06514624701415424
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001738863	0.06514624701415424
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001738863	0.06514624701415424
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001738863	0.06514624701415424
17Q11.2 MICRODUPLICATION SYNDROME	0.001738863	0.06514624701415424
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001738863	0.06514624701415424
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001738863	0.06514624701415424
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001738863	0.06514624701415424
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001738863	0.06514624701415424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001738863	0.06514624701415424
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001738863	0.06514624701415424
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001738863	0.06514624701415424
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001738863	0.06514624701415424
AL KAISSI SYNDROME; ALKAS	0.001738863	0.06514624701415424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001738863	0.06514624701415424
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001738863	0.06514624701415424
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001738863	0.06514624701415424
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001738863	0.06514624701415424
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001738863	0.06514624701415424
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001197444	0.044862063664369706
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.001197444	0.044862063664369706
NOONAN SYNDROME 3; NS3	0.001197444	0.044862063664369706
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.001197444	0.044862063664369706
14Q22Q23 MICRODELETION SYNDROME	0.001197444	0.044862063664369706
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.001197444	0.044862063664369706
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.001197444	0.044862063664369706
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001197444	0.044862063664369706
2Q32Q33 MICRODELETION SYNDROME	0.001197444	0.044862063664369706
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.001197444	0.044862063664369706
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.001197444	0.044862063664369706
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.001197444	0.044862063664369706
CARDIOFACIOCUTANEOUS SYNDROME	0.001197444	0.044862063664369706
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.001197444	0.044862063664369706
SEPTOOPTIC DYSPLASIA	0.001197444	0.044862063664369706
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001197444	0.044862063664369706
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.001197444	0.044862063664369706
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.001197444	0.044862063664369706
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.001197444	0.044862063664369706
MCKUSICK-KAUFMAN SYNDROME	0.001197444	0.044862063664369706
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.001197444	0.044862063664369706
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.001197444	0.044862063664369706
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001197444	0.044862063664369706
FORSYTHE-WAKELING SYNDROME; FWS	0.001197444	0.044862063664369706
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001197444	0.044862063664369706
CODAS SYNDROME	0.001197444	0.044862063664369706
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.001197444	0.044862063664369706
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.001197444	0.044862063664369706
NOONAN SYNDROME 11; NS11	0.001197444	0.044862063664369706
LARSEN-LIKE SYNDROME	0.001197444	0.044862063664369706
CHROMOSOME 18P DELETION SYNDROME	0.001197444	0.044862063664369706
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001197444	0.044862063664369706
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001197444	0.044862063664369706
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.001197444	0.044862063664369706
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001197444	0.044862063664369706
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001197444	0.044862063664369706
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001197444	0.044862063664369706
16P11.2P12.2 MICRODELETION SYNDROME	0.001197444	0.044862063664369706
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001197444	0.044862063664369706
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.001197444	0.044862063664369706
STEEL SYNDROME; STLS	0.001197444	0.044862063664369706
TYSHCHENKO SYNDROME	0.001197444	0.044862063664369706
FRIAS SYNDROME	0.001197444	0.044862063664369706
XQ27.3Q28 DUPLICATION SYNDROME	0.001197444	0.044862063664369706
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001197444	0.044862063664369706
HADZISELIMOVIC SYNDROME	0.001197444	0.044862063664369706
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001197444	0.044862063664369706
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.001197444	0.044862063664369706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001197444	0.044862063664369706
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001197444	0.044862063664369706
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.001197444	0.044862063664369706
NOONAN SYNDROME 6; NS6	0.001197444	0.044862063664369706
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001197444	0.044862063664369706
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.001197444	0.044862063664369706
COSTELLO SYNDROME; CSTLO	0.001197444	0.044862063664369706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.001197444	0.044862063664369706
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.001197444	0.044862063664369706
JOUBERT SYNDROME 26	0.001197444	0.044862063664369706
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001197444	0.044862063664369706
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.001197444	0.044862063664369706
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001197444	0.044862063664369706
MEIER-GORLIN SYNDROME 7	0.001197444	0.044862063664369706
THYROID HYPOPLASIA	0.001197444	0.044862063664369706
FAMILIAL THYROID DYSHORMONOGENESIS	0.001197444	0.044862063664369706
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.001197444	0.044862063664369706
ATHYREOSIS	0.001197444	0.044862063664369706
THYROID ECTOPIA	0.001197444	0.044862063664369706
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.001197444	0.044862063664369706
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.001197444	0.044862063664369706
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.001197444	0.044862063664369706
HOLMES-GANG SYNDROME	0.001197444	0.044862063664369706
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001197444	0.044862063664369706
OROFACIODIGITAL SYNDROME VI	0.001197444	0.044862063664369706
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.001197444	0.044862063664369706
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.001197444	0.044862063664369706
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.001197444	0.044862063664369706
TOLUENE EMBRYOPATHY	0.001197444	0.044862063664369706
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001197444	0.044862063664369706
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001197444	0.044862063664369706
ALAZAMI-YUAN SYNDROME	0.001197444	0.044862063664369706
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001197444	0.044862063664369706
COFFIN-SIRIS SYNDROME 6; CSS6	0.001197444	0.044862063664369706
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001197444	0.044862063664369706
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001197444	0.044862063664369706
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.001197444	0.044862063664369706
GERMAN SYNDROME	0.001197444	0.044862063664369706
MARINESCO-SJOGREN SYNDROME; MSS	0.001197444	0.044862063664369706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001197444	0.044862063664369706
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.001197444	0.044862063664369706
DE BARSY SYNDROME	0.001197444	0.044862063664369706
OXOGLUTARIC ACIDURIA	0.001197444	0.044862063664369706
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.001197444	0.044862063664369706
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001197444	0.044862063664369706
RAINE SYNDROME	0.001197444	0.044862063664369706
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001197444	0.044862063664369706
COLE-CARPENTER SYNDROME	0.001197444	0.044862063664369706
SAY-BARBER-MILLER SYNDROME	0.001197444	0.044862063664369706
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001197444	0.044862063664369706
OPTIC ATROPHY 11; OPA11	0.001197444	0.044862063664369706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.001197444	0.044862063664369706
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.001197444	0.044862063664369706
DUPLICATION OF THE PITUITARY GLAND	0.001197444	0.044862063664369706
CEREBROFACIOARTICULAR SYNDROME	0.001197444	0.044862063664369706
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.001197444	0.044862063664369706
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.001197444	0.044862063664369706
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.001197444	0.044862063664369706
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.001197444	0.044862063664369706
MENTAL RETARDATION, X-LINKED 99	0.001197444	0.044862063664369706
OTOFACIOCERVICAL SYNDROME	0.001197444	0.044862063664369706
PERMANENT CONGENITAL HYPOTHYROIDISM	0.001197444	0.044862063664369706
PRIMARY CONGENITAL HYPOTHYROIDISM	0.001197444	0.044862063664369706
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001197444	0.044862063664369706
CEREBELLOFACIODENTAL SYNDROME	0.001197444	0.044862063664369706
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.001197444	0.044862063664369706
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.001197444	0.044862063664369706
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.001197444	0.044862063664369706
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001197444	0.044862063664369706
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.001197444	0.044862063664369706
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001197444	0.044862063664369706
CULLER-JONES SYNDROME; CJS	0.001197444	0.044862063664369706
MICROPHTHALMIA, SYNDROMIC 3	0.001197444	0.044862063664369706
CRANIOFRONTONASAL SYNDROME; CFNS	0.001197444	0.044862063664369706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001197444	0.044862063664369706
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.001197444	0.044862063664369706
NOONAN SYNDROME 5; NS5	0.001197444	0.044862063664369706
SECKEL SYNDROME 8; SCKL8	0.001197444	0.044862063664369706
OCULO-PALATO-CEREBRAL SYNDROME	0.001197444	0.044862063664369706
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001197444	0.044862063664369706
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001197444	0.044862063664369706
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001197444	0.044862063664369706
COFFIN-SIRIS SYNDROME 7; CSS7	0.001197444	0.044862063664369706
SECKEL SYNDROME 9; SCKL9	0.001197444	0.044862063664369706
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.001197444	0.044862063664369706
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001197444	0.044862063664369706
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001197444	0.044862063664369706
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.001197444	0.044862063664369706
PSEUDOAMINOPTERIN SYNDROME	0.001197444	0.044862063664369706
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.001193309	0.04470714649642518
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001193309	0.04470714649642518
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001193309	0.04470714649642518
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.001193309	0.04470714649642518
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.001193309	0.04470714649642518
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.001193309	0.04470714649642518
CROME SYNDROME	0.001193309	0.04470714649642518
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001193309	0.04470714649642518
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001193309	0.04470714649642518
SPINOCEREBELLAR ATAXIA 47; SCA47	0.001193309	0.04470714649642518
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001193309	0.04470714649642518
1Q41Q42 MICRODELETION SYNDROME	0.001193309	0.04470714649642518
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.001193309	0.04470714649642518
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.001193309	0.04470714649642518
PERRAULT SYNDROME 3	0.001193309	0.04470714649642518
MICROFORM HOLOPROSENCEPHALY	0.001193309	0.04470714649642518
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001193309	0.04470714649642518
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.001193309	0.04470714649642518
FOUNTAIN SYNDROME	0.001193309	0.04470714649642518
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.001193309	0.04470714649642518
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.001193309	0.04470714649642518
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.001193309	0.04470714649642518
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001193309	0.04470714649642518
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001193309	0.04470714649642518
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.001193309	0.04470714649642518
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.001193309	0.04470714649642518
GM1 GANGLIOSIDOSIS	0.001193309	0.04470714649642518
TEMPLE-BARAITSER SYNDROME	0.001193309	0.04470714649642518
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.001193309	0.04470714649642518
MOMO SYNDROME	0.001193309	0.04470714649642518
MOYNAHAN SYNDROME	0.001193309	0.04470714649642518
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.001193309	0.04470714649642518
XP22.13P22.2 DUPLICATION SYNDROME	0.001193309	0.04470714649642518
DDOST-CDG	0.001193309	0.04470714649642518
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.001193309	0.04470714649642518
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001193309	0.04470714649642518
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.001193309	0.04470714649642518
CORNELIA DE LANGE SYNDROME	0.001193309	0.04470714649642518
2Q33.1 DELETION SYNDROME	0.001193309	0.04470714649642518
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.001193309	0.04470714649642518
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001193309	0.04470714649642518
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.001193309	0.04470714649642518
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.001193309	0.04470714649642518
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001193309	0.04470714649642518
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.001193309	0.04470714649642518
RETT SYNDROME	0.001193309	0.04470714649642518
ADRENOMYODYSTROPHY	0.001193309	0.04470714649642518
HYPOPHOSPHATASIA, CHILDHOOD	0.001193309	0.04470714649642518
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.001193309	0.04470714649642518
SANJAD-SAKATI SYNDROME	0.001193309	0.04470714649642518
GURRIERI SYNDROME	0.001193309	0.04470714649642518
SMITH-FINEMAN-MYERS SYNDROME	0.001193309	0.04470714649642518
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.001193309	0.04470714649642518
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.001193309	0.04470714649642518
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.001193309	0.04470714649642518
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001193309	0.04470714649642518
EPILEPSY-TELANGIECTASIA SYNDROME	0.001193309	0.04470714649642518
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.001193309	0.04470714649642518
SJOGREN-LARSSON SYNDROME; SLS	0.001193309	0.04470714649642518
MOWAT-WILSON SYNDROME	0.001193309	0.04470714649642518
FOUNTAIN SYNDROME	0.001193309	0.04470714649642518
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.001193309	0.04470714649642518
SIALIDOSIS TYPE 1	0.001193309	0.04470714649642518
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001193309	0.04470714649642518
AYME-GRIPP SYNDROME; AYGRP	0.001193309	0.04470714649642518
COFFIN-LOWRY SYNDROME; CLS	0.001193309	0.04470714649642518
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.001193309	0.04470714649642518
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.001193309	0.04470714649642518
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.001193309	0.04470714649642518
COFFIN-LOWRY SYNDROME	0.001193309	0.04470714649642518
2Q23.1 MICRODELETION SYNDROME	0.001193309	0.04470714649642518
ATKIN-FLAITZ SYNDROME	0.001193309	0.04470714649642518
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.001193309	0.04470714649642518
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.001193309	0.04470714649642518
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001193309	0.04470714649642518
5Q35 MICRODUPLICATION SYNDROME	0.001193309	0.04470714649642518
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001193309	0.04470714649642518
TRIPLE A SYNDROME	0.001193309	0.04470714649642518
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001193309	0.04470714649642518
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001193309	0.04470714649642518
LOWE OCULOCEREBRORENAL SYNDROME	0.001193309	0.04470714649642518
DYSEQUILIBRIUM SYNDROME	0.001193309	0.04470714649642518
HALL-RIGGS SYNDROME	0.001193309	0.04470714649642518
MENKES DISEASE	0.001193309	0.04470714649642518
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001193309	0.04470714649642518
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.001193309	0.04470714649642518
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.001193309	0.04470714649642518
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001193309	0.04470714649642518
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.04072328386751359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.04072328386751359
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.04072328386751359
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.04072328386751359
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.04072328386751359
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.04072328386751359
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.04072328386751359
DESANTO-SHINAWI SYNDROME	0.001086973	0.04072328386751359
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.04072328386751359
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.04072328386751359
DISTAL TRISOMY 17Q	0.001086973	0.04072328386751359
ANGELMAN SYNDROME	0.001086973	0.04072328386751359
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.04072328386751359
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.04072328386751359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001086973	0.04072328386751359
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.04072328386751359
20Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.04072328386751359
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.04072328386751359
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.04072328386751359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.04072328386751359
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.04072328386751359
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.04072328386751359
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.04072328386751359
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.04072328386751359
19P13.13 MICRODELETION SYNDROME	0.001086973	0.04072328386751359
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.04072328386751359
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.04072328386751359
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.04072328386751359
FUCOSIDOSIS	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.04072328386751359
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.001086973	0.04072328386751359
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001086973	0.04072328386751359
ARGININEMIA	0.001086973	0.04072328386751359
WALKER-WARBURG SYNDROME	0.001086973	0.04072328386751359
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.04072328386751359
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.04072328386751359
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.04072328386751359
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001086973	0.04072328386751359
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.04072328386751359
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.04072328386751359
RUVALCABA SYNDROME	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.04072328386751359
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.04072328386751359
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.04072328386751359
LEIGH SYNDROME; LS	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.04072328386751359
LISSENCEPHALY 8; LIS8	0.001086973	0.04072328386751359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.04072328386751359
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001086973	0.04072328386751359
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.04072328386751359
XQ28 (MECP2) DUPLICATION	0.001086973	0.04072328386751359
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.04072328386751359
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.04072328386751359
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.04072328386751359
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.04072328386751359
KETOADIPICACIDURIA	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.04072328386751359
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001086973	0.04072328386751359
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.04072328386751359
MACDERMOT-WINTER SYNDROME	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.04072328386751359
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.04072328386751359
LANDAU-KLEFFNER SYNDROME	0.001086973	0.04072328386751359
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.04072328386751359
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.04072328386751359
VICI SYNDROME; VICIS	0.001086973	0.04072328386751359
SEVERE CANAVAN DISEASE	0.001086973	0.04072328386751359
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.04072328386751359
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.04072328386751359
HEART AND BRAIN MALFORMATION SYNDROME	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.04072328386751359
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.04072328386751359
FILIPPI SYNDROME	0.001086973	0.04072328386751359
WEAVER SYNDROME	0.001086973	0.04072328386751359
STT3A-CDG	0.001086973	0.04072328386751359
SULFOCYSTEINURIA	0.001086973	0.04072328386751359
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.04072328386751359
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.04072328386751359
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.04072328386751359
PFEIFFER SYNDROME TYPE 2	0.001086973	0.04072328386751359
MEHMO SYNDROME; MEHMO	0.001086973	0.04072328386751359
ISOVALERIC ACIDEMIA	0.001086973	0.04072328386751359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001086973	0.04072328386751359
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.04072328386751359
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.04072328386751359
ELEJALDE DISEASE	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.04072328386751359
PEHO SYNDROME; PEHO	0.001086973	0.04072328386751359
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.001086973	0.04072328386751359
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.04072328386751359
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001086973	0.04072328386751359
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.04072328386751359
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.04072328386751359
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.04072328386751359
DISTAL MONOSOMY 19P13.3	0.001086973	0.04072328386751359
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.04072328386751359
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.001086973	0.04072328386751359
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.001086973	0.04072328386751359
STT3B-CDG	0.001086973	0.04072328386751359
SSR4-CDG	0.001086973	0.04072328386751359
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.04072328386751359
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001086973	0.04072328386751359
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.04072328386751359
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.04072328386751359
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.04072328386751359
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.04072328386751359
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.04072328386751359
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04072328386751359
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001086973	0.04072328386751359
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.04072328386751359
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001086973	0.04072328386751359
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.04072328386751359
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.04072328386751359
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001086973	0.04072328386751359
LISSENCEPHALY 1; LIS1	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.04072328386751359
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.001086973	0.04072328386751359
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.04072328386751359
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.04072328386751359
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.04072328386751359
MONOSOMY 9Q22.3	0.001086973	0.04072328386751359
JOUBERT SYNDROME	0.001086973	0.04072328386751359
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.04072328386751359
PYRUVATE DEHYDROGENASE DEFICIENCY	0.001086973	0.04072328386751359
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.001086973	0.04072328386751359
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.04072328386751359
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.04072328386751359
MONOSOMY 22Q13.3	0.001086973	0.04072328386751359
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.04072328386751359
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.04072328386751359
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.04072328386751359
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.04072328386751359
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.04072328386751359
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04072328386751359
LEBER CONGENITAL AMAUROSIS	0.001086973	0.04072328386751359
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.04072328386751359
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.04072328386751359
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001086973	0.04072328386751359
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.04072328386751359
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.04072328386751359
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.04072328386751359
HOLOPROSENCEPHALY 7	0.001086973	0.04072328386751359
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.04072328386751359
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.04072328386751359
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.04072328386751359
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001086973	0.04072328386751359
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.04072328386751359
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001086973	0.04072328386751359
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.04072328386751359
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.04072328386751359
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.04072328386751359
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.04072328386751359
MAPLE SYRUP URINE DISEASE	0.001086973	0.04072328386751359
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001086973	0.04072328386751359
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001086973	0.04072328386751359
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.04072328386751359
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.04072328386751359
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.04072328386751359
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.04072328386751359
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.04072328386751359
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001086973	0.04072328386751359
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.04072328386751359
SCHINDLER DISEASE, TYPE I	0.001086973	0.04072328386751359
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.04072328386751359
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.04072328386751359
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.04072328386751359
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.04072328386751359
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.04072328386751359
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.04072328386751359
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.04072328386751359
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.04072328386751359
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.04072328386751359
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.04072328386751359
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.04072328386751359
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.04072328386751359
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.04072328386751359
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.04072328386751359
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.04072328386751359
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.04072328386751359
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.04072328386751359
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.04072328386751359
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.04072328386751359
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.04072328386751359
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.04072328386751359
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001086973	0.04072328386751359
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.04072328386751359
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.04072328386751359
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.04072328386751359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.04072328386751359
SIMPSON-GOLABI-BEHMEL SYNDROME	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.04072328386751359
PETTIGREW SYNDROME	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.04072328386751359
HSD10 DISEASE	0.001086973	0.04072328386751359
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.04072328386751359
DPAGT1-CDG	0.001086973	0.04072328386751359
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.04072328386751359
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.04072328386751359
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.04072328386751359
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.04072328386751359
MAN1B1-CDG	0.001086973	0.04072328386751359
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.04072328386751359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.04072328386751359
SALLA DISEASE	0.001086973	0.04072328386751359
LATHOSTEROLOSIS	0.001086973	0.04072328386751359
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.04072328386751359
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.04072328386751359
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.001086973	0.04072328386751359
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.04072328386751359
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.04072328386751359
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.04072328386751359
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.04072328386751359
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.04072328386751359
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.04072328386751359
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.04072328386751359
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.04072328386751359
MUENKE SYNDROME	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.04072328386751359
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.04072328386751359
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.04072328386751359
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.04072328386751359
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.04072328386751359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.04072328386751359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.04072328386751359
GRISCELLI SYNDROME TYPE 1	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.04072328386751359
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.04072328386751359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.04072328386751359
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.04072328386751359
SCHIZENCEPHALY	0.001086973	0.04072328386751359
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.04072328386751359
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.04072328386751359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.04072328386751359
11Q22.2Q22.3 MICRODELETION SYNDROME	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.04072328386751359
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.04072328386751359
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.04072328386751359
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.04072328386751359
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001086973	0.04072328386751359
ALG3-CDG	0.001086973	0.04072328386751359
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.04072328386751359
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.04072328386751359
CK SYNDROME	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.04072328386751359
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.04072328386751359
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.04072328386751359
PITT-HOPKINS SYNDROME	0.001086973	0.04072328386751359
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.04072328386751359
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001086973	0.04072328386751359
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.04072328386751359
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001086973	0.04072328386751359
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001086973	0.04072328386751359
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.04072328386751359
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.04072328386751359
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.04072328386751359
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.04072328386751359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.04072328386751359
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.04072328386751359
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.04072328386751359
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.04072328386751359
19P13.12 MICRODELETION SYNDROME	0.001086973	0.04072328386751359
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.04072328386751359
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001086973	0.04072328386751359
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.04072328386751359
2P21 MICRODELETION SYNDROME	0.001086973	0.04072328386751359
ARGININOSUCCINIC ACIDURIA	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.04072328386751359
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.04072328386751359
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.04072328386751359
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.04072328386751359
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.04072328386751359
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.04072328386751359
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001086973	0.04072328386751359
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.04072328386751359
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.04072328386751359
TARP SYNDROME	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.04072328386751359
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.04072328386751359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.04072328386751359
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.04072328386751359
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.04072328386751359
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.04072328386751359
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001086973	0.04072328386751359
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.04072328386751359
EAST SYNDROME	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.04072328386751359
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.04072328386751359
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.04072328386751359
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001086973	0.04072328386751359
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.04072328386751359
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.04072328386751359
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.04072328386751359
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.04072328386751359
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.04072328386751359
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.04072328386751359
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.04072328386751359
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.04072328386751359
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001086973	0.04072328386751359
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.04072328386751359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.04072328386751359
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.04072328386751359
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.04072328386751359
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.04072328386751359
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.04072328386751359
DONNAI-BARROW SYNDROME	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.04072328386751359
RING CHROMOSOME 22 SYNDROME	0.001086973	0.04072328386751359
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.04072328386751359
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001086973	0.04072328386751359
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.04072328386751359
XP21 MICRODELETION SYNDROME	0.001086973	0.04072328386751359
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.04072328386751359
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.04072328386751359
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.04072328386751359
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.04072328386751359
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001086973	0.04072328386751359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.04072328386751359
ALG11-CDG	0.001086973	0.04072328386751359
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00065189	0.024422963146640657
SHORT FIFTH METACARPALS-INSULIN RESISTANCE SYNDROME	0.00065189	0.024422963146640657
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00065189	0.024422963146640657
BRUCK SYNDROME 2	0.00065189	0.024422963146640657
CEREBROCOSTOMANDIBULAR SYNDROME	0.00065189	0.024422963146640657
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00065189	0.024422963146640657
DYSOSTOSIS WITH BRACHYDACTYLY	0.00065189	0.024422963146640657
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00065189	0.024422963146640657
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00065189	0.024422963146640657
OSTEOGENESIS IMPERFECTA	0.00065189	0.024422963146640657
COXOAURICULAR SYNDROME	0.00065189	0.024422963146640657
CATEL-MANZKE SYNDROME	0.00065189	0.024422963146640657
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00065189	0.024422963146640657
HYALURONIDASE DEFICIENCY	0.00065189	0.024422963146640657
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00065189	0.024422963146640657
CORNEODERMATOOSSEOUS SYNDROME	0.00065189	0.024422963146640657
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00065189	0.024422963146640657
BIEMOND SYNDROME II	0.00065189	0.024422963146640657
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00065189	0.024422963146640657
EIKEN SYNDROME	0.00065189	0.024422963146640657
MASA SYNDROME	0.00065189	0.024422963146640657
SECKEL SYNDROME 2; SCKL2	0.00065189	0.024422963146640657
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00065189	0.024422963146640657
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00065189	0.024422963146640657
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00065189	0.024422963146640657
TARSAL-CARPAL COALITION SYNDROME	0.00065189	0.024422963146640657
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00065189	0.024422963146640657
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00065189	0.024422963146640657
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00065189	0.024422963146640657
608028 THAI SYMPHALANGISM SYNDROME	0.00065189	0.024422963146640657
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00065189	0.024422963146640657
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00065189	0.024422963146640657
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00065189	0.024422963146640657
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00065189	0.024422963146640657
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00065189	0.024422963146640657
NIEMANN-PICK DISEASE, TYPE B	0.00065189	0.024422963146640657
BIEMOND SYNDROME TYPE 2	0.00065189	0.024422963146640657
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00065189	0.024422963146640657
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.024422963146640657
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00065189	0.024422963146640657
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00065189	0.024422963146640657
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00065189	0.024422963146640657
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00065189	0.024422963146640657
SPONDYLOOCULAR SYNDROME; SOS	0.00065189	0.024422963146640657
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00065189	0.024422963146640657
CLEIDOCRANIAL DYSPLASIA	0.00065189	0.024422963146640657
RING CHROMOSOME 7 SYNDROME	0.00065189	0.024422963146640657
CEREBROFACIOTHORACIC DYSPLASIA	0.00065189	0.024422963146640657
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00065189	0.024422963146640657
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00065189	0.024422963146640657
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00065189	0.024422963146640657
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00065189	0.024422963146640657
RING CHROMOSOME 6 SYNDROME	0.00065189	0.024422963146640657
PFEIFFER SYNDROME	0.00065189	0.024422963146640657
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00065189	0.024422963146640657
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.024422963146640657
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00065189	0.024422963146640657
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00065189	0.024422963146640657
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.024422963146640657
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00065189	0.024422963146640657
SAGLIKER SYNDROME	0.00065189	0.024422963146640657
MELNICK-NEEDLES SYNDROME	0.00065189	0.024422963146640657
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00065189	0.024422963146640657
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00065189	0.024422963146640657
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00065189	0.024422963146640657
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00065189	0.024422963146640657
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00065189	0.024422963146640657
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00065189	0.024422963146640657
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.024422963146640657
HAIRY ELBOWS	0.00065189	0.024422963146640657
BARTTER SYNDROME	0.00065189	0.024422963146640657
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00065189	0.024422963146640657
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.024422963146640657
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00065189	0.024422963146640657
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00065189	0.024422963146640657
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00065189	0.024422963146640657
BRANCHIOGENIC DEAFNESS SYNDROME	0.00065189	0.024422963146640657
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00065189	0.024422963146640657
AROMATASE EXCESS SYNDROME	0.00065189	0.024422963146640657
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00065189	0.024422963146640657
AURICULOOSTEODYSPLASIA	0.00065189	0.024422963146640657
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00065189	0.024422963146640657
BRACHYDACTYLY, TYPE E2; BDE2	0.00065189	0.024422963146640657
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00065189	0.024422963146640657
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00065189	0.024422963146640657
TEMPLE SYNDROME	0.00065189	0.024422963146640657
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00065189	0.024422963146640657
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00065189	0.024422963146640657
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00065189	0.024422963146640657
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00065189	0.024422963146640657
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00065189	0.024422963146640657
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00065189	0.024422963146640657
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00065189	0.024422963146640657
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.024422963146640657
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00065189	0.024422963146640657
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00065189	0.024422963146640657
HYPOPHOSPHATEMIC BONE DISEASE	0.00065189	0.024422963146640657
FEINGOLD SYNDROME 2; FGLDS2	0.00065189	0.024422963146640657
STICKLER SYNDROME, TYPE V; STL5	0.00065189	0.024422963146640657
HYPERTELORISM, TEEBI TYPE; TBHS	0.00065189	0.024422963146640657
SECKEL SYNDROME 5; SCKL5	0.00065189	0.024422963146640657
MARTSOLF SYNDROME	0.00065189	0.024422963146640657
ALOPECIA ANTIBODY DEFICIENCY	0.00065189	0.024422963146640657
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00065189	0.024422963146640657
MULIBREY NANISM	0.00065189	0.024422963146640657
FRAXE INTELLECTUAL DISABILITY	0.00065189	0.024422963146640657
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00065189	0.024422963146640657
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00065189	0.024422963146640657
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00065189	0.024422963146640657
METAPHYSEAL ANADYSPLASIA	0.00065189	0.024422963146640657
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00065189	0.024422963146640657
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00065189	0.024422963146640657
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00065189	0.024422963146640657
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00065189	0.024422963146640657
ACROGERIA	0.00065189	0.024422963146640657
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00065189	0.024422963146640657
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00065189	0.024422963146640657
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00065189	0.024422963146640657
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00065189	0.024422963146640657
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00065189	0.024422963146640657
EXOSTOSES, MULTIPLE, TYPE II	0.00065189	0.024422963146640657
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00065189	0.024422963146640657
EXOSTOSES, MULTIPLE, TYPE I	0.00065189	0.024422963146640657
MULTIMINICORE MYOPATHY	0.00065189	0.024422963146640657
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00065189	0.024422963146640657
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00065189	0.024422963146640657
SHELDON-HALL SYNDROME	0.00065189	0.024422963146640657
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00065189	0.024422963146640657
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00065189	0.024422963146640657
NOONAN SYNDROME 4; NS4	0.00065189	0.024422963146640657
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.00065189	0.024422963146640657
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00065189	0.024422963146640657
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00065189	0.024422963146640657
ACROCAPITOFEMORAL DYSPLASIA	0.00065189	0.024422963146640657
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00065189	0.024422963146640657
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00065189	0.024422963146640657
LATERAL MENINGOCELE SYNDROME	0.00065189	0.024422963146640657
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00065189	0.024422963146640657
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00065189	0.024422963146640657
MIRROR POLYDACTYLY-VERTEBRAL SEGMENTATION-LIMBS DEFECTS SYNDROME	0.00065189	0.024422963146640657
STIFF SKIN SYNDROME	0.00065189	0.024422963146640657
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00065189	0.024422963146640657
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00065189	0.024422963146640657
MACS SYNDROME	0.00065189	0.024422963146640657
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00065189	0.024422963146640657
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00065189	0.024422963146640657
ATKIN-FLAITZ SYNDROME	0.00065189	0.024422963146640657
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00065189	0.024422963146640657
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00065189	0.024422963146640657
THREE M SYNDROME 2; 3M2	0.00065189	0.024422963146640657
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00065189	0.024422963146640657
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00065189	0.024422963146640657
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00065189	0.024422963146640657
BALLER-GEROLD SYNDROME	0.00065189	0.024422963146640657
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00065189	0.024422963146640657
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00065189	0.024422963146640657
BLOOM SYNDROME	0.00065189	0.024422963146640657
BONNEMANN-MEINECKE-REICH SYNDROME	0.00065189	0.024422963146640657
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00065189	0.024422963146640657
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00065189	0.024422963146640657
MARSHALL SYNDROME	0.00065189	0.024422963146640657
BRANCHIO-OCULO-FACIAL SYNDROME	0.00065189	0.024422963146640657
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00065189	0.024422963146640657
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.024422963146640657
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00065189	0.024422963146640657
MULTIPLE METAPHYSEAL DYSPLASIA	0.00065189	0.024422963146640657
HURLER-SCHEIE SYNDROME	0.00065189	0.024422963146640657
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00065189	0.024422963146640657
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00065189	0.024422963146640657
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00065189	0.024422963146640657
CHUDLEY-LOWRY-HOAR SYNDROME	0.00065189	0.024422963146640657
JUBERG-MARSIDI SYNDROME	0.00065189	0.024422963146640657
CARPENTER-WAZIRI SYNDROME	0.00065189	0.024422963146640657
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00065189	0.024422963146640657
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.00065189	0.024422963146640657
SPONDYLOPERIPHERAL DYSPLASIA	0.00065189	0.024422963146640657
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00065189	0.024422963146640657
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00065189	0.024422963146640657
SONODA SYNDROME	0.00065189	0.024422963146640657
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00065189	0.024422963146640657
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00065189	0.024422963146640657
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00065189	0.024422963146640657
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00065189	0.024422963146640657
SACCHAROPINURIA	0.00065189	0.024422963146640657
RODRIGUES BLINDNESS	0.00065189	0.024422963146640657
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00065189	0.024422963146640657
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00065189	0.024422963146640657
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00065189	0.024422963146640657
DISTAL TRISOMY 5Q	0.00065189	0.024422963146640657
WERNER SYNDROME; WRN	0.00065189	0.024422963146640657
BRACHYDACTYLY TYPE A4	0.00065189	0.024422963146640657
THORACOPELVIC DYSOSTOSIS	0.00065189	0.024422963146640657
BRACHYDACTYLY TYPE A1	0.00065189	0.024422963146640657
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00065189	0.024422963146640657
MENTAL RETARDATION, X-LINKED 84	0.00065189	0.024422963146640657
MENTAL RETARDATION, X-LINKED 45	0.00065189	0.024422963146640657
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00065189	0.024422963146640657
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00065189	0.024422963146640657
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.00065189	0.024422963146640657
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00065189	0.024422963146640657
MENTAL RETARDATION, X-LINKED 2	0.00065189	0.024422963146640657
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00065189	0.024422963146640657
ABRUZZO-ERICKSON SYNDROME	0.00065189	0.024422963146640657
EEC SYNDROME	0.00065189	0.024422963146640657
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00065189	0.024422963146640657
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00065189	0.024422963146640657
FETAL METHYLMERCURY SYNDROME	0.00065189	0.024422963146640657
BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.024422963146640657
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00065189	0.024422963146640657
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00065189	0.024422963146640657
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00065189	0.024422963146640657
DENT DISEASE 1	0.00065189	0.024422963146640657
PELVISCAPULAR DYSPLASIA	0.00065189	0.024422963146640657
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	0.00065189	0.024422963146640657
BRACHYDACTYLY TYPE C	0.00065189	0.024422963146640657
BRACHYDACTYLY TYPE E	0.00065189	0.024422963146640657
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.024422963146640657
RAPADILINO SYNDROME	0.00065189	0.024422963146640657
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00065189	0.024422963146640657
PYGMY	0.00065189	0.024422963146640657
MUCOLIPIDOSIS III ALPHA/BETA	0.00065189	0.024422963146640657
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00065189	0.024422963146640657
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00065189	0.024422963146640657
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00065189	0.024422963146640657
FRYNS-SMEETS-THIRY SYNDROME	0.00065189	0.024422963146640657
NEUTRAL LIPID STORAGE MYOPATHY	0.00065189	0.024422963146640657
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00065189	0.024422963146640657
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00065189	0.024422963146640657
CAT-EYE SYNDROME (TYPE I)	0.00065189	0.024422963146640657
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00065189	0.024422963146640657
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00065189	0.024422963146640657
MYOTONIA PERMANENS	0.00065189	0.024422963146640657
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00065189	0.024422963146640657
GEMIGNANI SYNDROME	0.00065189	0.024422963146640657
3MC SYNDROME 3	0.00065189	0.024422963146640657
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00065189	0.024422963146640657
245800 LAURENCE-MOON SYNDROME	0.00065189	0.024422963146640657
GLAUCOMA-ECTOPIA LENTIS-MICROSPHEROPHAKIA-STIFF JOINTS-SHORT STATURE SYNDROME	0.00065189	0.024422963146640657
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00065189	0.024422963146640657
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00065189	0.024422963146640657
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00065189	0.024422963146640657
ACROCRANIOFACIAL DYSOSTOSIS	0.00065189	0.024422963146640657
ERMINE PHENOTYPE	0.00065189	0.024422963146640657
FREEMAN-SHELDON SYNDROME	0.00065189	0.024422963146640657
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00065189	0.024422963146640657
TIBIAL HEMIMELIA-POLYSYNDACTYLY-TRIPHALANGEAL THUMB SYNDROME	0.00065189	0.024422963146640657
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00065189	0.024422963146640657
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00065189	0.024422963146640657
GLYCOGEN STORAGE DISEASE IXB	0.00065189	0.024422963146640657
260150 PALANT CLEFT PALATE SYNDROME	0.00065189	0.024422963146640657
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.024422963146640657
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00065189	0.024422963146640657
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00065189	0.024422963146640657
PRIMROSE SYNDROME; PRIMS	0.00065189	0.024422963146640657
OROFACIODIGITAL SYNDROME IV; OFD4	0.00065189	0.024422963146640657
SMITH-MAGENIS SYNDROME	0.00065189	0.024422963146640657
OCULOPALATOCEREBRAL SYNDROME	0.00065189	0.024422963146640657
FEMUR-FIBULA-ULNA COMPLEX	0.00065189	0.024422963146640657
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00065189	0.024422963146640657
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00065189	0.024422963146640657
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00065189	0.024422963146640657
FIBROCHONDROGENESIS	0.00065189	0.024422963146640657
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00065189	0.024422963146640657
22Q11.2 DISTAL DELETION SYNDROME	0.00065189	0.024422963146640657
15Q24 RECURRENT MICRODELETION SYNDROME	0.00065189	0.024422963146640657
NASODIGITOACOUSTIC SYNDROME	0.00065189	0.024422963146640657
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00065189	0.024422963146640657
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00065189	0.024422963146640657
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00065189	0.024422963146640657
CHROMOSOME XP11.3 DELETION SYNDROME	0.00065189	0.024422963146640657
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00065189	0.024422963146640657
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00065189	0.024422963146640657
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00065189	0.024422963146640657
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00065189	0.024422963146640657
THUMB DEFORMITY AND ALOPECIA	0.00065189	0.024422963146640657
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00065189	0.024422963146640657
KENNERKNECHT SYNDROME	0.00065189	0.024422963146640657
600736 VELOFACIOSKELETAL SYNDROME	0.00065189	0.024422963146640657
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00065189	0.024422963146640657
SATOYOSHI SYNDROME	0.00065189	0.024422963146640657
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00065189	0.024422963146640657
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00065189	0.024422963146640657
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00065189	0.024422963146640657
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00065189	0.024422963146640657
WARBURG MICRO SYNDROME 1	0.00065189	0.024422963146640657
EIKEN SYNDROME	0.00065189	0.024422963146640657
DISTAL MONOSOMY 17Q	0.00065189	0.024422963146640657
WIDOW'S PEAK SYNDROME	0.00065189	0.024422963146640657
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.024422963146640657
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00065189	0.024422963146640657
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.00065189	0.024422963146640657
SPASTIC PARAPARESIS AND DEAFNESS	0.00065189	0.024422963146640657
DYSSPONDYLOENCHONDROMATOSIS	0.00065189	0.024422963146640657
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00065189	0.024422963146640657
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00065189	0.024422963146640657
MAFFUCCI SYNDROME	0.00065189	0.024422963146640657
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00065189	0.024422963146640657
SPINAL DYSPLASIA, ANHALT TYPE	0.00065189	0.024422963146640657
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00065189	0.024422963146640657
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.024422963146640657
LEGG-CALVÉ-PERTHES DISEASE	0.00065189	0.024422963146640657
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00065189	0.024422963146640657
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00065189	0.024422963146640657
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00065189	0.024422963146640657
CONGENITAL LARYNGEAL WEB	0.00065189	0.024422963146640657
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00065189	0.024422963146640657
COOPER-JABS SYNDROME	0.00065189	0.024422963146640657
RHYNS SYNDROME; RHYNS	0.00065189	0.024422963146640657
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00065189	0.024422963146640657
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00065189	0.024422963146640657
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00065189	0.024422963146640657
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00065189	0.024422963146640657
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00065189	0.024422963146640657
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00065189	0.024422963146640657
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00065189	0.024422963146640657
COXOAURICULAR SYNDROME	0.00065189	0.024422963146640657
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00065189	0.024422963146640657
CRANIODIAPHYSEAL DYSPLASIA	0.00065189	0.024422963146640657
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.024422963146640657
CRANIOFACIAL DYSSYNOSTOSIS	0.00065189	0.024422963146640657
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00065189	0.024422963146640657
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00065189	0.024422963146640657
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00065189	0.024422963146640657
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00065189	0.024422963146640657
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00065189	0.024422963146640657
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00065189	0.024422963146640657
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00065189	0.024422963146640657
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00065189	0.024422963146640657
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.024422963146640657
X-LINKED HYPOPHOSPHATEMIA	0.00065189	0.024422963146640657
AURICULOOSTEODYSPLASIA	0.00065189	0.024422963146640657
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.024422963146640657
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00065189	0.024422963146640657
FRONTOFACIONASAL DYSPLASIA	0.00065189	0.024422963146640657
PERIPHERAL DYSOSTOSIS	0.00065189	0.024422963146640657
DYSOSTOSIS, STANESCU TYPE	0.00065189	0.024422963146640657
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00065189	0.024422963146640657
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00065189	0.024422963146640657
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00065189	0.024422963146640657
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00065189	0.024422963146640657
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00065189	0.024422963146640657
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.00065189	0.024422963146640657
MENTAL RETARDATION, X-LINKED 92	0.00065189	0.024422963146640657
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00065189	0.024422963146640657
LOWRY-WOOD SYNDROME	0.00065189	0.024422963146640657
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.024422963146640657
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00065189	0.024422963146640657
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.024422963146640657
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00065189	0.024422963146640657
WAGR SYNDROME	0.00065189	0.024422963146640657
DYSOSTEOSCLEROSIS	0.00065189	0.024422963146640657
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00065189	0.024422963146640657
FOCAL DERMAL HYPOPLASIA; FDH	0.00065189	0.024422963146640657
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00065189	0.024422963146640657
XP22.3 MICRODELETION SYNDROME	0.00065189	0.024422963146640657
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00065189	0.024422963146640657
ISOLATED OSTEOPOIKILOSIS	0.00065189	0.024422963146640657
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00065189	0.024422963146640657
ODONTOCHONDRODYSPLASIA	0.00065189	0.024422963146640657
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00065189	0.024422963146640657
ARGININOSUCCINIC ACIDURIA	0.00065189	0.024422963146640657
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00065189	0.024422963146640657
TOWNES-BROCKS SYNDROME	0.00065189	0.024422963146640657
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00065189	0.024422963146640657
TRISOMY XQ28	0.00065189	0.024422963146640657
NATIVE AMERICAN MYOPATHY	0.00065189	0.024422963146640657
BRACHYDACTYLY, TYPE A6	0.00065189	0.024422963146640657
MASA SYNDROME	0.00065189	0.024422963146640657
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00065189	0.024422963146640657
CHARGE-LIKE SYNDROME, X-LINKED	0.00065189	0.024422963146640657
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00065189	0.024422963146640657
TRISOMY 5P	0.00065189	0.024422963146640657
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00065189	0.024422963146640657
TETRASOMY 12P	0.00065189	0.024422963146640657
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00065189	0.024422963146640657
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00065189	0.024422963146640657
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00065189	0.024422963146640657
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00065189	0.024422963146640657
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00065189	0.024422963146640657
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00065189	0.024422963146640657
HIRSCHSPRUNG DISEASE	0.00065189	0.024422963146640657
SAY SYNDROME	0.00065189	0.024422963146640657
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00065189	0.024422963146640657
ULNAR-MAMMARY SYNDROME	0.00065189	0.024422963146640657
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00065189	0.024422963146640657
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00065189	0.024422963146640657
GORDON SYNDROME	0.00065189	0.024422963146640657
GOLDENHAR SYNDROME	0.00065189	0.024422963146640657
RUVALCABA SYNDROME	0.00065189	0.024422963146640657
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00065189	0.024422963146640657
XYLT1-CDG	0.00065189	0.024422963146640657
ACRODERMATITIS ENTEROPATHICA	0.00065189	0.024422963146640657
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00065189	0.024422963146640657
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00065189	0.024422963146640657
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00065189	0.024422963146640657
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00065189	0.024422963146640657
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00065189	0.024422963146640657
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00065189	0.024422963146640657
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00065189	0.024422963146640657
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00065189	0.024422963146640657
SHOX-RELATED SHORT STATURE	0.00065189	0.024422963146640657
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00065189	0.024422963146640657
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00065189	0.024422963146640657
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00065189	0.024422963146640657
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00065189	0.024422963146640657
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00065189	0.024422963146640657
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00065189	0.024422963146640657
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00065189	0.024422963146640657
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00065189	0.024422963146640657
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00065189	0.024422963146640657
COSTELLO SYNDROME	0.00065189	0.024422963146640657
NATHALIE SYNDROME	0.00065189	0.024422963146640657
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00065189	0.024422963146640657
LEGG-CALVE-PERTHES DISEASE	0.00065189	0.024422963146640657
13Q12.3 MICRODELETION SYNDROME	0.00065189	0.024422963146640657
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00065189	0.024422963146640657
OVARIAN DYSGENESIS 5; ODG5	0.00065189	0.024422963146640657
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00065189	0.024422963146640657
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00065189	0.024422963146640657
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00065189	0.024422963146640657
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00065189	0.024422963146640657
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00065189	0.024422963146640657
SATOYOSHI SYNDROME	0.00065189	0.024422963146640657
LOEYS-DIETZ SYNDROME 5	0.00065189	0.024422963146640657
ANAUXETIC DYSPLASIA 2; ANXD2	0.00065189	0.024422963146640657
PROGEROID SYNDROME, PETTY TYPE	0.00065189	0.024422963146640657
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00065189	0.024422963146640657
RICHIERI COSTA-DA SILVA SYNDROME	0.00065189	0.024422963146640657
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00065189	0.024422963146640657
GMS SYNDROME	0.00065189	0.024422963146640657
SHPRINTZEN OMPHALOCELE SYNDROME	0.00065189	0.024422963146640657
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00065189	0.024422963146640657
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.00065189	0.024422963146640657
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00065189	0.024422963146640657
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00065189	0.024422963146640657
OVARIAN DYSGENESIS 4; ODG4	0.00065189	0.024422963146640657
RUIJS-AALFS SYNDROME; RJALS	0.00065189	0.024422963146640657
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00065189	0.024422963146640657
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00065189	0.024422963146640657
PRECOCIOUS PUBERTY, CENTRAL	0.00065189	0.024422963146640657
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00065189	0.024422963146640657
PARANA HARD SKIN SYNDROME	0.00065189	0.024422963146640657
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00065189	0.024422963146640657
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.024422963146640657
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00065189	0.024422963146640657
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00065189	0.024422963146640657
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00065189	0.024422963146640657
STÜVE-WIEDEMANN SYNDROME	0.00065189	0.024422963146640657
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.024422963146640657
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00065189	0.024422963146640657
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00065189	0.024422963146640657
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00065189	0.024422963146640657
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00065189	0.024422963146640657
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00065189	0.024422963146640657
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00065189	0.024422963146640657
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.024422963146640657
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00065189	0.024422963146640657
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00065189	0.024422963146640657
OROFACIODIGITAL SYNDROME XVII	0.00065189	0.024422963146640657
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00065189	0.024422963146640657
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00065189	0.024422963146640657
9P13 MICRODELETION SYNDROME	0.00065189	0.024422963146640657
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00065189	0.024422963146640657
SHORT STATURE, BRUSSELS TYPE	0.00065189	0.024422963146640657
CLASSIC MULTIMINICORE MYOPATHY	0.00065189	0.024422963146640657
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00065189	0.024422963146640657
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00065189	0.024422963146640657
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00065189	0.024422963146640657
RADIAL-RENAL SYNDROME	0.00065189	0.024422963146640657
BRUCK SYNDROME	0.00065189	0.024422963146640657
TEMPLE SYNDROME	0.00065189	0.024422963146640657
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00065189	0.024422963146640657
CHITAYAT SYNDROME	0.00065189	0.024422963146640657
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00065189	0.024422963146640657
IMMUNODEFICIENCY 58; IMD58	0.00065189	0.024422963146640657
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00065189	0.024422963146640657
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00065189	0.024422963146640657
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00065189	0.024422963146640657
NEURALGIC AMYOTROPHY	0.00065189	0.024422963146640657
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00065189	0.024422963146640657
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00065189	0.024422963146640657
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00065189	0.024422963146640657
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00065189	0.024422963146640657
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00065189	0.024422963146640657
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00065189	0.024422963146640657
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00065189	0.024422963146640657
MICROTRIPLICATION 11Q24.1	0.00065189	0.024422963146640657
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00065189	0.024422963146640657
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00065189	0.024422963146640657
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00065189	0.024422963146640657
VELO-FACIAL-SKELETAL SYNDROME	0.00065189	0.024422963146640657
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00065189	0.024422963146640657
URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.024422963146640657
STIMMLER SYNDROME	0.00065189	0.024422963146640657
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00065189	0.024422963146640657
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00065189	0.024422963146640657
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00065189	0.024422963146640657
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00065189	0.024422963146640657
ACROOTOOCULAR SYNDROME	0.00065189	0.024422963146640657
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00065189	0.024422963146640657
PSEUDOPROGERIA SYNDROME	0.00065189	0.024422963146640657
HYPOPHOSPHATEMIC RICKETS	0.00065189	0.024422963146640657
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00065189	0.024422963146640657
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00065189	0.024422963146640657
RING CHROMOSOME Y SYNDROME	0.00065189	0.024422963146640657
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00065189	0.024422963146640657
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00065189	0.024422963146640657
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00065189	0.024422963146640657
PELVIS-SHOULDER DYSPLASIA	0.00065189	0.024422963146640657
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00065189	0.024422963146640657
NOONAN SYNDROME 8; NS8	0.00065189	0.024422963146640657
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00065189	0.024422963146640657
JOUBERT SYNDROME 28	0.000545554	0.020439100517729052
CHAR SYNDROME	0.000545554	0.020439100517729052
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020439100517729052
ISOLATED PLAGIOCEPHALY	0.000545554	0.020439100517729052
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.020439100517729052
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.020439100517729052
TRISOMY 9P	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020439100517729052
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020439100517729052
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.020439100517729052
N SYNDROME	0.000545554	0.020439100517729052
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020439100517729052
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.020439100517729052
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020439100517729052
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020439100517729052
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.020439100517729052
CDAGS SYNDROME	0.000545554	0.020439100517729052
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020439100517729052
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020439100517729052
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.020439100517729052
JOUBERT SYNDROME 27	0.000545554	0.020439100517729052
ALG6-CDG	0.000545554	0.020439100517729052
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.020439100517729052
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020439100517729052
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.020439100517729052
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020439100517729052
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020439100517729052
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020439100517729052
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020439100517729052
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020439100517729052
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020439100517729052
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020439100517729052
AL-RAQAD SYNDROME; ARS	0.000545554	0.020439100517729052
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.020439100517729052
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.020439100517729052
LATERAL MENINGOCELE SYNDROME	0.000545554	0.020439100517729052
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020439100517729052
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020439100517729052
CURRY-JONES SYNDROME	0.000545554	0.020439100517729052
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.020439100517729052
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.020439100517729052
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020439100517729052
MECKEL SYNDROME 13; MKS13	0.000545554	0.020439100517729052
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020439100517729052
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.020439100517729052
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020439100517729052
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020439100517729052
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020439100517729052
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020439100517729052
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020439100517729052
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020439100517729052
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.020439100517729052
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020439100517729052
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020439100517729052
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020439100517729052
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.020439100517729052
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020439100517729052
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020439100517729052
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020439100517729052
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020439100517729052
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020439100517729052
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020439100517729052
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020439100517729052
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.020439100517729052
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.020439100517729052
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020439100517729052
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020439100517729052
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020439100517729052
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020439100517729052
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020439100517729052
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020439100517729052
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020439100517729052
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020439100517729052
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.020439100517729052
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020439100517729052
JOUBERT SYNDROME 15	0.000545554	0.020439100517729052
FRONTOOCULAR SYNDROME	0.000545554	0.020439100517729052
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020439100517729052
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020439100517729052
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020439100517729052
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020439100517729052
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020439100517729052
MOSAIC TRISOMY 9	0.000545554	0.020439100517729052
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020439100517729052
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.020439100517729052
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020439100517729052
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020439100517729052
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020439100517729052
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020439100517729052
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020439100517729052
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.020439100517729052
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020439100517729052
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020439100517729052
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.020439100517729052
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020439100517729052
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
EVEN-PLUS SYNDROME	0.000545554	0.020439100517729052
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020439100517729052
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020439100517729052
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020439100517729052
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020439100517729052
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.020439100517729052
TREACHER-COLLINS SYNDROME	0.000545554	0.020439100517729052
HYPERTRICHOSIS CUBITI	0.000545554	0.020439100517729052
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020439100517729052
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020439100517729052
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020439100517729052
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020439100517729052
LAMB-SHAFFER SYNDROME	0.000545554	0.020439100517729052
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.020439100517729052
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020439100517729052
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020439100517729052
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020439100517729052
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020439100517729052
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020439100517729052
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.020439100517729052
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.020439100517729052
BARATELA-SCOTT SYNDROME	0.000545554	0.020439100517729052
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.020439100517729052
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020439100517729052
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020439100517729052
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.020439100517729052
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020439100517729052
2P15P16.1 MICRODELETION SYNDROME	0.000545554	0.020439100517729052
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.020439100517729052
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020439100517729052
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020439100517729052
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020439100517729052
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020439100517729052
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.020439100517729052
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.020439100517729052
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.020439100517729052
FRIED SYNDROME	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020439100517729052
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.020439100517729052
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020439100517729052
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.020439100517729052
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020439100517729052
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020439100517729052
AUSTRALIA ANTIGEN	0.000545554	0.020439100517729052
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.020439100517729052
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020439100517729052
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020439100517729052
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.020439100517729052
LOWRY-MACLEAN SYNDROME	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020439100517729052
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020439100517729052
AU-KLINE SYNDROME; AUKS	0.000545554	0.020439100517729052
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.020439100517729052
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020439100517729052
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000545554	0.020439100517729052
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.020439100517729052
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020439100517729052
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020439100517729052
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020439100517729052
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020439100517729052
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020439100517729052
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020439100517729052
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.020439100517729052
JOUBERT SYNDROME 25	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020439100517729052
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020439100517729052
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020439100517729052
USHER SYNDROME TYPE 1	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020439100517729052
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020439100517729052
BRESEK SYNDROME	0.000545554	0.020439100517729052
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020439100517729052
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.020439100517729052
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.020439100517729052
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020439100517729052
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020439100517729052
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020439100517729052
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020439100517729052
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.020439100517729052
JOUBERT SYNDROME 1	0.000545554	0.020439100517729052
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020439100517729052
JOUBERT SYNDROME 24	0.000545554	0.020439100517729052
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.020439100517729052
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020439100517729052
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020439100517729052
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020439100517729052
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020439100517729052
3MC SYNDROME 2	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020439100517729052
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020439100517729052
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020439100517729052
XIA-GIBBS SYNDROME	0.000545554	0.020439100517729052
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.020439100517729052
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020439100517729052
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020439100517729052
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.020439100517729052
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020439100517729052
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.020439100517729052
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020439100517729052
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.020439100517729052
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020439100517729052
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020439100517729052
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020439100517729052
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.020439100517729052
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.020439100517729052
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020439100517729052
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.020439100517729052
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020439100517729052
MONOSOMY 13Q34	0.000545554	0.020439100517729052
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020439100517729052
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020439100517729052
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020439100517729052
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.020439100517729052
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.020439100517729052
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020439100517729052
JAWAD SYNDROME	0.000545554	0.020439100517729052
RAHMAN SYNDROME	0.000545554	0.020439100517729052
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020439100517729052
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.020439100517729052
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 6	0.000545554	0.020439100517729052
OPITZ G/BBB SYNDROME	0.000545554	0.020439100517729052
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020439100517729052
PELLAGRA-LIKE SYNDROME	0.000545554	0.020439100517729052
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020439100517729052
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020439100517729052
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020439100517729052
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 8	0.000545554	0.020439100517729052
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020439100517729052
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020439100517729052
CHAR SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 21	0.000545554	0.020439100517729052
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.020439100517729052
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.020439100517729052
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020439100517729052
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020439100517729052
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020439100517729052
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.020439100517729052
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020439100517729052
MIETENS SYNDROME	0.000545554	0.020439100517729052
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.020439100517729052
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020439100517729052
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020439100517729052
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.020439100517729052
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020439100517729052
JOUBERT SYNDROME 7	0.000545554	0.020439100517729052
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.020439100517729052
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.020439100517729052
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020439100517729052
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020439100517729052
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020439100517729052
ZEBRA BODY MYOPATHY	0.000545554	0.020439100517729052
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020439100517729052
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020439100517729052
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020439100517729052
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020439100517729052
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020439100517729052
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020439100517729052
ATELOSTEOGENESIS TYPE III	0.000545554	0.020439100517729052
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020439100517729052
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.020439100517729052
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020439100517729052
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020439100517729052
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020439100517729052
MARDEN-WALKER SYNDROME	0.000545554	0.020439100517729052
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.020439100517729052
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.020439100517729052
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020439100517729052
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.020439100517729052
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.020439100517729052
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020439100517729052
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.020439100517729052
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020439100517729052
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.020439100517729052
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.020439100517729052
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
BARDET-BIEDL SYNDROME 2	0.000545554	0.020439100517729052
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.020439100517729052
THYROID HEMIAGENESIS	0.000545554	0.020439100517729052
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020439100517729052
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020439100517729052
ZECHI-CEIDE SYNDROME	0.000545554	0.020439100517729052
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.020439100517729052
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020439100517729052
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020439100517729052
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020439100517729052
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020439100517729052
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.020439100517729052
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020439100517729052
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020439100517729052
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020439100517729052
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.020439100517729052
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020439100517729052
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.020439100517729052
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.020439100517729052
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.020439100517729052
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020439100517729052
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020439100517729052
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020439100517729052
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020439100517729052
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.020439100517729052
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020439100517729052
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.020439100517729052
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020439100517729052
HOLOPROSENCEPHALY 11	0.000545554	0.020439100517729052
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020439100517729052
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020439100517729052
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.020439100517729052
AURICULOCONDYLAR SYNDROME	0.000545554	0.020439100517729052
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.020439100517729052
DISTAL MONOSOMY 6P	0.000545554	0.020439100517729052
TURNPENNY-FRY SYNDROME; TPFS	0.000545554	0.020439100517729052
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020439100517729052
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020439100517729052
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020439100517729052
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.020439100517729052
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020439100517729052
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.02028418334978453
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.02028418334978453
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.02028418334978453
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.02028418334978453
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.02028418334978453
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.02028418334978453
RENPENNING SYNDROME	0.000541419	0.02028418334978453
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02028418334978453
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.02028418334978453
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.02028418334978453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.02028418334978453
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.02028418334978453
ISOLATED BILIARY ATRESIA	0.000541419	0.02028418334978453
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.02028418334978453
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.02028418334978453
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.02028418334978453
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.02028418334978453
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.02028418334978453
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.000541419	0.02028418334978453
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.02028418334978453
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.02028418334978453
ATYPICAL RETT SYNDROME	0.000541419	0.02028418334978453
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.02028418334978453
CLARK-BARAITSER SYNDROME	0.000541419	0.02028418334978453
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.02028418334978453
1P36 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.02028418334978453
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.02028418334978453
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.02028418334978453
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.02028418334978453
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02028418334978453
RAMON SYNDROME	0.000541419	0.02028418334978453
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.02028418334978453
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.02028418334978453
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.02028418334978453
CYSTATHIONINURIA	0.000541419	0.02028418334978453
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.02028418334978453
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.02028418334978453
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.02028418334978453
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.02028418334978453
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.02028418334978453
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.02028418334978453
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.02028418334978453
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.02028418334978453
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.02028418334978453
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.02028418334978453
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.02028418334978453
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.02028418334978453
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.02028418334978453
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.02028418334978453
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.02028418334978453
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.02028418334978453
ALEXANDER DISEASE	0.000541419	0.02028418334978453
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.02028418334978453
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.02028418334978453
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.02028418334978453
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.02028418334978453
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02028418334978453
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.02028418334978453
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.02028418334978453
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.02028418334978453
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.02028418334978453
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.02028418334978453
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.02028418334978453
HYPERPROLINEMIA, TYPE II	0.000541419	0.02028418334978453
NON-DISTAL MONOSOMY 20Q	0.000541419	0.02028418334978453
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.02028418334978453
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.02028418334978453
HADDAD SYNDROME	0.000541419	0.02028418334978453
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.02028418334978453
COG8-CDG	0.000541419	0.02028418334978453
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.02028418334978453
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.02028418334978453
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.02028418334978453
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.02028418334978453
MARDEN-WALKER SYNDROME	0.000541419	0.02028418334978453
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.02028418334978453
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.02028418334978453
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.02028418334978453
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.02028418334978453
FILIPPI SYNDROME; FLPIS	0.000541419	0.02028418334978453
THREONINEMIA	0.000541419	0.02028418334978453
PARTINGTON SYNDROME	0.000541419	0.02028418334978453
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.02028418334978453
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.02028418334978453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.02028418334978453
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.02028418334978453
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.02028418334978453
CONGENITAL HYDROCEPHALUS	0.000541419	0.02028418334978453
FRONTAL ENCEPHALOCELE	0.000541419	0.02028418334978453
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.02028418334978453
FRYNS SYNDROME	0.000541419	0.02028418334978453
PFEIFFER SYNDROME TYPE 3	0.000541419	0.02028418334978453
PHENYLKETONURIA	0.000541419	0.02028418334978453
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.02028418334978453
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.02028418334978453
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.02028418334978453
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.02028418334978453
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.02028418334978453
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.02028418334978453
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000541419	0.02028418334978453
SECONDARY SYRINGOMYELIA	0.000541419	0.02028418334978453
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.02028418334978453
PORENCEPHALY	0.000541419	0.02028418334978453
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.02028418334978453
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.02028418334978453
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.02028418334978453
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.02028418334978453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.02028418334978453
KIFAFA SEIZURE DISORDER	0.000541419	0.02028418334978453
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02028418334978453
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.02028418334978453
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.02028418334978453
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.02028418334978453
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.02028418334978453
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02028418334978453
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02028418334978453
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.02028418334978453
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.02028418334978453
XYLOSIDASE DEFICIENCY	0.000541419	0.02028418334978453
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02028418334978453
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.02028418334978453
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.02028418334978453
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.02028418334978453
20P13 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.02028418334978453
HEREDITARY HYPEREKPLEXIA	0.000541419	0.02028418334978453
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.02028418334978453
GITELMAN SYNDROME	0.000541419	0.02028418334978453
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.02028418334978453
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.02028418334978453
HYPER-BETA-ALANINEMIA	0.000541419	0.02028418334978453
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.02028418334978453
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02028418334978453
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.02028418334978453
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.02028418334978453
LISSENCEPHALY 3; LIS3	0.000541419	0.02028418334978453
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02028418334978453
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.02028418334978453
OCULODENTODIGITAL DYSPLASIA	0.000541419	0.02028418334978453
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.02028418334978453
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.02028418334978453
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.02028418334978453
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02028418334978453
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.02028418334978453
DIAMINOPENTANURIA	0.000541419	0.02028418334978453
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.02028418334978453
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.02028418334978453
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02028418334978453
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.02028418334978453
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.02028418334978453
LIPOID PROTEINOSIS	0.000541419	0.02028418334978453
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.02028418334978453
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.02028418334978453
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02028418334978453
BETA-MANNOSIDOSIS	0.000541419	0.02028418334978453
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.02028418334978453
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.02028418334978453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.02028418334978453
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.02028418334978453
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.02028418334978453
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.02028418334978453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.02028418334978453
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.02028418334978453
AICA-RIBOSIDURIA	0.000541419	0.02028418334978453
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.02028418334978453
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.02028418334978453
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.02028418334978453
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.02028418334978453
STURGE-WEBER SYNDROME	0.000541419	0.02028418334978453
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.02028418334978453
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.02028418334978453
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.02028418334978453
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.02028418334978453
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.02028418334978453
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.02028418334978453
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.02028418334978453
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.02028418334978453
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02028418334978453
NEVUS COMEDONICUS SYNDROME	0.000541419	0.02028418334978453
DYSOSTEOSCLEROSIS	0.000541419	0.02028418334978453
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.02028418334978453
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.02028418334978453
CENTRONUCLEAR MYOPATHY	0.000541419	0.02028418334978453
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.02028418334978453
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.02028418334978453
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.02028418334978453
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.02028418334978453
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.02028418334978453
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.02028418334978453
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.02028418334978453
EPILEPSY, READING	0.000541419	0.02028418334978453
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.02028418334978453
PITT-HOPKINS SYNDROME	0.000541419	0.02028418334978453
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.02028418334978453
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.02028418334978453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.02028418334978453
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.02028418334978453
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.02028418334978453
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.02028418334978453
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.02028418334978453
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.02028418334978453
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02028418334978453
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.02028418334978453
LISSENCEPHALY 5; LIS5	0.000541419	0.02028418334978453
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.02028418334978453
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02028418334978453
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.02028418334978453
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.02028418334978453
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.02028418334978453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.02028418334978453
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.02028418334978453
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.02028418334978453
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.02028418334978453
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.02028418334978453
14Q12 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.02028418334978453
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.02028418334978453
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.02028418334978453
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.02028418334978453
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.02028418334978453
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.02028418334978453
SECKEL SYNDROME 7; SCKL7	0.000541419	0.02028418334978453
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.02028418334978453
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.02028418334978453
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.02028418334978453
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.02028418334978453
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.02028418334978453
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.02028418334978453
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.02028418334978453
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.02028418334978453
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.02028418334978453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.02028418334978453
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.02028418334978453
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.02028418334978453
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.02028418334978453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.02028418334978453
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.02028418334978453
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.02028418334978453
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.02028418334978453
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.02028418334978453
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.02028418334978453
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.02028418334978453
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.02028418334978453
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.02028418334978453
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.02028418334978453
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.02028418334978453
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02028418334978453
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.02028418334978453
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.02028418334978453
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.02028418334978453
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.02028418334978453
ROMANO-WARD SYNDROME	0.000541419	0.02028418334978453
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.02028418334978453
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.02028418334978453
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.02028418334978453
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.02028418334978453
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.02028418334978453
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.02028418334978453
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.02028418334978453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.02028418334978453
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.02028418334978453
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.02028418334978453
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.02028418334978453
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.02028418334978453
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.02028418334978453
CAMOS SYNDROME	0.000541419	0.02028418334978453
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.02028418334978453
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02028418334978453
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.02028418334978453
MEHMO SYNDROME	0.000541419	0.02028418334978453
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.02028418334978453
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.02028418334978453
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.02028418334978453
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.02028418334978453
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.02028418334978453
2Q24 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.02028418334978453
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.02028418334978453
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.02028418334978453
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.02028418334978453
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.02028418334978453
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.02028418334978453
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.02028418334978453
AUTISM	0.000541419	0.02028418334978453
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.02028418334978453
KNOBLOCH SYNDROME	0.000541419	0.02028418334978453
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.02028418334978453
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.02028418334978453
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.02028418334978453
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.02028418334978453
47,XYY SYNDROME	0.000541419	0.02028418334978453
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.02028418334978453
POTOCKI-SHAFFER SYNDROME	0.000541419	0.02028418334978453
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.02028418334978453
PORPHYRIA VARIEGATA	0.000541419	0.02028418334978453
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.02028418334978453
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.02028418334978453
TYROSINEMIA TYPE 2	0.000541419	0.02028418334978453
EPILEPSY-TELANGIECTASIA	0.000541419	0.02028418334978453
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.02028418334978453
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.02028418334978453
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.02028418334978453
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.02028418334978453
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.02028418334978453
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.000541419	0.02028418334978453
IMMUNODEFICIENCY 47	0.000541419	0.02028418334978453
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.02028418334978453
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.02028418334978453
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.02028418334978453
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.02028418334978453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.02028418334978453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.02028418334978453
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.02028418334978453
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.02028418334978453
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02028418334978453
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02028418334978453
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02028418334978453
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.02028418334978453
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.02028418334978453
DUPLICATION/INVERSION 15Q11	0.000541419	0.02028418334978453
TETRASOMY 18P	0.000541419	0.02028418334978453
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.02028418334978453
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.02028418334978453
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.02028418334978453
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.02028418334978453
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.02028418334978453
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.000541419	0.02028418334978453
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.02028418334978453
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02028418334978453
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.02028418334978453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.02028418334978453
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.02028418334978453
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.02028418334978453
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.000541419	0.02028418334978453
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.02028418334978453
RING CHROMOSOME 10 SYNDROME	0.000541419	0.02028418334978453
FRYNS SYNDROME; FRNS	0.000541419	0.02028418334978453
DARIER-WHITE DISEASE; DAR	0.000541419	0.02028418334978453
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.02028418334978453
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.02028418334978453
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02028418334978453
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.02028418334978453
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.02028418334978453
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.02028418334978453
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.02028418334978453
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02028418334978453
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02028418334978453
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.02028418334978453
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.02028418334978453
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.02028418334978453
ANGELMAN SYNDROME	0.000541419	0.02028418334978453
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.02028418334978453
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.02028418334978453
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.02028418334978453
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.02028418334978453
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.02028418334978453
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.02028418334978453
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.02028418334978453
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.02028418334978453
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.02028418334978453
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.02028418334978453
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.02028418334978453
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.02028418334978453
CROUZON SYNDROME	0.000541419	0.02028418334978453
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.02028418334978453
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.02028418334978453
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.02028418334978453
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.02028418334978453
CHIME SYNDROME	0.000541419	0.02028418334978453
MOGS-CDG	0.000541419	0.02028418334978453
PAPILLORENAL SYNDROME	0.000541419	0.02028418334978453
DPM1-CDG	0.000541419	0.02028418334978453
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.02028418334978453
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.02028418334978453
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02028418334978453
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.02028418334978453
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.02028418334978453
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.02028418334978453
GALACTOSIALIDOSIS	0.000541419	0.02028418334978453
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02028418334978453
HEREDITARY COPROPORPHYRIA	0.000541419	0.02028418334978453
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.02028418334978453
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.02028418334978453
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.02028418334978453
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.02028418334978453
EPISODIC ATAXIA TYPE 3	0.000541419	0.02028418334978453
DEND SYNDROME	0.000541419	0.02028418334978453
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.02028418334978453
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.02028418334978453
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.02028418334978453
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.02028418334978453
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02028418334978453
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02028418334978453
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02028418334978453
4Q21 MICRODELETION SYNDROME	0.000541419	0.02028418334978453
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.02028418334978453
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02028418334978453
